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Abstract 
Magnocellular neurones (MCNs) are capable of secreting vasopressin and oxytocin 
from the somato-dendritic compartment, which can occur independently to secretion 
from nerve terminals.  One hypothesis of the mechanism that regulates this 
differential release is that dendrites utilise different vesicle pools compared to those 
found in terminals.   
 
Little is known for the function of neuronal dendrites, especially the mechanism for 
peptide release.  One theory is that vesicles stored in dendrites are non-released 
vesicles ready for recycling or degradation.  Immunofluorescent labelling was 
performed on hypothalamic slices of the transgenic rat where enhanced green 
fluorescent protein (eGFP) was tagged to vasopressin.  Lysosomes were detected by 
the lysosome-associated membrane protein LAMP1.  Correlation analysis of LAMP1 
labelling and VP-eGFP had shown that localisation of lysosomes in dendrites is 
positively correlated to loci of high vasopressin expression.  This suggests active 
degradation of vesicles in dendrites. 
 
It is not known whether preferential release of peptides occurs along the profile of 
dendrites.   Experiments were carried out using a temperature block to block exit of 
vesicles from the Golgi apparatus.  Release of the temperature block triggered release 
of a wave of newly synthesised vesicles from the Golgi apparatus.  Measurement of 
the fluorescent intensity of VP-eGFP showed that preferential release of peptides 
does not occur along the profile of dendrites.  
 
I have also utilised confocal live cell imaging to study the dynamics of dendritic 
vasopressin release using VP-eGFP slice explants.  Experiments using high 
potassium stimulation showed significant increase in the release of vasopressin after 
priming with thapsigargin (intracellular calcium mobiliser), in accordance to in vitro 
release and microdialysis studies.  These results demonstrate that live cell imaging 
can be achieved in magnocellular neurons, providing a robust model system in the 
study of dendritic peptide release. 
 
Large dense core vesicles (LDCVs) in other cell types such as bovine adrenal 
chromaffin cells were shown to segregate according to vesicle age, suggesting that 
vesicle age is an important factor in the regulation of peptide release.  Whether 
vesicles of different age groups exist in magnocellular dendrites is not known.  Thus, 
biolistic transfection with exogenous fluorescent proteins for expression under 
temporal control was carried out.  However, low transfection rate in magnocellular 
neurones and the high background fluorescence caused by scattered gold particles 
used as bullets for transfection deemed this method inappropriate for the purpose of 
imaging vesicles.  Hence, development of an adenoviral transduction system was 
employed.  By using an inducible adenovirus gene construct coupled with a 
fluorescent reporter gene, it is possible to visualise vesicle pool segregation under 
different experimental conditions.   Subcloning of a red fluorescent construct tagged 
to ppANF was tested on PC12 cells to show targeting of fluorescence expression to 
LDCVs. Successful production of an inducible adenoviral DNA with the red 
fluorescent construct insert was confirmed by PCR and DNA sequencing.  Whilst the 
generation of viral particles is still to be achieved, successful production of the virus 
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Neurons transmit information via the release of neurotransmitters and 
neuromodulators.  Neurons also communicate with each other via synapses.  
Classical synapses connect axons from one neuron to dendrites of another, where 
information is passed on through neurotransmission.  In classical neurotransmission, 
dendrites have always been regarded as the “receiving” end of neurons in that they 
receive information from axonal afferent terminals and relay the information to the 
cell body.  Ramon Cajal (Cajal 1891) proposed that information flows in a 
unidirectional manner from dendrites towards the soma and then along the axons.  
This concept still applies to most of the information processing in neurons, but there 
is strong evidence that electrical signals not only travel from dendrites towards the 
cell body, but can be generated in dendrites and propagate from the soma into the 
dendrite (Stuart et al. 1997).  There is also evidence that dendrites can release neuro-
active substances like those found in the nerve terminals.  Studies on the dendrites of 
dopaminergic neurons in the substantia nigra (Cheramy et al. 1981; Conde 1992; 
Pucak & Grace 1994) demonstrated that their dendrites release dopamine, and the 
main functions of dendritic dopamine release is auto-regulation, modulation of 
neurotransmitter release from afferent terminals and modulation of activity in 
adjacent cells (Cheramy et al. 1981; Conde 1992; Pucak & Grace 1994).   
 
Dendritic peptide release from magnocellular neurons is amongst the most 
extensively studied. Magnocellular neurons can be described as vasopressinergic or 
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oxytocinergic, depending on which of either of the two hormones they synthesise and 
release.  Both hormones are released into the peripheral circulation via the posterior 
pituitary.  Vasopressin is best known for its antidiuretic properties (Bankir 2001) 
whilst oxytocin is crucial in lactation and believed to play a role in parturition 
(Luckman et al. 1993; Lee et al. 2008).  Oxytocin also acts on OT receptors in the 
kidneys and induce natriuresis (Verbalis & Dohanics 1991).  Early studies using in 
vitro preparations of the supraoptic nucleus (SON) and the paraventricular nucleus 
(PVN) of the hypothalamus have shown vasopressin and oxytocin release from these 
hypothalamic nuclei (Moos et al. 1984).  Further studies found in vivo oxytocin 
release in the SON during the milk ejection reflex (Moos et al. 1989).  Vasopressin 
release in the SON and the PVN has also been measured in vivo in response to 
osmotic stimulation (Landgraf & Ludwig 1991).  The SON is made up of 
vasopressin- and oxytocin-expressing magnocellular neurons and axons of these 
neurons all project to the posterior pituitary, leaving the soma and dendrites in the 
nucleus.  This anatomical arrangement suggested that vasopressin and oxytocin 
release in the SON came from release from either the soma or the dendrites, or both, 
of magnocellular neurons. The PVN contains vasopressin- and oxytocin-releasing 
magnocellular neurons as well as parvocellular neurons, which secrete other neuro-
active peptides such as corticotrophin-releasing hormone (CRH), thyrotropin-
releasing hormone (TRH) and vasopressin.  Moreover, the PVN receives 
vasopressinergic inputs from the suprachiasmatic nucleus (SCN) (Kalsbeek et al. 
1993).  This makes it difficult to study dendritic vasopressin release in the PVN.  
Hence, the SON is often used as a model system to study the mechanisms of 
dendritic release.  This chapter aims to introduce the vasopressin and oxytocin 
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systems, focussing on the regulation, physiological significance, and mechanisms of 
dendritic peptide release of magnocellular neurons.   
 
 
1.1 The Vasopressin and Oxytocin Systems 
1.1.1 Architecture of the Vasopressin and Oxytocin Systems 
Vasopressin-expressing magnocellular neurons are located in the ventral part of the 
SON and more medial part of the PVN and oxytocin-expressing neurons are located 
in the dorsal part of the SON and lateral part of the PVN (see Figure 1-1 for 
immunohistochemical staining of vasopressin and oxytocin in the hypothalamus).  
Magnocellular neurons have large cell bodies (20 – 40 µm in diameter) which 
contain one to three dendrites (Armstrong et al. 1982; Dyball & Kemplay 1982).  
Vasopressin and oxytocin producing neurons in the SON generally have a single 
axon that projects to the posterior pituitary terminating on capillaries where peptides 
are released into the blood stream (Fisher et al. 1979).  The magnocellular neurons in 
the PVN have the same morphology but their dendrites project to the parvocellular 
part of the PVN, towards the third ventricle (Armstrong et al. 1980).  Axons of 
magnocellular neurons in the PVN also terminate in the neural lobe (Alonso & 
Assenmacher 1981).  The parvocellular neurons in the PVN project to the median 
eminence (Vandesande et al. 1977), nucleus tractus solitaries (NTS), brain stem and 
spinal cord (Swanson & Sawchenko 1983), and limbic area (Buijs & Swaab 1979).  
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For the purpose of this thesis, the introduction is going to focus on vasopressin- and 
oxytocin-expressing magnocellular neurons in the SON. 
 
Magnocellular neurons have very simple dendritic morphology and dendrites 
generally contain few dendritic spines (Armstrong 1995).  Branching in dendrites 
was also found to be rare.  Vasopressin and oxytocin dendrites have the same 
morphological properties in the SON and in the PVN.  Dendrites of SON neurons 
extend ventrally and run adjacent to the ventral glial lamina for hundreds of 
micrometers providing extensive coverage of the brain surface and contact to 
cerebrospinal fluid (CSF) (Morris 2005). Along the profile of dendrites, large 
dilations were found to be filled with secretory vesicles (Sofroniew & Glasmann 
1981) although vesicles are also contained in undilated parts.  Figure 1-2 shows the 
morphology of vasopressin-expressing magnocellular neurons in the SON. 
 
1.1.2 Actions of Vasopressin and Oxytocin 
Peripheral actions of vasopressin mainly include osmoregulation (Bankir 2001; Inoue 
et al. 2001; Bourque 1998) and blood pressure regulation (Aisenbrey et al. 1981).  
Osmoregulation is mediated through activation of Vasopressin-2 (V2) receptors 
found in the distal convoluted tubules and collecting ducts in the kidneys (Bankir 
2001).  Activation of Vasopressin-1a (V1a) receptors mediates vasoconstriction 
(Aisenbrey et al. 1981).  Oxytocin is important in parturition (Luckman et al. 1993) 
and lactation (Lee et al. 2008)).  Figure 1-3 shows the downstream signalling 
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pathways of the VP and OT receptors.  Actions of oxytocin are mediated through 
activation of oxytocin receptors found in the myometrium and mammary smooth 
muscles (Gimpl & Fahrenholz 2001).  In the brain, vasopressin affects the regulation 
of aggression in male and female rats (Caldwell et al. 2008b; Nephew & Bridges 
2008), facilitation of pair bonding in prairie voles (Cho et al. 1999; Insel et al. 1994), 
regulation of the stress axis via control of adrenocorticotropic hormone (ACTH) 
release (Aguilera & Rabadan-Diehl 2000), and regulation of circadian rhythm (Buijs 
et al. 2003).  The V1a receptor is the most abundant vasopressin receptor found in the 
brain (Zingg 1996).  V1b receptors are mainly found in the adenohypophysis and its 
main function is to stimulate secretion of ACTH from the anterior pituitary (Volpi et 
al. 2004).  Oxytocin acting on oxytocin receptors in the brain is involved in the 
regulation of maternal behaviour (Fahrbach et al. 1985; Pedersen & Prange, Jr. 
1979), sexual behaviour (Caldwell & Moe 1999; Melis et al. 2007), pair bonding 
(Insel & Hulihan 1995) and aggression (Bosch et al. 2005; DeVries et al. 1997; 
Winslow et al. 2000) in both male and female rats, facilitation of social memory in 
mice and humans (Lee et al. 2008; Rimmele et al. 2009), and regulation of stress and 
anxiety (Ring et al. 2006; Windle et al. 1997).  Since vasopressin and oxytocin 
released from the posterior pituitary enter the blood stream and do not cross the 
blood-brain barrier (Ermisch et al. 1993), the peptides found in CSF are a result of 
central release in the brain.  Sources of central release are the parvocellular 
vasopressin and oxytocin neurons of the PVN, vasopressin neurons in the SCN, and 
magnocellular soma and dendrites of the PVN and SON.  Concentrations of both 
peptides have been found to be high in CSF, indicating possible functions of peptides 
in the brain (reviewed in (Leng & Ludwig 2008).  Also, both vasopressin and 
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oxytocin receptors are expressed throughout the brain (Caldwell et al. 2008a; Gimpl 
& Fahrenholz 2001).   Vasopressin released from the parvocellular neurons 
stimulates ACTH release from the anterior pituitary by acting on V1b receptors (for 
review see (Antoni 1993) and acts as an important regulator of stress (Aguilera & 
Rabadan-Diehl 2000).  The suprachiasmatic vasopressin neuron also projects 
centrally to the PVN and releases vasopressin in a diurnal rhythm (Kalsbeek et al. 
1993; Kalsbeek et al. 1995).  Parvocellular oxytocin neurons mainly project to the 
brain stem and spinal cord and there, they are involved in the regulation of 
behaviours such as penile erection and yawning (Kita et al. 2006; Gimpl & 
Fahrenholz 2001) as well as modulation of nociception (Gerardo et al. 2010) via 
actions on oxytocin receptors.  However, these are the main sites of parvocellular 
neuronal projection and innervations of other sites in the brain where vasopressin and 
oxytocin receptors are expressed are sparse.   Vasopressin and oxytocin release from 
magnocellular neurones in the PVN is particularly important in the modulation of 
stress and anxiety-related behavioural response and also maternal behaviour in 
pregnant rats (Neumann et al. 2000; Neumann 2007).  Magnocellular neurons 
contain a large resource of vasopressin and oxytocin, where most of their peptides 
are stored in the soma and in dendrites (Morris & Pow 1988; Leng & Ludwig 2008); 
suggesting that somato-dendritic release could be a main source of vasopressin and 
oxytocin in the brain.  Vasopressin and oxytocin are cleared in the brain by 
aminopeptidases and have half-lives of 26 and 19 min in the CSF respectively (Mens 
et al. 1983).  Since both oxytocin and vasopressin have long half-lives in the CSF, it 
is possible for both peptides to act on distant sites in the brain, which are not 
innervated by the respective neurons, via diffusion (Ludwig & Leng 2006).   As 
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discussed above, dendrites of SON neurons extend for hundreds of micrometers 
providing coverage of a large portion of the brain surface (Morris 2005). The 
extensive coverage of the brain surface by magnocellular dendrites, and the fact that 
these dendrites are in close contact with CSF, offer an anatomical advantage to 
dendritically released peptides to act on distant sites.  
 
1.1.3 Evidence of Dendritic Peptide Release 
Several neuropeptides had been shown to be released from somato-dendritic 
compartments of different cell types.  Galanin, which was found to co-exist with 
vasopressin in magnocellular neurons (Melander et al. 1986), is thought to be 
preferentially targeted to dendritic compartments and is believed to exert 
autocrine/paracrine control on membrane hyperpolarisation (Landry et al. 2005).  
Dynorphin, the peptide opiate, is synthesised in granule cells of the dentate gyrus and 
the majority of the peptide was found to be located in dendrites where its release 
negatively regulates afferent inputs (Drake et al. 1994).  First evidence of dendritic 
peptide release from magnocellular neurons came from electron-microscopic studies 
with tannic acid fixation of dense core vesicles (Buma et al. 1984) applied to slices 
of the hypothalamus capturing exocytosis of vesicle cargo from dendrites (Pow & 
Morris 1989).  Studies using dendrosomes of magnocellular neurons, which are 
portions of dendrites isolated to form membrane-bounded structures, showed release 
of vasopressin and oxytocin by hyperpolarising stimulus via exocytosis (Pow et al. 
1990).  Measurement of vasopressin and oxytocin levels by in vivo microsampling 
also showed high concentrations of the peptides in the extracellular fluid of the SON 
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(Landgraf & Ludwig 1991).  In addition, secretion of vasopressin and oxytocin in the 
SON had been shown in vitro using high K
+
 to depolarise cells in slices (Mason et al. 
1986).  Since the SON has no afferent inputs of vasopressin or oxytocin, contain very 
few axon collaterals, and as mentioned above, vasopressin and oxytocin released into 
the blood do not cross the blood brain barrier, it is clear that the peptides measured in 
the SON in these experiments were released from the somata and dendrites of 
magnocellular neurons.  
 
1.1.4 Regulation of Dendritic Vasopressin and Oxytocin Release 
The SON receives inputs from the subfornical organ, the organum vasculosum of the 
lamina terminalis, the brain stem, the nucleus of the solitary tract, and the 
ventrolateral medulla (see reviews (Leng et al. 1999; Swanson & Sawchenko 1983).  
Aside from inputs from these areas, the SON also receives inputs from neurons just 
outside the nucleus in the perinuclear zone.  Figure 1-4 summarises the afferent 
inputs to the HNS (Burbach et al. 2001).  Glutamate and γ-Aminobutyric acid – 
GABA are the major excitatory and inhitory neurotransmitter input respectively.  
Other inputs include noradrenaline, serotonin, and dopamine.  Noradrenergic inputs 
are mainly derived from the medulla oblongata and induce an increase in the firing 
rate of both VP-ergic and OT-ergic neurones (Randle et al. 1984).  Serotonin input 
originates from the brain stem and was found to increase expression of OT but not 
VP in the SON (Vacher et al. 2002).  Dopaminergic input from the brain stem 
increases peripheral release of both VP and OT (Buijs et al. 1984).  In addition to 
peptidergic inputs from the brain stem, peripheral release of VP and OT are also 
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stimulated by angiotensin II (Ang II) which is important in salt and water 
homeostasis (Phillips 1987).  Intravenous and intracerebral injection of Ang II both 
stimulates increase in neuronal activity in the SON (Rowland et al. 1994b; Rowland 
et al. 1994a).  Moreover, direct application of Ang II to SON slice preparations 
increased the firing rate of magnocellular neurons (Okuya et al. 1987), indicating 
that magnocellular neuronal activity is also regulated by peripheral peptides. 
 
Many studies have been done on the regulation of dendritic vasopressin and oxytocin 
release, testing both physiological and pharmacological agents.  Ludwig 1998 
reviewed a list of physiological and pharmacological stimuli to dendritic vasopressin 
and oxytocin release.  Osmotic challenge (Landgraf & Ludwig 1991; Ludwig et al. 
1996b; Ludwig & Landgraf 1992), dehydration (vasopressin) (Ludwig et al. 1996b), 
and suckling during lactation (oxytocin) (Moos et al. 1989; Neumann et al. 1993b) 
all had effects on dendritic vasopressin and oxytocin release, suggesting a 
physiological role for dendritic release.   Agonist and antagonist treatment in the 
SON had also been demonstrated to affect dendritic peptide release, suggesting that 
these peptides act on vasopressin/oxytocin receptors in the SON to elicit their 
functions (Moos et al. 1984; Wotjak et al. 1994).  In a review article, Landgraf and 
Neumann (Landgraf & Neumann 2004) added a series of behavioural stimuli to this 
list such as social behaviour, maternal behaviour and a range of stress stimuli.  
Sabatier et al. (Sabatier et al. 2003) found that α-melanocyte-stimulating hormone 
activates dendritic oxytocin release.  All these findings indicate that the vasopressin 
and oxytocin system is regulated by a range of stimuli, which affects dendritic 
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vasopressin and oxytocin release to differing degrees. The physiological significance 
of dendritic peptide release during various physiological states including parturition, 
lactation, and dehydration is discussed below. 
 
 
1.2 Physiological Significance of Dendritic Peptide Release 
1.2.1 Morphological Plasticity 
Interesting morphological changes occur after the onset of parturition and during 
lactation.  At the end of pregnancy and in lactation, the dendrites of oxytocin neurons 
become bundled together without intervening glia (Theodosis & Poulain 2001), 
allowing synaptic boutons to contact more than one dendrite or cell body (Theodosis 
et al. 1998).  An increase in the general numbers of synaptic terminals were found 
and these terminals were found to be of GABA-ergic, glutamatergic and 
noradrenergic synapses (Theodosis et al. 1998).  Glial retraction promotes 
juxtapositioning of dendrites and somata, which could facilitate synchronisation of 
neuronal electrical activity (Theodosis et al. 2008).  These kinds of synaptic 
plasticity regress after lactation, depend on dendritic oxytocin release (Theodosis 
2002) and can be mimicked in in vitro slice culture of the rat hypothalamus using in 
vitro administration of oxytocin and the effect was blocked by oxytocin receptor 
antagonist (Langle et al. 2003).  These effects of oxytocin on synaptic plasticity are 
facilitated by female sex steroids (Montagnese et al. 1990).  Oxytocin gene 
expression had been shown to be increased by activation by sex steroids in the rat 
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(Crowley & Amico 1993) and oestrogen was shown to selectively induce vasopressin 
and oxytocin release from cell bodies and dendrites but not from axonal terminals 
(Wang et al. 1995).  This kind of neuronal modelling does not only occur during 
pregnancy and lactation, but also under acute osmotic stimulation where there is an 
increase in oxytocin synthesis and release (Beagley & Hatton 1992; Perlmutter et al. 
1985; Tweedle & Hatton 1984).  Vasopressin’s role in structural remodelling is 
unclear since osmotically induced morphological changes occur in Brattleboro rats, 
which lack vasopressin (Chapman et al. 1986). Synaptic plasticity and neuronal 
remodelling promote communication between afferent and efferent neurons and also 
between bundled oxytocin neurons.  This can facilitate synchronisation of electrical 
activity (Theodosis & Poulain 1992), however, it is not essential for synchronised 
burst activity of oxytocin neurons since burst firing was observed before neuronal 
remodelling, reviewed in (Russell et al. 2003), and that absence of neuronal 
remodelling, prevented by removal of the sialylated isoform of the neural cell 
adhesion molecule, shown to be a prerequisite to neuronal remodelling, did not 
inhibit burst firing of oxytocin neurons during parturition and lactation (Catheline et 
al. 2006).  Nevertheless, glial retraction and dendritic bundling encourage 
communication between oxytocin neurons and formation of glutamate and GABA 
synapses as a result is important in the fine tuning of oxytocin electrical activity. 
 
1.2.2 Parturition and the Milk-Ejection Reflex 
The role of centrally released oxytocin is important in parturition but not essential, as 
oxytocin gene knockout mice give birth normally (Young, III et al. 1996).  It had 
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been proposed that vasopressin could have compensated for the effects of oxytocin 
deficiency; supported by the fact that vasopressin can act on oxytocin receptors 
(Barberis et al. 1998).  Nevertheless, oxytocin release from the SON and PVN was 
found to be increased by 254% and 300% respectively during parturition (Neumann 
et al. 1993b), suggesting a role for central oxytocin release.  Moreover, oxytocin 
antagonist treatment after the onset of labour was shown to slow down the process of 
pup-delivery (Neumann et al. 1996).  At parturition, increase in local glutamate 
release stimulates dendritic release of oxytocin (Herbison et al. 1997), which acts on 
oxytocin receptors on oxytocin neurons to stimulate a positive feedback release of 
oxytocin in the SON (Moos et al. 1984).  Moreover, oxytocin cells inhibit 
neighbouring cells via the release of endocannabinoids (Hirasawa et al. 2004), which 
are also released centrally by oxytocin neurons.   This coupling of oxytocin neurons 
facilitates burst firing by enabling coupled neurons to be stimulated by a surge of 
glutamatergic activity (reviewed in (Brunton & Russell 2008).  Synchronised firing 
of oxytocin neurons mediated by dendritic oxytocin release can then facilitate bursts 
of oxytocin release from the posterior pituitary at parturition.  
 
In the rat, prolactin release is stimulated by oxytocin (Murai & Ben Jonathan 1987) 
and surges before parturition to prepare the mammary gland for the production of 
milk (Andrews 2005).  This trigger of lactation, together with oxytocin neuron burst 
firing results in milk ejection when stimulated by suckling.  The physiological aspect 
of dendritic oxytocin release was first shown in the milk-ejection reflex (Moos et al. 
1989).  It was shown that oxytocin antagonist administered to the SON disrupts the 
  Chapter 1 Introduction 
13 
milk ejection reflex by reducing burst amplitude and frequency of oxytocin neurons 
(Lambert et al. 1993), demonstrating the importance of centrally released oxytocin in 
the bursting behaviour of oxytocin neurons.  In lactating rats, oxytocin injection into 
the SON or PVN stimulated bursting activity in oxytocin cells (Moos & Richard 
1989).  Injection of oxytocin in one SON or PVN resulted in firing of oxytocin 
neurons in the contralateral nucleus and this effect is specific to the magnocellular 
nuclei since injection of oxytocin away from the SON and PVN did not result in 
synchronised burst activity (Moos & Richard 1989).  Direct evidence of central 
oxytocin release during the milk-ejection reflex came from in vivo push pull 
experiments where increase in oxytocin release was measured in the SON just before 
milk ejection (Freund-Mercier et al. 1988).  These evidences suggested a positive 
feedback mechanism where oxytocin facilitates its own release.  Moreover, this 
effect is specific to oxytocin since intra-cerebroventricular (icv) administration of 
vasopressin did not induce burst firing of oxytocin cells or milk let-down (Freund-
Mercier & Richard 1981).  Oxytocin facilitates oxytocin burst firing in the 
magnocellular nuclei and once the reflex is started, more oxytocin is released from 
the somata and dendrites to sustain the pulsatile release from the axon terminals in 
the posterior pituitary needed for foetus expulsion and milk let-down.   
 
1.2.3 Autonomic Control  
Vasopressin neurons respond to changes in plasma osmolality and peripheral 
vasopressin secretion results in high osmolality, leading to reabsorption of water in 
the kidney collecting tubules.  Systemic administration of hyperosmotic stimuli such 
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as hypertonic saline results in both vasopressin and oxytocin secretion from the 
posterior pituitary and also from the SON (Ludwig et al. 1994a).  Magnocellular 
neurons, being osmosensitive, respond to plasma osmolality changes not only by 
activation of cell surface osmoreceptors but by afferent inputs from 
circumventricular organs (for review see (McKinley et al. 2001).  Lesion of the 
anterior and ventral region of the third ventricle abolished intranuclear release in 
response to systemic hyperosmotic stimulation (Ludwig et al. 1996a).  Also, 
administration of tetrodotoxin, which blocks voltage-gated sodium channels and 
hence the generation of action potentials, diminished release of vasopressin and 
oxytocin in the SON in response to systemic hyperosmotic stimulation (Ludwig et al. 
1995), indicating the importance of afferent inputs in the regulation of dendritic 
peptide release in the SON.  Recently, nitric oxide (NO) has been implicated in 
dendritic vasopressin release in the SON in response to osmotic stimulus (Gillard et 
al. 2007).   Water deprivation (Ueta et al. 1995) and salt loading (Villar et al. 1994) 
increased nitric oxide synthase activity in magnocellular neurons.  Gillard et al. 
found that NO stimulated increased dendritic vasopressin release after systemic 
osmotic stimulation and this increase of dendritic vasopressin release was due to 
increase in glutamatergic signalling.  Hence, NO released from magnocellular 
dendrites enhance presynaptic glutamatergic input to vasopressin neurons, increasing 
dendritic vasopressin release and actions on V1a receptor activation (Gillard et al. 
2007). 
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It was found that different osmotic stimuli result in differential regulation of 
dendritic vasopressin release.  For example, water deprivation, but not salt loading, 
triggers vasopressin release in the SON after acute osmotic challenge, while release 
from posterior pituitary was unaffected (Ludwig et al. 1996b).  Salt loading depletes 
somato-dendritic stores of vasopressin and has a major impact on plasma sodium 
concentration while water deprivation has an impact on plasma volume.  The 
consequent dendritic vasopressin release after water deprivation is then due to 
activation of baroreceptors-mediated pathways.  Vasopressin is important in the 
regulation of cardiovascular function, and central vasopressin release from the SON 
was found to be important in blood pressure regulation (Toba et al. 1994).  The 
baroceptor pathway provides tonic inhibition of magnocellular neurons in the SON 
via activation of afferents in the NTS and GABA release from the perinuclear zone 
(Grindstaff & Cunningham 2001).  Angiotensin administration through icv increases 
vasopressin release from both the dendrites of the SON and PVN and the posterior 
pituitary (Moriguchi et al. 1994), in accordance to vasopressin’s role in blood 
volume regulation.  There is evidence that intranuclear vasopressin release is 
regulated by interactions between baroreceptor inhibition and chemoreceptor 
activation in the aortic arch and carotid body.  Denervation of baroreceptors was 
found to increase release of vasopressin and oxytocin from the posterior pituitary and 
in the SON after hyperosmotic stimulation (Callahan et al. 1997; Morris & 
Alexander 1989).   Hyperosmolar stimulation of the SON was also found to stimulate 
release of vasopressin from both the SON and neural lobe and this stimulus was 
found to increase mean arterial blood pressure (Ludwig et al. 1994b).  Application of 
a V1 receptor antagonist intravenously was found to have no effect on mean arterial 
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pressure, indicating that central activation of vasopressin release is important in 
regulation of blood pressure.   
 
1.2.5 Stress and Other Effects 
Vasopressin and oxytocin had been implicated in behavioural regulation where 
physical and emotional stress is implied, for example in forced swimming, it was 
shown that there was an increase in vasopressin and oxytocin release in the SON and 
PVN (Wotjak et al. 1998).  Interestingly, vasopressin release from the posterior 
pituitary, unlike oxytocin release, was not increased in parallel to release in the SON 
and PVN in forced swimming.  A more recent study using the morris watermaze as a 
swim stress paradigm showed that vasopressin release in the PVN, and oxytocin 
release in the SON, was increased during the swim stress (Engelmann et al. 2006).  
These increases in intrahypothalamic release also coincided with an increase in the 
plasma stress hormone (ACTH) levels.  Involvement of dendritic vasopressin and 
oxytocin release has been shown in other stress paradigms.  Microdialysis studies 
have shown that dendritic oxytocin release is involved in the male social defeat 
paradigm (Engelmann et al. 1999).  Moreover, oxytocin release in the PVN was 
found to be elevated in lactating female rats defending their litter (maternal defence) 
in highly aggressive rats (Bosch et al. 2005).  Meanwhile, oxytocin infusion to the 
PVN was found to reduce anxiety-related behaviour in male rats (Blume et al. 2008). 
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1.3 Mechanisms of Dendritic Peptide Secretion 
As discussed so far, dendritic release of vasopressin and oxytocin does not always 
match release from the neural lobe.  Stimulated secretion of vasopressin by 
dehydration or intravenous/intraperitoneal bolus hypertonic saline administration 
showed that vasopressin released in the SON is delayed compared to peripheral 
release, and occurs over a much longer duration (Ludwig et al. 1994a; Ludwig et al. 
1994b).  The spatial and temporal differences in peripheral and central release 
indicate differences in secretory mechanisms in the different cellular compartments.  
Immunocytochemical and electron-microscopic studies revealed peptide-containing 
dense core vesicles in the dendrites of magnocellular neurons (Pow & Morris 1989).  
These peptides, i.e. vasopressin and oxytocin, were found to be quite distal from the 
cell body and were contained in the classical 160 nm dense core secretory vesicles. 
However, little is known about the differential regulation of transport mechanisms of 
vesicles in dendrites compared to axon terminals.  It had been proposed that 
neurosecretory vesicles are transported to the dendrites in the same way they are 
transported down axonal microtubules (Pow & Morris 1989).   
 
Unlike release from axon terminals, dendritic peptide release from magnocellular 
neurons was not blocked by the sodium channel blocker tetrodotoxin (Scala-Guenot 
et al. 1987), suggesting that dendritic release is not potentiated by action potentials.  
However, voltage-gated Ca
2+
 channels have been reported on somata and these Ca
2+
 
channel subtypes were found to be different to those in axon terminals (Fisher & 
Bourque 1995; Fisher & Bourque 1996).  Moreover, like stimulated release from 




 was found to be important in dendritic release of magnocellular 
neurons (Mason et al. 1986; Neumann et al. 1993b; Wang et al. 1995).  Hence, 
extracellular Ca
2+
 entry is important in triggering dendritic peptide release, but as 
discussed in more details below, it is not the only Ca
2+
 requirement for release.   
 
1.3.1 The Importance of Intracellular Calcium 
Under normal conditions, dendritic release of peptides does not occur from electrical 
stimulus.  However, dendritic vasopressin and oxytocin release was found to be 
stimulated by high K
+
 levels and is dependent on Ca
2+
 concentrations and central 
release of oxytocin induced by suckling in lactating rats was shown to be diminished 
by microdialysis with Ca
2+
-free solution (Neumann et al. 1993b).  Similarly, addition 
of K
+
 to hypothalamic slices stimulates vasopressin and oxytocin release and this 
release is blocked in Ca
2+
-free medium (Mason et al. 1986; Wang et al. 1995).   
 
The inhibition of vasopressin and oxytocin release in the absence of Ca
2+
 indicates 




 channels in the dendritic 
plasma membrane.  However, application of 100 nM oxytocin in a low Ca
2+
-EGTA 
buffer can induce oxytocin release by triggering Ca
2+
 release from intracellular stores 
(Dayanithi et al. 2000) meaning that calcium entry through the plasma membrane is 
important in the initiation of stimulus-triggered dendritic release but intracellular 
Ca
2+
 mobilisation is important in the maintenance of dendritic release.  These stores 
were found to be thapsigargin-sensitive stores of the endoplasmic reticulum – 
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thapsigargin inhibits the Ca
2+
ATPase found on endoplasmic membrane and hence 
inhibits endoplasmic re-uptake of Ca
2+
 (Lytton et al. 1991).  Oxytocin is thought to 
induce calcium release from thapsigargin sensitive calcium stores since application 
of oxytocin to isolated oxytocin cells after thapsigargin treatment did not induce 
further rise in intracellular calcium (Lambert et al. 1994) and oxytocin failed to elicit 
[Ca
2+
]i increase after prolonged exposure to thapsigargin (Dayanithi et al. 2000).  
Oxytocin can mobilise Ca
2+
 from intracellular Ca
2+
 stores via G-protein coupled 
oxytocin receptors on dendritic membrane or on the soma (Chevaleyre et al. 2000; 
Lambert et al. 1994; Moos et al. 1989).  Binding of oxytocin to its receptor activates 
PLC coupled to G-protein, which leads to conversion of phosphatidylinositol-4,5-
bisphosphate (PI(4,5)P2) to inositol triphosphate (IP3).  IP3 binds to IP3-sensitive 
receptors on the endoplasmic reticulum membrane facilitating release of calcium into 
the cytoplasm (Molnar & Hertelendy 1990) (Figure 1-3).  Thus, oxytocin released 
from dendrites could trigger sufficient intracellular Ca
2+
 release to sustain its own 
release, and this release could be long-lasting.   
 
Application of vasopressin to magnocellular neurons in the SON was also found to 
induce an increase in [Ca
2+
]i but this increase is not only due to the release from 
intracellular stores but activation of voltage-gated calcium channels on the cell 
membrane (Dayanithi et al. 2000).  Removal of extracellular Ca
2+
 completely 
abolished the effects of vasopressin and continuous application of vasopressin was 
found to desensitise the calcium response.  Similar to oxytocin neurons, vasopressin 
neurons contain thapsigargin-sensitive calcium stores (Dayanithi et al. 2000).  
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Thapsigargin was also found to stimulate vasopressin release from isolated SON 
preparation by inducing a rise in intracellular [Ca
2+
] (Ludwig et al. 2005).  
Application of thapsigargin to vasopressin neurons in Ca
2+
-EDTA buffer elicited an 
increase in [Ca
2+
]i, demonstrating that intracellular calcium release can contribute to 
vasopressin induced increase in [Ca
2+
]i (Dayanithi et al. 2000).  However, prolonged 
stimulation by thapsigargin did not abolish the vasopressin induced rise in Ca
2+
, 
unlike in oxytocin neurons, further confirming the importance of extracellular Ca
2+
 
influx in vasopressin neurons. Dendritically released vasopressin can act on V1 
receptors to facilitate further vasopressin release through coupling to different second 
messenger systems.  V1a receptor was found to be coupled to PLC and also activates 
adenylate cyclase (AC) (Sabatier et al. 1998).  Inhibition of protein kinase C (PKC) 
and protein kinase A (PKA) attenuated intracellular calcium release (Sabatier et al. 
2004) (Figure 1-3) pointing to a role in calcium channel phosphorylation.  There 
have been contrasting reports on whether V1b receptors were expressed in the SON 
(Hernando et al. 2001; Hurbin et al. 1998; Hurbin et al. 2002; Vaccari et al. 1998).  
V1b agonist was found to have no effect on intracellular calcium release (Sabatier et 
al. 2004) although V1b receptors are coupled to PLC via Gβλ-protein (Jard et al. 1987; 
Michell et al. 1979).  Hence, it is difficult to conclude whether V1b receptors play a 
physiological role in somato-dendritic release.   
 
1.3.2 Autoregulation 
One of the major functions of dendritic release is autoregulation.  Vasopressin and 
oxytocin are packaged with various neuro-active substances such as the endogenous 
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opioid dynorphin and the κ-receptor which dynorphin acts on (Shuster et al. 1999; 
Watson et al. 1982), providing an inhibitory effect on neuronal activity.   
Endocannabinoids, anandamide and 2-arachidonoyl glycerol, were found to be 
released from magnocellular neurons in an activity dependent manner to negatively 
regulate vasopressin and oxytocin neuronal activity by modulating presynaptic 
glutamate release (Di et al. 2005).  Nitric oxide synthase (NOS), the enzyme that 
synthesises NO, is found to be upregulated in the SON by a range of osmotic stimuli 
(Ueta et al. 2002).  NO can activate guanylyl cyclase in magnocellular neurons 
(Stern & Zhang 2005) which results in inhibition of calcium entry into the cell, 
leading to decrease in intracellular calcium concentration (Ignarro 1990).  NOS is 
expressed in both vasopressin and oxytocin neurons (Hokfelt et al. 1994) and seems 
to have a dual regulatory effect on vasopressin and oxytocin neurons in that NO 
tonically inhibits vasopressin and oxytocin neuronal activity but enhances dendritic 
vasopressin release during osmotic stimulation (Gillard et al. 2007).  Figure 1-5 
summarises the autocrine and paracrine actions of dendritic peptide release.   
 
Of interest is that vasopressin and oxytocin themselves can modulate neuronal 
activity by acting on different subtypes of receptors.  Early in vitro studies indicated 
that dendritic secretion of vasopressin and oxytocin act as autocrine and/or paracrine 
signals to modulate activities of vasopressin and oxytocin neurons (Gouzenes et al. 
1998; Richard et al. 1991).  This action of the magnocellular peptides is further 
demonstrated by the fact that vasopressin and oxytocin neurons express vasopressin 
and oxytocin receptors respectively (Hurbin et al. 2002; Freund-Mercier et al. 1994).  
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Furthermore, vasopressin receptors co-localise with vasopressin in the same 
secretory vesicles (Hurbin et al. 2002), indicating that vasopressin could act on its 
own receptors, which are delivered to the plasma membrane at the same time as the 
exocytosis of vasopressin.   
 
In parturition and lactation, dendritic oxytocin release was shown to facilitate axonal 
oxytocin release and dendritic oxytocin release has also been shown to enhance 
activity of oxytocin neurons during hyperosmolarity (Morris et al. 1993; Richard et 
al. 1991).  Oxytocin receptors are coupled to phospholipase C (PLC) (Gimpl et al. 
2008) which activates mobilisation of Ca
2+
 from intracellular stores.  This increase in 
[Ca
2+
]i activates exocytosis of large dense core vesicles (LDCVs) from oxytocinergic 
dendrites.  Unlike oxytocin, vasopressin’s modulation of vasopressin neurons is less 
straight forward.  Central application of vasopressin in the SON via microdialysis 
was shown to induce, and V1 receptor antagonist reduced, vasopressin release in the 
SON (Wotjak et al. 1994).  Since vasopressin acts on V1a/V1b receptors coupled to 
PLC to induce intracellular increase in Ca
2+
, it is not surprising that vasopressin acts 
on vasopressin receptors to increase dendritic release.  On the other hand, 
vasopressin was shown to inhibit phasic firing of vasopressin neurons via activation 
of V1 receptors (Ludwig & Leng 1997).  Icv administration of vasopressin was found 
to decrease plasma vasopressin concentration (Wang et al. 1982), suggesting an 
inhibitory role of dendritic vasopressin release on the activity of vasopressinergic 
neurons.  It was proposed that vasopressin’s activation of voltage-gated calcium 
channels induces rapid hyperpolarisation of vasopressin neurons leading to inhibition 
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of firing rate.  Moreover, it had been shown that vasopressin facilitates pre-synaptic 
GABA release by increasing GABA-ergic neuronal activity (Hermes et al. 2000), 
indicating that the inhibitory effects of dendritically released vasopressin could be 
mediated through modulation of inhibitory inputs.  Vasopressin has also been shown 
to reduce excitatory post-synaptic current acting on V1 receptors (Kombian et al. 
2000).  Dendritic vasopressin release was found to be temporally different from 
vasopressin release in the posterior pituitary under systemic hyperosmotic challenge 
or intranuclear osmotic stimulation via microdialysis (Ludwig et al. 1994a; Ludwig 
et al. 1994b).  Since dendritic release is delayed and outlasts release into the plasma, 
it was proposed that dendritic release of vasopressin stimulates further dendritic 
release until intranuclear vasopressin concentration reached a threshold that is able to 
trigger hyperpolarisation or increased GABA activity (Ludwig & Leng 1997; 
Ludwig 1998).  This function of dendritic vasopressin is proposed to sustain the 
phasic firing of vasopressin neurons where continuous stimulation does not induce 
maximal vasopressin release and phasic firing induce maximal vasopressin secretion 
(Ludwig & Leng 2006).  Moreover, there have been reports that both V1a and V1b 
receptors were found in the brain (Hurbin et al. 1998; Hurbin et al. 2002), leading to 
the speculation that the dual property of vasopressin’s effect on the firing rate of 
vasopressinergic neurons, is exerted via the activation of the two subtypes of 
receptors (Gillard et al. 2007; Gouzenes et al. 1998; Ludwig & Leng 2006).   
 
1.3.3 Facilitation of dendritic release via vesicle recruitment - priming 
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As mentioned above administration of thapsigargin to the SON was able to potentiate 
dendritic oxytocin release subsequent to an activating stimulus (Ludwig et al. 2002).  
In the same study, it was shown that application of an oxytocin agonist was able to 
generate the same effect.  The action of oxytocin inducing dendritic oxytocin release 
is important because basal spike activity or antidromic stimulation of oxytocin 
neurons do not stimulate dendritic oxytocin release (Ludwig et al. 2002).  However, 
after administration of thapsigargin or oxytocin to the SON, high-K
+
 stimulation 
causes a remarkable increase in dendritic oxytocin release (Ludwig et al. 2002).  The 
authors called this phenomenon the self-priming of dendritic oxytocin release where 
oxytocin acts on oxytocin autoreceptors to prepare oxytocin-expressing neurons for 
further activity-dependent release.  This potentiation of oxytocin release was shown 
to be long-lasting (increased oxytocin release 30, 60 and 90 min after thapsigargin or 
oxytocin pre-treatment).  Thus, oxytocin serves an important role in priming 
dendritic stores to enable activity-dependent dendritic oxytocin release for a 
prolonged period.  On the contrary, even though vasopressin could induce dendritic 
vasopressin release, it does not induce priming.  Priming of dendritic vasopressin 
release only occurs after thapsigargin pre-treatment (Ludwig et al. 2005), indicating 
the importance of intracellular Ca
2+
 mobilisation.   The priming action of oxytocin is 
also thought to be dependent on the release of calcium from endoplasmic stores since 
the oxytocin receptor is coupled to PLC (Gimpl et al. 2008), which can activate 
release of endoplasmic stores of Ca
2+
 via conversion of I(4,5)P2 to IP3.  A study 
based on quantifying the number of vesicles at 500 nm proximity to the plasma 
membrane showed that thapsigargin priming involves the recruitment of vesicles 
closer to the plasma membrane, making vesicles more readily releasable (Tobin et al. 
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2004) (see Figure 1-6).  In bovine adrenal chromaffin cells, it was found that dense 
core vesicle translocation to the plasma membrane during activity-dependent 
potentiation (ADP), a phenomenon similar to vesicle priming in dendrites where 
LDCVs were translocated to the plasma membrane, is dependent on F-actin 
disassembly and MAP kinase activity (Park et al. 2006). The level of activated MAP 
kinase was found to be correlated to the level of calcium influx and inhibition of 
MAP kinase was found to inhibit F-actin disassembly, leading to decreased ADP.  It 
is possible that the thapsigargin-induced rise in intracellular calcium concentration 
could activate similar mechanisms leading to LDCV translocation and exocytosis, 
however, this is yet unknown.  Similarly, actin remodelling was found to be 
important in the self-priming of gonadotrophin-releasing hormone (GnRH) on 
gonadotrophs, where exposure of gonadotrophs to oestrogen and subsequently 
GnRH, produced an enhanced secretory response from the gonadotrophs in later 
GnRH stimulation (Aiyer et al. 1974).  Inhibition of actin polymerisation by 
cytochalasin B was found to abolish the self-priming effect of GnRH (Lewis et al. 
1985).  Remodelling of the actin cytoskeleton was also found to be important in 
dendritic peptide release since active depolymerisation of F-actin by latrunculin was 
found to significantly increase high K
+
 induced dendritic peptide release and 
polymerisation of actin by jasplakinolide inhibited release in vitro (Tobin & Ludwig 
2007b).  Axonal release was found to be unaffected by the two drugs mentioned.  In 
the same study, thapsigargin-primed dendritic release of peptides was blocked by 
both the actin polymerising and depolymerising agents, suggesting that priming of 
vesicle release is affected by actin remodelling.  Further studies using the 
transcription inhibitor antinomycin D and the translation inhibitor cycloheximide 
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showed that priming in oxytocin dendrites was not prevented by these two drugs, 
indicating that priming of vesicles by thapsigargin is not dependant on de novo 
synthesis of vesicles (Tobin & Ludwig 2007a).   
 
So far, I have discussed that dendritic vasopressin and oxytocin release have 
important physiological effects and that release from dendrites is temporally and 
functionally separated from release in the neural lobe.  To understand the mechanism 
regulating release from magnocellular dendrites, it is important to understand the 
molecular machinery governing release itself.  The section below will concentrate on 
the regulation of exocytosis in reference to dendritic vasopressin and oxytocin 
release with comparison to axonal release. 
 
 
1.4 Exocytosis in Magnocellular Dendrites 
Ever since tannic acid fixation of dense core cargo in magnocellular dendrites (Pow 
& Morris 1989), it had been accepted that the magnocellular peptides are located in 
LDCVs and release of these peptides is via regulated secretion.  Vasopressin and 
oxytocin are both synthesised as preprohormones (the nonapeptide oxytocin or 
vasopressin are synthesised with their respective neurophysin and a glycopeptide in 
the case of vasopressin).  The function of neurophysin was found to be critical in 
sorting the prohormone into the regulated secretory pathway (Zhang et al. 2005).  
Abolishment of hormone-neurophysin association by point mutation in the 
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vasopressin domain was found to cause the prohormone to be trapped in the 
endoplasmic reticulum of neuroblastoma (N2a) cells (de Bree et al. 2003).  The 
processed prohormone (neurophysin and vasopressin/oxytocin) then enters the Golgi 
apparatus for further glycosylation and packaging into LDCVs (for review see 
(Brownstein 1983).  The hormones are then cleaved by enzymes that are packaged in 
the secretory granules along with secretory proteins such as chromogranin to mature 
(Loh 1987).  The secretory granule enters the regulated secretory pathway and 
releases its contents upon stimulus (Huttner et al. 1995).  Figure 1-7 summarises the 
regulated secretory pathway of neuroendocrine cells.  Upon activating stimuli, the 
plasma membrane depolarises, leading to calcium entry into the cell through voltage 
gated calcium channels, triggering fusion of vesicle membrane with plasma 
membrane, which results in release of the peptides, a process known as exocytosis.  
This regulated secretory pathway is different from the constitutive secretory pathway 
that is present in all cell types.  Constitutive secretion also involves vesicles 
packaged in the Golgi apparatus and release of vesicle cargo is also via exocytosis.  
However, in constitutive secretion, an external stimulus, like an action potential or 
plasma membrane receptor activation is not required (Kelly 1985).   
 
In axonal terminals, exocytosis of LDCVs is regulated by a plethora of proteins.   
The Soluble NSF (N-ethylmaleimide-sensitive factor) Attachment protein Receptors 
(SNARE) proteins were found to be critical (Jurgutis et al. 1996).  There are many 
different important members of the SNARE family which participate at different 
stages of exocytosis.  The regulated secretory pathway requires vesicles to be 
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transported from the cytoplasm to the plasma membrane, where they become docked 
and release their cargo when the correct stimulus arrives.  Molecular evidence of 
exocytosis in dendrites came from the findings that important parts of the exocytotic 
machinery are also found in magnocellular dendrites (de Kock et al. 2003; Schwab et 
al. 2001).  Many of these proteins have been identified in axon terminals, and 
proteins crucial for forming the SNARE complex, in which SNARE proteins 
anchored at the plasma membrane (t-SNAREs) and those that are found on vesicular 
membrane (v-SNAREs), have also been identified in dendrites of magnocellular 
neurons.  Synaptotagmin (Ca
2+
 sensor found on vesicular membrane), SNAP-25 and 
syntaxin (both t-SNAREs) were found in dendrites of neonatal hypothalamic neurons 
(Schwab et al. 2001).  Synaptobrevin (v-SNARE) has also been implicated in 
dendritic oxytocin release where membrane capacitance change was decreased in the 
presence of tetanus toxin which cleaves synaptobrevin in hypothalamic slice 
preparation (de Kock et al. 2003).  α-soluble-NSF-attachment protein (αSNAP) 
which has an important role in detaching the SNARE complex after exocytosis has 
also been reported in magnocellular dendrites (Morris et al. 2000).  In synaptic 
terminals, exocytosis involves recruitment of vesicles close to the plasma membrane.  
Three different pools of vesicles with different release properties and mobilisation 
kinetics have been found (Kuromi & Kidokoro 1998; Richards et al. 2003; 
Schneggenburger et al. 1999).  As discussed above, priming of vesicle release in 
magnocellular dendrites was shown to recruit vesicles to closer proximity to the 
plasma membrane and this recruitment did not require protein synthesis (Tobin et al. 
2004; Tobin & Ludwig 2007b).  This points to the possibility of the existence of 
differentially regulated vesicle pools in magnocellular dendrites, similar to those 
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found in axon terminals (Hsu & Jackson 1996).  The regulation of vesicle pools is 
further discussed below. 
 
1.4.1 Vesicle pools 
Much of our understanding of vesicle pools came from studies of synaptic vesicles 
(SVs).  Most synaptic terminals rely on three vesicle pools for neurotransmission: the 
readily releasable pool (RRP), the reserve pool (RP) and a recycling pool of vesicles 
(Rizzoli & Betz 2005).  Studies in synaptic terminals revealed that neurotransmitter 
release from vesicles displayed differences in kinetics within the same terminal 
(Kuromi & Kidokoro 1998; Richards et al. 2003; Schneggenburger et al. 1999).  One 
store of transmitters releases readily upon electrical stimulation (RRP) and another 
that releases upon intense or prolonged stimulation (RP).  The RRP is made up of a 
small number of vesicles immobilised (docked) at the plasma membrane (Heuser et 
al. 1979) and the release of the RRP can be exhausted with high frequency electrical 
stimulation.  Since these vesicles are docked at the plasma membrane, they are 
available for instantaneous release upon stimulation.  Moreover, these vesicles are 
gathered at “active zones” where there is a concentration of Ca
2+
 channels (Neher 
1998)and hence, upon activating stimulus, influx of Ca
2+
 through voltage dependent 
Ca
2+
 channels trigger exocytosis of the vesicles docked at these sites (Murthy & De 
Camilli 2003).  This concentration of Ca
2+
 channels means that a high level of Ca
2+
 
does not have to be reached in the whole cell but only at active zones.  The proximity 
of vesicle pools and Ca
2+
 channels also mean that activation of exocytosis is a quick 
process.  However, as opposed to SVs release, LDCV release in magnocellular nerve 
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terminal and in magnocellular dendrites does not seem to be associated with active 
zones since release is possible at all areas of the dendritic plasma membrane (Pow & 
Morris 1989).  The non-association of vesicle release and active release sites is 
probably one of the reasons why latency to release after stimulation is longer in 
peptide-secreting neurons.  Moreover, in axonal terminals, recycling SVs also 
facilitate quick exocytosis via rapid endocytosis which enables endocytosed vesicles 
to be re-released by joining a recycling vesicle pool (Harata et al. 2001).  The 
recycling pool of vesicles is an intermediary pool found between the RRP and RP.  It 
contains more vesicles than the RRP but less than the RP and is released under more 
prolonged stimulation than required for RRP release, but less than required for RP 
release (Harata et al. 2001; Kuromi & Kidokoro 2003).  There is a possibility that the 
recycling pool of vesicles is made up of vesicles that has gone through ‘kiss-and-run’ 
exocytosis, where vesicles fuse with the plasma membrane, release part of their 
cargo content, and are quickly retrieved, whereby then they join the recycling vesicle 
pool which can be mobilised when the RRP is depleted (Aravanis et al. 2003).  
‘Kiss-and-run’ exocytosis has recently been demonstrated in LDCV secretion from 
the soma and neurites of cultured hippocampal neurons (Xia et al. 2009).  Vesicles 
which have partially released their contents were also shown to re-participate in 
release within a short period of time, suggesting that a recycling vesicle pool might 
be present in the LDCV secretory pathway.  This has also been shown in mouse 
chromaffin cells where endocytosed LDCVs can be re-recruited for release (Bay et 
al. 2007).  However, a recycling vesicle pool has yet to be demonstrated in 
magnocellular dendrites.  The third vesicle pool, the RP, is the largest pool and is 
released only after the depletion of the RRP and the recycling pool.  The 
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physiological function of the RP is unclear since physiological stimulation does not 
mobilise this pool.  However, release of RP vesicles under prolonged stimulation 
suggests that this vesicle pool act as a reserve of vesicles which can be released 
under high physiological demand (Kuromi & Kidokoro 1998).   
 
Given that the neural lobe contains ~1.48 x 10
10
 vasopressin and around the same 
number of oxytocin vesicles (Leng & Ludwig 2008), there seems to be an excessive 
amount of peptides stored in the neural lobe.  In the magnocellular oxytocin system, 
the milk-ejection reflex releases about 0.5 pg of oxytocin per burst fired (~5 vesicles 
from all the oxytocin terminals in the neural lobe) (Leng & Ludwig 2008), leaving a 
large pool of vesicles unreleased.  It was also found that each dendrite and soma 
contains ~15000 oxytocin vesicles and ~60000 for vasopressin (Leng & Ludwig 
2008).   Since the biggest pool of vesicle comes from the RP, it is intriguing as to 
why the magnocellular cells contain such a vast amount of vesicles that do not 
release under normal physiological stimulation.  However, unlike SVs that are 
replenished by endocytic recycling of neurotransmitters near the plasma membrane 
(Morris & Schmid 1995), LDCVs have to be synthesised and packaged in cell 
bodies.  Since sites of release are often far away from the somata, it is probable that 
the abundance of vesicles stored in the RP in axonal terminals in the magnocellular 
neurosecretory system could serve a purpose in maintaining a constant supply of 
peptides in the event of prolonged shortage of water where vasopressin release has to 
be maintained until water is found, or in the case of oxytocin, an increased demand 
of milk from the young might require release from the RP and this may also apply to 
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dendritic release.  Magnocellular axonal terminals also contain a non-releasable pool 
of vesicles found in specialised swellings known as Herring Bodies (Heap et al. 
1975; Krsulovic et al. 2005).  It is not known whether dendrites also contain a non-
releasable vesicle pool.  This is further discussed in the next section. 
 
1.4.2 Regulation of LDCV pools 
Tobin & Ludwig postulated that cortical actin microtubules are involved in 
regulating vesicle pools in magnocellular dendrites (Tobin & Ludwig 2007a).  The 
involvement of F-actin in vesicle pool regulation has also been found to be key in 
bovine adrenal chromaffin cells (Vitale et al. 1995; Trifaro et al. 2000).  It was 
shown that magnocellular dendritic peptide release requires the depolymerisation of 
the filamentous or F-actin cytoskeleton beneath the plasma membrane (Tobin & 
Ludwig 2007a) since the actin polymerising agent jasplakinolide inhibited and 
latrunculin (actin depolymerising)  enhanced high K
+
 -induced peptide release.  
However, this is specific to dendritic peptide release since jasplakinolide did not 
block high K
+
-induced peptide release from axon terminals.  Latrunculin facilitated 
peptide release from the neural lobe but did not potentiate further release by high K
+
 
depolarisation (Tobin & Ludwig 2007b; Tobin & Ludwig 2007a).  Potentiation of 
peptide release in dendrites by K
+
 after latrunculin also indicates that actin 
depolymerisation can access a pool of vesicles inaccessible by K
+
 depolarisation.  
Involvement of F-actin in the regulation of exocytosis has been shown in other 
neuroendocrine cell types such as pancreatic β-cells (Wilson et al. 2001), isolated rat 
islet cells (Thurmond et al. 2003), bovine adrenal chromaffin cells (Vitale et al. 
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1995), and pheochromocytoma (PC12) cells (Matter et al. 1989). Jasplakinolide was 
shown to inhibit high K
+
-induced insulin release in pancreatic β-cells and latrunculin 
was shown to potentiate high K
+
-induced release (Thurmond et al. 2003; Wilson et 
al. 2001), much similar to the events in magnocellular dendritic peptide release.  In 
bovine adrenal chromaffin cells, disruption of F-actin increased the number of 
vesicles at subplasmalemal level indicating that F-actin is important in the regulation 
of movement of vesicles from the RP to the RRP (Vitale et al. 1995).  The two 
vesicle pools have been proposed to be linked by cytoskeletal elements, one of which 
is actin (Hirokawa et al. 1989).  Actin filaments has been implicated in the 
movement of vesicles and also translocation of RP vesicles to RRP (Doussau & 
Augustine 2000; Kuromi & Kidokoro 2003).  As discussed above, priming of 
oxytocin release involves translocation of vesicles to the plasma membrane, making 
them more readily releasable.  If priming does not involve de novo synthesis of 
vesicles and if actin is involved in the recruitment of vesicles during priming, then it 
is very possible that vesicles from a RP are recruited to the plasma membrane in 
dendrites during priming.  Figure 1-8 summarises the possible mechanism for 
oxytocin priming in magnocellular dendrites.  Hence, it is possible that regulation of 
dendritic peptide release is more similar to the regulation of LDCV release from 
endocrine cells than release from the neural lobe.  In bovine adrenal chromaffin cells, 
it had been shown that newly synthesised LDCVs become ‘docked’ at the plasma 
membrane soon after their biogenesis and join the RRP (Figure 1-9).  These newly 
synthesised vesicles were found to be docked at the plasma membrane and could be 
released by nicotine stimulation.  Matured LDCVs was found to make up the RP.  
These matured LDCVs were found to occupy the cell centre and were not 
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immediately released by nicotinic stimulation.  The same study showed that different 
sets of stimuli could stimulate the release of different vesicle pools independently 
(Duncan et al. 2003; Wiegand et al. 2003).  Hence, it was hypothesised that newly 
synthesised vesicles were docked at the plasma membrane for a short period of time 
and when exocytosis does not occur, they undock and translocate to the functionally 
different RP.  The underlying mechanism for this age-dependency on vesicle sorting 
is, however, unknown.  It is currently unknown whether dendrites also contain these 
functionally distinct pools of vesicles.   
 
Routing of LDCVs into dendrites can occur via several pathways.  LDCVs can be 
synthesised directly in dendrites, transported from the soma to dendrites, or 
transported retrogradely from axonal terminals.  One study found that deletion of a 
single nucleotide could prevent the targeting of vasopressin mRNA to the axons but 
not to the dendrites (Mohr et al. 1995).  This nucleotide deletion resulted in a 
disruption in the stop codon for mRNA translation.  Hence, it was proposed that 
peptide transport to the axon terminal occur after translation and since transport to 
dendrites was not disrupted, mRNA translocation to dendrites must occur before 
translation.  Magnocellular dendrites were found to contain ribosomes and rough 
endoplasmic reticulum, hence, mRNA may be translocated to dendrites for 
translation (Trembleau et al. 1994).  However, although Golgi elements were found 
in the proximal parts of dendrites (Ma & Morris 2002), polyribosomes were found to 
extend to distal locations of dendrites, making it unclear whether protein biosynthesis 
actually occur in dendrites.   It is unclear why mRNA is transported to the dendrite if 
  Chapter 1 Introduction 
35 
translation doesn not occur in dendrites.  Moreover, since elements of the GA, which 
is essential for vesicle packaging and is the last stage of vesicle synthesis before 
trafficking into the cytoplasm, were mostly found in the proximal parts of dendrites, 
close to the soma, translocation of vesicles still mainly occurs from the soma to 
dendrites  It had been proposed that neurosecretory vesicles are transported to the 
dendrites in the same way they are transported down axonal microtubules (Morris & 
Ludwig 2004).  In magnocellular neurons, another peptide, galanin, was found to be 
specifically routed to dendrites (Landry et al. 2003).  Galanin which was co-
expressed in the same LDCV as vasopressin was found to be targeted to the axon 
terminals whereas dendritically located galanin was mostly not found to be co-
expressed with vasopressin.  The mechanism of this routing, however, is not clear.  
Unlike the routing of galanin, specific targeting of vasopressin and oxytocin to 
dendrites has not been shown.  If vesicle pools can be regulated by age, would 
vesicle age affect the preference of translocation along the length of dendrites?   
Another interesting question is whether routing of LDCVs could be dependent or 
independent on vesicle age.  It is also possible that dendrites do not contain different 
pools of vesicles segregated by age, but instead, vesicles that are not released from 
the axon terminal may translocate in a retrograde fashion (Alonso & Assenmacher 
1983) to the dendrite, making up the dendritic pool of vesicles.    If dendritic vesicles 
were made up of retrogradely transported vesicles from the neuronal terminal, 
dendrites may also be important compartments for degradation since matured 
vesicles would eventually enter the degradation pathway (Broadwell et al. 1980; 
Krsulovic et al. 2005; Heap et al. 1975).  Since normal physiological conditions do 
not release all vesicles in magnocellular neurons, a vast amount of vesicles remain 
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unreleased.  In the magnocellular neuronal terminals, RRP vesicles enter endings of 
magnocellular terminals where stimulation triggers peptide release.  Unreleased 
vesicles join the RP in swellings where they could be re-recruited for release (Heap 
et al. 1975; Krsulovic et al. 2005).  However, a separate pool of vesicles was found 
in the specialised swellings, the Herring Bodies (Heap et al. 1975; Krsulovic et al. 
2005), which contain an abundance of lysosomes.  It is believed that unreleased 
vesicles are translocated to these specialised compartments for degradation.  
Moreover, it was found that vesicles which have entered these Herring Bodies could 
not be re-recruited for secretion, making up a non-releasable pool of vesicles.  It is 
uncertain whether magnocellular dendrites also contain a non-releasable pool of 
vesicles and whether magnocellular dendrites contain specialised compartments for 
degradation.  Although dilations were found in parts of dendrites (Sofroniew & 
Glasmann 1981), these dilations were not found to be different in properties from the 
rest of the dendrite.  Electron microscopy and immunohistochemistry have revealed 
the presence of lysosomes in magnocellular dendrites (Ma & Morris 2002), although 
the physiological significance of these lysosomes has not yet been verified.  If 
dendrites are important destinations for aged vesicles ready for degradation, then 
thapsigargin priming represents a unique way of recruitment of aged vesicles in 
magnocellular dendrites which does not occur in magnocellular axon terminals.  On 
the other hand, like their axonal counterparts, dendrites can contain specialised 
compartments for degradation, which will lead to the speculation of the presence of 
both newly synthesised and aged LDCVs.  Nevertheless, evidence of the existence of 
different vesicle pools in magnocellular dendrites is still lacking and questions about 
whether these vesicle pools, if they exist, can be differentially regulated, would be 
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The dynamics of dendritic release of vasopressin and oxytocin has been extensively 
studied.  However, the mechanisms that govern dendritic release of peptides are still 
unknown.  Meanwhile, dendritic peptide release had been shown to be temporally 
segregated from axon terminal release (Ludwig et al. 1994a) indicating that 
mechanisms governing release at the two ends of a neuron can be different.  
Evidence of vesicle priming in magnocellular dendrites (Ludwig et al. 2002) and 
study inducing actin (de)polymerisation (Tobin & Ludwig 2007b) suggested the 
existence of differentially regulated vesicle pools. It had been shown that priming did 
not require synthesis of new proteins (Tobin & Ludwig 2007a), pointing to the 
existence of a reserve pool of vesicles in magnocellular dendrites that are made up of 
aged vesicles and can be recruited.  It is likely that vesicle pools exist in dendrites 
and these vesicle pools are differentially regulated to those found in axon terminals.  
The hypothesis of this thesis is that vesicle pools exist in magnocellular dendrites and 
these vesicle pools may be differentially regulated.   The aim of this study is to find 
out the mechanisms of vasopressin release in dendrites by addressing the question of 
how LDCVs are organised in and released from dendrites of magnocellular neurons.   
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With the production of a transgenic rat line where endogenous vasopressin is tagged 
to enhanced green fluorescent protein (VP-eGFP) (Ueta et al. 2005), it is now 
possible to visualise vasopressin-containing cells under fluorescence without pre-
treatment.  The transgene used to produce VP-eGFP transgenic rats consists of the 
eGFP coding sequence inserted in exon III of the VP structural gene (Figure 1-10).  
VP-eGFP mRNA and eGFP fluorescence in the SON and PVN was shown to be 
increased after dehydration for 2 days, in accordance with normal physiological 
response of endogenous vasopressin (Ueta et al. 2005).  Further electrophysiological 
recordings by the authors confirmed that eGFP-expressing cells have membrane 
properties characteristic of vasopressin cells.  Because the SON only contain 
magnocellular cell bodies and dendrites, with very few vasopressinergic axonal 
collaterals, it is feasible to dissect out the SON and study specifically the dendrites.  
Previous studies expressing a similar VP-eGFP chimera in PC12 cells has found that 
the VP-eGFP transgene enters the regulated secretory pathway (Zhang et al. 2005).  
Hence, eGFP targeted to LDCVs is an ideal tool to study the dynamics of vesicle 
pools in magnocellular dendrites.  Since vasopressin is endogenously tagged to 
eGFP, identification of vasopressin and vasopressin-expressing neurons does not 
require immunohistochemical labelling of vasopressin.  This helps avoid the 
disadvantages of immunohistochemical labelling where the level of peptide detection 
hugely depends upon the method of tissue fixation.  Correlation studies of 
endogenous VP-eGFP with lysosomes in magnocellular dendrites can be carried out 
to investigate whether dendrites are important destinations for aged vesicles and also 
whether dendrites contain compartments for degradation by analysing the amount of 
endogenous VP-eGFP where lysosome staining is seen.  Endogenous tagging of VP-
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eGFP also allows for the tracing of vesicles along dendritic profiles according to age 
by using a timed release protocol following a block in vesicle exit from the Golgi 
apparatus (GA).  LDCV release from the GA is inhibited at 20
o
C (Saraste et al. 
1986).  By inhibiting LDCV release from the GA and releasing this exit block by 
increasing incubation temperature of in vitro hypothalamic slices, it is possible to 
trace LDCVs that are newly packaged and released from the GA. This investigation 
allows one to study whether newly synthesised LDCVs are translocated to dendrites 
and also, whether these vesicles are preferentially targeted along the profiles of 
dendrites.  In addition to the in vitro visualisation of eGFP-tagged vasopressin 
LDCVs in magnocellular dendrites, one of the most interesting aspects that is 
afforded by the use of endogenous VP-eGFP tagging is the possibility for live cell 
imaging.  Using organotypic slice explants of the hypothalamus, the soma and 
dendrites of magnocellular neurons are retained and can be cultured for up to weeks 
(Stoppini et al. 1991; Wellmann et al. 1999).  Live cell imaging of VP-eGFP-
expressing magnocellular dendrites in organotypic slice cultures coupled with 
differential stimulation offers a possibility to analyse release of LDCVs in terms of 
fluorescent intensities in living magnocellular neurons.  It is also possible to express 
a time stamp in these cells using either fluorescent compounds that change their 
fluorescent properties during maturation (Duncan et al. 2003; Terskikh et al. 2000) 
or an inducible fluorescent construct can be expressed where a pulse-chase time 
lapse protocol can be used to study regulation of newly synthesised and older 
vesicles in magnocellular dendrites to establish the existence of vesicle pools.  This 
study also allows for the use of different pharmacological interventions to study the 
functional significance in terms of vesicle release of the different vesicle pools 
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found.  The aim of this thesis is to establish the existence of vesicle pools in 




It is not known whether vesicle pools in magnocellular dendrites are segregated by 
vesicle age and whether LDCVs destined for magnocellular dendrites are specifically 
targeted.  As discussed above, parts of the protein synthesis machinery are found in 
magnocellular dendrites (Ma & Morris 2002) but the non-association of the 
biosynthetic pathway makes the theory that LDCVs are synthesised directly in 
dendrites unlikely.  Retrograde transport from neuronal terminals to dendrites occurs 
in magnocellular neurons (Alonso & Assenmacher 1983) and hence, it is possible 
that the dendritic vesicle pool could be made up of retrogradely transported LDCVs.  
As unreleased LDCVs mature, they undergo degradation.  Hence, if the dendritic 
vesicle pool was made up of retrogradely transported vesicles, a high incidence of 
lysosomes will be expected in dendrites.  The first objective of this project is to 
establish whether magnocellular dendrites are important sites for vesicle degradation 
through labelling of lysosomes and correlation of lysosomal locations, and hence the 
importance of dendrites as a compartment for degradation, with density of VP-eGFP 
in those locations.  On the other hand, the dendritic vesicle pool may exist separately 
from the axonal pool.  The second objective of this project is to find out whether 
newly synthesised LDCVs translocate from the soma to the dendrites.  By blocking 
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vesicle exit from the GA, newly packaged VP-eGFP vesicles can be traced.  Tracing 
of the change in fluorescent intensity along dendritic profiles will provide an idea of 
whether newly synthesised vesicles translocate to dendrites, and also whether there 
are any preferential sites for translocation of newly synthesised vesicles.  The third 
objective is to study LDCV release from magnocellular dendrites via live cell 
imaging of cultured hypothalamic slices of the VP-eGFP transgenic rat.  This study 
will also look at the effects of thapsigargin priming in live magnocellular neurons.  In 
addition, to establish whether dendrites contain vesicle pools of different age and 
whether these vesicle pools were segregated by age, transfection studies will be 
carried out to express reporter proteins targeted to LDCV.  A fluorescent time stamp 
which changes colour as it matures over time can be used to image LDCVs of 
different age.  Another way to segregate vesicles by their age is by the expression of 
an inducible reporter protein via neuronal transfection where the induction of protein 
expression can be controlled.  By fixing or imaging magnocellular neurons at 
specific time points after induction of protein expression, LDCVs of different age 
can be visualised.  The final objective of this project is to establish a system whereby 
difficult to transfect magnocellular neurons can be transfected to express reporter 








Figure 1-1.  Coronal section of the hypothalamus showing the supraoptic and 
paraventricular nuclei (SON and PVN).  Immunofluorescent labelling shows 
vasopressin cells (green) are located in the ventral part of the SON and medial part of 
the PVN and oxytocin cells (red) are located in the dorsal part of the SON and lateral 
part of the PVN.  3V = third ventricle and OC = optic chiasm.  (Taken from Ludwig 










Figure 1-2.  Coronal section of the hypothalamus showing the SON.  Cell bodies and 
dendrites of vasopressin expressing neurons (green) can clearly be identified.  OC = 










Figure 1-3.  Downstream signalling pathways of VP and OT receptors.  V1a, V1b and 
OT receptors are coupled to PLC via Gq protein.  Activation of PLC leads to 
conversion of PIP2 to IP3 and DAG.  IP3 binds to IP3 receptors on membranes of the 
ER to activate Ca
2+
 release into the cytoplasm. DAG activates PKC.  V2 receptors are 
coupled to AC via Gs protein.  Activation of AC via Gs protein to induce cAMP 






Figure 1-4.  Afferent inputs to the vasopressin and oxytocin magnocellular neurons 
of the HNS.  DBB = diagonal band of Broca; LC = locus coeruleus; MnPO = median 
preoptic nucleus; NTS = nucleus of the tractus solitarius; OB = main and accessory 
olfactory bulbs; OVLT = organum vasculosum of the lamina terminalis; PNZ = 
perinuclear zones adjacent to the supraoptic and tuberomammillary nuclei; SFO = 
subfornical organ; SCN = suprachiasmatic nucleus; TMN = tuberomammillary 






Figure 1-5.  Figure showing the different functional aspects of dendritic peptide 
release.  Dendritic peptide release is involved in the modulation of pre-synaptic 
transmission (red arrows = inhibition and green arrows = facilitation).   
Autoregulation of dendritic release occurs via modulation by dendritically released 
peptides and co-released substances such as opiods (enkaphalin and dynorphin), 
endocannabinoids, and nitric oxide.  In the case of oxytocin dendrites, oxytocin acts 
on paracrine oxytocin receptors to stimulate further oxytocin release.  Both 
vasopressin and oxytocin can act on dendritic autoreceptors to regulate neuronal 
activity (Ludwig & Leng 2006).  At the onset of parturition, during lactation, and 
during acute osmotic challenges, dendrites become morphologically plastic and 
bundling of dendrites occur due to glial retraction (Theodosis et al. 2008).  Nitric 
oxide tonically inhibits dendritic release but induced glutamatergic activation of 
dendritic release during stimulation (Gillard et al. 2007). Endocannabinoids released 
from magnocellular neurons contributing to retrograde signalling and inhibition of 
paracrine dendritic release (Hirasawa et al. 2004) which plays a role in 
synchronisation of dendritic oxytocin release during burst firing.  (Figure adapted 
from Ludwig & Pittman 2003). 
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Figure 1-6.  Electron micrographs showing dendritic distributions of dense core 
vesicles from (a) a control, (b) a salt-loaded control, and (c) a salt-loaded 
thapsigargin-treated rat.  Scale bar = 1 µm.  Dense core vesicles were found to have 
translocated to close proximity of the plasma membrane after thapsigargin treatment, 







Figure 1-7.  Simplified figure of the regulated secretory pathway.  Vasopressin and 
oxytocin are packaged with their respective neurophysins, and glycopeptide in the 
case of vasopressin, into secretory vesicles in the Golgi apparatus and enter the 
regulated secretory pathway.  Peptides concentrate in secretory vesicles and form 
dense core vesicles which translocate to the plasma membrane where they are 
docked and ready for release.  Upon stimulation, calcium enters through voltage 
gated calcium channels (VGCCs) which triggers fusion of vesicle and plasma 
membrane, resulting in release of vesicular cargo (exocytosis).  (Adapted 























Figure 1-8.  Possible mechanism of priming of dendritic release.  Oxytocin binds to 
G-protein (G) coupled oxytocin receptor (OTR) which activates phospholipase C to 
convert phosphatidylinositol-4,5-bisphosphate (PI(4,5)P2) to inositol triphosphate 
(IP3).  IP3 activates IP3 receptors (IP3R) on the endoplasmic reticulum (ER) to release 
Ca
2+
 into the cytoplasm.  Increase in intracellular Ca
2+
 could cause vesicles in the 
reserve pool (RP, red) to join the readily releasable pool (RRP, green) docked at the 




























Figure 1-9.  Images from bovine adrenal chromaffin cells transfected with a 
fluorescent time-stamp that changes colour from green to red as the fluorescent 
protein matures within 16 hr showing that newly synthesised LDCVs (green) were 
docked at the plasma membrane while older vesicles (yellow and red) resided further 







Figure 1-10.  Structure of the VP-eGFP transgene used to generate VP-eGFP rats.  
The eGFP coding sequence was inserted between exon III in frame with the VP 
structural gene, downstream of the VP promoter, and exons I and II of the VP gene 
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2. DEGRADATION SITES IN MAGNOCELLULAR DENDRITES 
 
2.1 Introduction 
The neural lobe contains a large amount of vasopressin and oxytocin (~1.48x10
10
 
vesicles of each peptide hormone) (Leng & Ludwig 2008).  This large store of 
vesicles is not all released under physiological stimuli.  High intensity in vivo acute 
electrical stimulation was shown to release approximately 10% of vasopressin from 
the neural lobe (Leng et al. 1994) (also reviewed in (Leng & Ludwig 2008).  Acute 
electrical stimulation in in vitro neural lobe preparations showed a similar percentage 
of release of both vasopressin and oxytocin (Bicknell & Leng 1981).  Chronic 
osmotic stimulation by salt loading released ~85% of vasopressin vesicles from the 
neural lobe, leaving ~15% unreleased (Ehrhart-Bornstein et al. 1990).  Hence, there 
seems to be three pools of vesicles in the magnocellular axon terminal: ~10 % of 
vesicles are readily released under stimulation, ~ 75% of vesicles released under 
prolonged stimulation, and a non-releasable pool.  The neurosecretory axons in the 
neural lobe are made up of different compartments consisting of undilated segments, 
endings and swellings (Heap et al. 1975).  Vesicles were proposed to arrive at the 
endings through the undilated segments, and become stored in the swellings if they 
were not released (Heap et al. 1975; Krsulovic et al. 2005).  A specialised 
compartment, known as the Herring body, was found to be filled with lysosomes 
(Dellmann & Rodriguez 1970) and was found to be the site of degradation for aged, 
non-released vesicles (Krsulovic et al. 2005).  Hence, the three different pools of 
vesicles found in the magnocellular neuronal terminals are stored in different 
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compartments.  In comparison, magnocellular dendrites typically contain ~60000 
vesicles of vasopressin per soma or dendrite and ~15000 vesicles of oxytocin (Morris 
& Pow 1991) (reviewed in (Leng & Ludwig 2008) and it is not known whether 
distinct vesicle pools exist and whether specialised compartments exist for 
degradation.  Regarding somato-dendritic release, high potassium depolarisation 
applied to the SON for 10 -15 min released ~2.5% of oxytocin vesicles (Ludwig et 
al. 2002), and 30 min microdialysis in the SON of suckling rats released ~10% of 
oxytocin vesicles from the somato-dendritic compartment (Neumann et al. 1993b; 
Neumann et al. 1993a).  Hence, it is possible that there are non-releasable vesicle 
pools residing in dendrites.  Moreover, magnocellular dendrites could be important 
sites for the storage and degradation of aged vesicles.  However, morphological 
studies of magnocellular neurons in the SON (Morris & Dyball 1974) have not found 
specialised compartments for degradation. 
 
There are three pathways in which substrates destined for degradation can be 
delivered to lysosomes: endocytosis, phagocytosis and autophagy (Luzio et al. 2007).  
The various lysosomal pathways are summarised in Figure 2-1.  Substrates such as 
ligand-receptor complexes from the plasma membrane enter the endocytic pathway 
where they are delivered to endosomes en-route to lysosomes.  There are several 
theories regarding the delivery of endosomal materials to lysosomes including 
maturation of endosomes into lysosomes, budding of vesicles from endosomes to 
fuse with lysosomes, a “kiss and run” vesicular fusion, and a hybrid formation model 
where endosomes and lysosomes fuse to form a hybrid organelle.  Each of these 
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models have been studied and reviewed and are not thought to be mutually exclusive 
of one another (Bright et al. 2005; Gu & Gruenberg 1999; Luzio et al. 2007; Murphy 
1991; Pillay et al. 2002; Storrie & Desjardins 1996).  Phagocytosis occurs in 
specialised cells and serves to engulf foreign materials like bacteria and other 
pathogens and also apoptotic cells to form phagosomes which fuse with lysosomes 
(Jahraus et al. 1998) and will not be discussed in this chapter.  Autophagy is the 
process in which spent and/or damaged organelles become degraded (Levine & 
Klionsky 2004).  Autophagy is thought to play a crucial role in the regulation of 
intracellular homeostasis and disruption in the autophagic pathway can lead to the 
development and progression of several neurodegenerative diseases (Boland & 
Nixon 2006; Gorman 2008; Jellinger & Stadelmann 2000).  Aged, non-released 
vesicles, like aged organelles, undergo degradation via the autophagic pathway.  
Ultrastructural studies of lysosomes in the magnocellular neurosecretory terminals 
had found that non-released neurosecretory vesicles were engulfed in toto in 
autophagosomes which were positively labelled for acid phosphatase, an acid 
hydrolase found in lysosomes (Whitaker & LaBella 1972).   Acid hydrolases are 
enzymes important for the hydrolysis lysosomal contents.  One acid hydrolase, 
Cathepsin D which is a protease, had been shown to increase in expression when a 
mutant transgene expressed in vasopressinergic neurons resulted in increased protein 
degradation by autophagy (Davies & Murphy 2002).  This, and other studies 
demonstrated that lysosomes are plastic organelles which increase in number and 
activity when the demand for degradation is high.  For example, when there is an 
increase in misfolded proteins which do not enter the secretory pathway (Davies & 
Murphy 2002); or when a dehydration protocol was exercised to stimulate release of 
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vasopressin where an increased amount of vesicular membranes retrieved after 
vasopressin release were sequestered for degradation (Whitaker & LaBella 1972; 
Kobayashi et al. 1962).   
 
In neurons, endocytosis had been shown to occur throughout the length of 
hippocampal dendrites and endocytosed material was found to be transported to the 
cell bodies where the lysosomes were found for degradation (Parton et al. 1992).  
However, evidence of lysosome staining had been seen in magnocellular dendrites 
(Morris & Dyball 1974).  Since dendrites can extend to hundreds of micrometers, 
endocytosed materials will have to travel for long distances if degradation only 
occurs in cell bodies.  There is evidence of autophagosomes, a double membrane 
structure which sequesters spent/damaged organelles and fuses with or mature to 
form lysosomes for degradation (Klionsky 2005; Levine & Klionsky 2004) in the 
dendrites of cerebral cortical neurons (Koike et al. 2005).  Even though there is no 
direct evidence of autophagososomes, lysosomes had been visualised in 
magnocellular dendrites (Ma & Morris 2002).   Moreover, as discussed above, 
dendrites may contain aged, non-released secretory vesicles.  Hence, it is possible 
that magnocellular dendrites are important sites for degradation, similar to the 
functions of Herring bodies for local proteolysis.  To investigate the significance of 
lysosomes and the regulation for lysosome expression in magnocellular dendrites, 
this chapter discusses lysosomal localisations in magnocellular dendrites by 
identification of lysosomes locations in correlation to peptide vesicle density.   
 




2.2 Material and Methods 
2.2.1 Fixation by Transcardial Perfusion 
Four adult male transgenic VP-eGFP rats (200 – 300 g), were anaesthetised with 1 
ml sodium pentobarbitone and laid on their backs until response to toe pinching 
ceased.  A horizontal incision to the skin under the diaphragm was made and the 
chest was opened up by cutting through the rib cage on either side.  Whilst the heart 
was still beating, a blunted 21-gauge needle connected to heparin-saline (hep-saline) 
solution (appendix I) was inserted through the left ventricle into the aorta.  When the 
needle was in place, a small cut was made to the left atrium of the heart so that blood 
and perfusion solution could flow out.  The perfusion pump was then started and 
Hep-saline solution was perfused through the heart until the liver turned pale (100 – 
200 ml).  When most of the blood was cleared out by hep-saline solution, the 
perfusion solution was changed to 4% (w/v) PFA (appendix I).  Perfusion with 4% 
(w/v) PFA was performed until the animal was completely fixed (300 – 400ml).  The 
brain was removed and the hypothalamus was dissected into a block and stored in 
post-fix solution (15% sucrose w/v in 4% PFA (w/v)) at 4
o
C until the tissue block 
sank to the bottom of the container.  The tissue block was stored in cryoprotective 
solution (30% (w/v) sucrose in 0.1M PB) at 4
o
C overnight, and snap-frozen on dry 
ice.  The hypothalamus was subsequently sectioned using a freezing microtome.  52 
µm sections were collected in 0.1 M PB and stored in cryoprotectant (appendix I) at 
20
o
C until use.  




2.2.3 Indirect Immunofluorescence Labelling for Free-floating Sections 
Sections were washed three times for 10 min in 0.1 M PBS (appendix I) if they were 
stored in cryoprotectant.  An orbital rotation platform was used at all the incubation 
steps described here.  The sections were first incubated in 50 mM NH4Cl for 10 min 
and then washed three times in 0.1 M PBS.  If sections were to be used immediately 
after cutting, the first three washes were not carried out.  After washing in 0.1 M 
PBS, sections were incubated in a blocking solution which contained 0.1 M PBS, 
0.3% (v/v) Triton X100, and 10% (v/v) pre-immune goat serum for 30 min at room 
temperature.  The primary antibody used to label lysosomes is the mouse monoclonal 
IgG raised against lysosomal associated membrane protein 1 (LAMP-1, LY1C6, 
Santa Cruz Biotechnology, Inc.) and recognises a single band at 120 kDa in Western 
blot of fibroblasts whole cell lysates (manufacturer’s specification).  LAMP-1 was 
found to be important in the regulation of cathepsin D distribution in the brain 
(Andrejewski et al. 1999) and together with LAMP-2, is required for the recruitment 
of the small GTPase Rab7 to autophagic vacuoles (pre-lysosomal bodies), impairing 
fusion with or formation of mature lysosomes (Eskelinen et al. 2004; Eskelinen 
2006).  Primary anti-LAMP1 antibody was added to the blocking solution at 1:50 
dilution (4 µg/ml) and sections were incubated in the primary antibody cocktail at 
4
o
C overnight.  Negative controls were carried out by replacing primary antibody 
incubation with pre-immune serum incubation.  The next day, the primary antibody 
was washed off three times in 0.1 M PBS for 10 min.  Then, a secondary antibody 
cocktail of 1:500 dilution of AlexaFluor 568 (Invitrogen) was made up in blocking 
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solution.  Slices were incubated in the secondary antibody cocktail at 4
o
C overnight.  
The secondary antibody cocktail was then washed off with 0.1 M PBS for three times 
10 min.  The sections were mounted onto gelatinised slides (appendix I), air dried 
and mounted with mowiol (appendix I, medium refractive index 1.4) mounting 
medium and coverslipped.  The mounting medium was left to cure overnight 
protected from light and sections were imaged once the medium was dry. 
 
2.2.3 Microscopic Image Acquisition 
The Zeiss LSM510 inverted microscope was used for all imaging.  The 488 nm line 
of the Argon laser was used to excite eGFP which has an excitation maximum of 488 
nm and an emission maximum of 509 nm.   A dichroic beam splitter, HFT 488, was 
in place and the excitation laser passed through two mirrors before the emitted light 
was collected by a band pass 500 – 550 filter.  The helium-neon 1 (HeNe1) laser line 
(excitation wavelength 543 nm) was used to excite the AlexaFluor 568 staining 
(excitation maximum 578 nm, emission maximum 603 nm).  The photomultiplier 
tube (PMT) settings and laser powers were kept exactly the same for all samples.  
The pinhole was adjusted to 1 Airy unit for confocal image acquisition.  Figure 2-2 
shows the excitation and emission filter settings used.  Images were acquired by 
sequential scanning to avoid bleed through of emitted light from either channel.  An 
x63 oil immersion objective (NA1.4) was used.  Images were acquired close to 
double Nyquist sampling rate to avoid under sampling (Nyquist calculator available 
at www.svi.nl).    3-dimensional images were obtained by scanning the x, y –planes 
at 60 nm, achieved by line scanning 1024 x 1024 pixels with an optical zoom of 2.4, 
  Chapter 2 Degradation sites in magnocellular dendrites 
59 
 
and intervals of 170 nm along the z-axis.  8 bit pixel depth, line averaging of 1 (no 
averaging) and maximum scan speed were chosen for image acquisition to avoid 
photobleaching. 
 
2.2.4 Image Processing  
The acquired stack of images was deconvolved to remove aberrations caused by the 
intrinsic physical properties of the microscope.  Deconvolution of images was 
achieved by use of the Huygens Essential software (Scientific Volume Imaging, NL, 
www.svi.nl) available in the IMPACT imaging facility in our centre.  The Huygens 
deconvolution software restores convolution in images taken by removing blurring 
caused by diffraction of light and noise introduced by the microscope photomultiplier 
tube.  Image restoration is based on the iterative application of a maximum 
likelihood estimate algorithm where the point spread function – the smallest 
fluorescent single point object that can be resolved in 3 dimensions by the 
microscopic parameters used, is used to calculate and reassign out-of focus light 
signals to the point of origin (Shaw PJ & Rawlins DJ 1991).   
 
The microscopic parameters used for deconvolution was set according to the 
parameters used for imaging: microscope type – confocal; numerical aperture – 1.4; 
lens immersion and medium refractive indices – 1.51 and 1.4; x and y sample sizes – 
60 nm; z sample size – 170 nm; excitation wavelengths – 488 nm, 543 nm; emission 
wavelength – 509 nm, 603 nm; excitation photon count – 1; pinhole = 1 Airy unit.  
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These parameters help the deconvolution software to calculate a theoretical point 
spread function used.  A signal to noise ratio is used in the software to control the 
sharpness of the restoration result of the image and can be calculated as the square 
root of the brightest intensity in the image divided by the average intensity of a single 
photon hit caused by photon noise.  Generally, the lowest signal to noise ratio, 3, was 
employed, assuming a very noisy image, so that no background noise would be 
enhanced by deconvolution.  Because of the calculations involved in deconvolution, 
8 bit unsigned images, where pixel intensities were described by 256 shades of grey, 









2.3.1 Localisations of Lysosomes in Correlation with VP-eGFP in Dendrites 
26 dendrites from 4 rats were imaged according to the protocol described above.  
Images were selected with long profiles of dendrites where no overlapping with other 
dendrites could be seen clearly.  Lysosomes were located by going through optical 
sections in the z direction to ensure that stained lysosomes analysed were not from 
presynaptic terminals but occurred within the dendrites.  Images were separated into 
the green (eGFP signal) and red (LAMP-1 staining) channels using ImageJ 
(http://rsb.info.nih.gov/ij/).  The scale of the image was calibrated using ImageJ.  The 
two channels were merged into RGB colour images and locations where lysosome 
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staining was observed, an area of interest of 1 µm in diameter was drawn around it.  
This area of interest was saved and the same was carried out for the whole dendrite.  
Correlation analysis, but not colocalisation analysis, was carried out because lytic 
activity in the lysosome could change eGFP excitation and/or emission or simply 
deform the eGFP fluorophore.  Emission of green fluorescent protein is also highly 
pH sensitive (Tsien 1998).  Hence, the low pH, pH 4.5, found in lysosomes will 
greatly reduce the fluorescent intensity of eGFP.   Moreover, correlation analysis will 
give an idea of whether lysosomes are located where there is a high density of 
vasopressin eGFP vesicles.  After all the areas of interest were obtained, the red 
channel was switched off and the original 32-bit image of the green channel was 
used for a “SUM” projection of the image where pixel intensities were summed up in 
each column of pixels in the z-stack using ImageJ to take into account the whole 
dendrite in 3 dimension.  The saved areas of interest were then superimposed onto 
the green channel where mean VP-eGFP intensity measurements (density/area) were 
calculated for each area (spot intensity).  Areas of interest were also made for whole 
dendrites and mean VP-eGFP intensity measurements recorded.  Please refer to 
Figure 2-3 for a diagrammatic representation of the image analysis and an example 
of areas of interest drawn on a representative dendrite. 
 
To compare whether lysosomal locations are preferentially situated where there is a 
high density of vasopressin-containing vesicles, the difference between the mean 
spots VP-eGFP fluorescent intensity and the whole dendrite VP-eGFP fluorescent 
intensity was obtained and compared using the Chi-square test where positive 
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intensity = location of lysosome correlated to high VP-eGFP density, zero = no 
difference and negative intensity = location of lysosome correlated to low VP-eGFP 
density (all measurements are relative to whole dendrite VP-eGFP intensity).  Figure 
2-4 shows the Chi-square plot (mean spot intensity – mean whole dendrite intensity 
for each dendrite measured).  Chi-square test showed that the spot intensities were 
significantly different from zero (p<0.001) suggesting a positive correlation of 
lysosome locations and areas with high vasopressin vesicle density.  Figure 2-5 
shows optical sections of a portion of a representative dendrite in the z-direction 
where lysosome labelling is in red and VP-eGFP is in green.  It is clearly shown in 
these images that lysosomes were preferentially located at areas where there was 





The Herring bodies in magnocellular terminals are filled with lysosomes and are the 
final destination for aged vesicles (Krsulovic et al. 2005) providing a local capacity 
for degradation where aged vesicles do not need to be transported back to the cell 
body.   It is not known whether dendrites, like neuhypophyseal terminals contain 
specialised compartments for degradation.  Magnocellular dendrites have been 
shown to contain lysosomes (Morris & Dyball 1974), however, their functional 
significance in dendrites is not known.  In hippocampal neurons, lysosomes were 
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found only in cell bodies and very proximal segments of dendrites, and endocytosed 
materials were found to be retrogradely transported to cell bodies, where lysosomes 
were found (Parton et al. 1992).  Having identified lysosomes in dendrites of 
magnocellular neurons in the present study, it is certain that local degradation occurs 
in this compartment.  Since magnocellular dendrites contain a large reserve of 
vesicles, it is possible that “centres” for degradation occur in the dendritic 
compartment.  In the present study, it was found that instead of clustering of 
lysosomes found in one special part of the dendrite, lysosomes were found to be 
located at areas where there was high density of vasopressin vesicles.  These hot 
spots for degradation were found throughout the dendrites.  Since magnocellular 
dendrites were not found to contain accumulations of lysosome clusters, it is unlikely 
that dendrites are the destination of all aged and non-released vesicles.  However, 
lysosomes were found where vasopressin-eGFP vesicles cluster suggesting that non-
released vesicles gather as a pool around these lysosomes or lysosomes were 
preferentially transported to these non-released pools of vesicles.  Dendritic 
lysosomal content is known to be variable where the number of lysosomes increases 
during high cellular activity, e.g. dehydration, and decreases during low activity, e.g. 
rehydration  (Morris & Dyball 1974).  Similarly, in axon terminals, lysosomes-
containing Herring bodies were found to be abolished during rehydration (Krsulovic 
et al. 2005) suggesting that Herring bodies are plastic structures that disappeared 
when old vesicles were spent and newly synthesised vesicles do not enter the 
lysosomal pathway.  Hence, it is likely that lysosomes are targeted to loci where 
there is a high demand for degradation; i.e. where pools of non-released secretory 
vesicles reside.  In the magnocellular neuronal terminal, the smooth endoplasmic 
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reticulum (SER) was found to contribute to the formation of lysosomes (Whitaker & 
LaBella 1972).  Elements of the rough endoplasmic reticulum (RER) had been 
shown in magnocellular dendrites (Ma & Morris 2002), however, elements of the 
SER had not been studied.  Hence, there could be two ways in which lysosomes are 
targeted to dendrites: 1) translocation from the soma to sites of aged, non-released 
vesicle pools in dendrites; and/or 2) local synthesis of lysosomes in dendrites.  
However, the capability of dendrites to synthesise lysosomes require further studies. 
 
In many different cell types, lysosomal degradation is a plastic process which 
increases in activity according to the demand of the cell.  Early studies in rat anterior 
pituitary cells showed that lysosomes have important functions in the regulation of 
prolactin secretion (Smith & Farquhar 1966).  When suckling pups were separated 
from lactating mothers, production of prolactin continued until there was an increase 
in the number of lysosomes and lysosomal enzyme activity.  In secretion deficient β-
pancreatic islet cells, increased autophagic activity was shown to control hormone 
content in the cells under stimulation for insulin production (Marsh et al. 2007).  
Autophagy was proposed to have roles in cell death and cell survival.  Inhibition of 
autophagy was shown to increase cell death in neuroblastom cells expressing a 
mutant VP transgene, indicating that autophagy acted as a cell protective mechanism 
(Castino et al. 2005a).  However, in the same model, autophagy-triggered apoptotic 
cell death was found in cells exposed to oxidative stress (Castino et al. 2005b). In 
cortical neurons, inhibition of autophagosome activity or fusion with lysosomes 
resulted in an accumulation of autophagic vacuoles, similar to that seen in 
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Alzheimer’s disease (Boland et al. 2008).  Disruption of the autophagic pathway in 
dopaminergic neurons was found to play a similar role in Parkinson’s disease 
(Cuervo et al. 2004).  In magnocellular neurons, autophagy has been shown to be 
linked to a specific form of diabetes insipidus (familial neurohypophysial diabetes 
insipidus, FNDI) (Davies & Murphy 2002).  Autophagy was found to be responsible 
for the degradation of mutated vasopressin gene product and also normal vasopressin 
gene product associated with the mutated form, leading to increased degradation of 
vasopressin and decreased secretion.  In magnocellular neurons of FNDI transgenic 
rats, increased lysosome staining was found in SON tissue preparations using 
western blotting (Davies & Murphy 2002).  Since the transgene used caused 
truncation of vasopressin gene product and did not affect the lysosomal pathway, it 
indicates that lysosomal activity increased in the somato-dendritic compartment 
when the demand for degradation increased and hence, controlled somato-dendritic 
hormone content.   
 
In addition to autophagy, dendrites participate in endocytosis and recycling of 
substrates.  In the magnocellular neuronal terminal, it was found that dehydration, 
which stimulates an increase in vasopressin release into the circulation, led to an 
increase in lysosomal activity (Whitaker & LaBella 1972).  In the same study, it was 
found that during dehydration, lysosomes contained microvesicles which were 
electron-translucent.  These electron-translucent microvesicles represent recycled 
membranes from endocytosis.  In control conditions, non-released neurosecretory 
granules were seen to be engulfed by autosomes.  This suggests that lysosomes are 
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not only important for degradation of non-released secretory vesicles but also 
important for membrane recycling after exocytosis.  Endocytosis in the 
magnocellular somato-dendritic compartment had been shown in isolated SON 
neurons from virgin and lactating rats and that the amplitude of endocytosis is 
directly proportional to the rate of exocytosis (de Kock et al. 2003).  This indicates a 
local regulation of plasma membrane content in the soma and dendrites.  Aside from 
local degradation, it has been found that materials endocytosed at the 
neurohypophyseal terminals undergo retrograde transport to enter the lysosomal 
pathway in the cell bodies and dendrites (Theodosis 1982).  Moreover, it was found 
that these endocytosed materials were sequestered in pre-existing lysosomes 
(Broadwell et al. 1980; Theodosis 1982) indicating that dendrites are involved in 
endolysosomal degradation of retrograde transported materials.  Endocytosis is an 
important pathway to lysosomal degradation and recycling of substrates (Maxfield & 
McGraw 2004).  Endocytosed substrates can either be delivered to lysosomes for 
degradation or be sorted for recycling in endosomes.  These substrates, including 
plasma membrane receptors, can be directly transported back to the plasma 
membrane for re-use or delivered to the Golgi apparatus where they are further 
sorted for degradation or recycling.  Since there is no evidence that magnocellular 
dendrites contain the Golgi apparatus, it is likely that substrates destined for sorting 
in the Golgi will be transported back to the cell body.  Further experiments will have 
to be carried out to find out whether endosomal sorting occurs in magnocellular 
dendrites.  In hippocampal neurons, functional differences in endocytic pathways 
were found between axonal and somato-dendritic compartments where brefeldin A 
changed protein distribution in the endocytic pathway of dendrites but not in axon 
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terminals (Mundigl et al. 1993).  This kind of functional difference has not been 
found in magnocellular dendrites.   
 
In the present study, it was also found that lysosomes are located in the centre of 
dendrites (observation, Figure 2-5).  As discussed in the previous chapter, in bovine 
adrenal chromaffin cells newly synthesised vesicles are preferentially targeted to the 
cell membrane and aged vesicles reside in the centre of the cell (Duncan et al. 2003).  
Since aged vesicles were shown to be associated with lysosomal degradation, 
(Krsulovic et al. 2005), this suggests that aged, non-released vesicles reside in the 
centre of dendrites allowing newly synthesised vesicles to be primed close to the 
plasma membrane in accordance with the findings in bovine adrenal chromaffin 
cells.   
 
In conclusion, the present study suggests that dendrites are not centres for 
degradation and recycling but contain hot spots of lysosomes where local 
degradation and regulation of peptide and membrane content occurs.  In contrast to 
magnocellular neuronal terminals, ultrastructural studies of the perikarya in the SON 
had shown that the number of lysosome bodies found after dehydration was 
unchanged (Morris & Dyball 1974), suggesting that release of neurosecretory 
vesicles, which subsequently leads to plasma membrane retrieval, from the cell soma 
is less significant than release from the neural lobe.  Interestingly, Morris & Dyball 
found an increase in the number of lysosome bodies in the perikarya after a 
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dehydration-rehydration regime.  The authors concluded that lysosomes found in the 
perikarya are important sites for the disposal (autophagy) of the biosynthetic 
machinery involved in the increased peptide synthesis during dehydration.  Whether 
the plasticity in lysosomal degradation in dendrites resembles that in the soma or in 
the neuronal terminal is unknown.  However, water deprivation and salt loading had 
been found to stimulate release of vasopressin from the SON (Ludwig et al. 1996b) 
and from magnocellular dendrites (Tobin et al. 2004).  Hence, it is possible that 
regulation of lysosomes in dendrites will be similar to that found in magnocellular 
neuronal terminal.  Nevertheless, this study showed that lysosomes are targeted to 
loci of high vasopressin expression indicating that lysosomes found in dendrites are 
important for the disposal of non-released LDCVs.  Whether lysosomal contents in 
dendrites change similarly to that found in neuronal terminals during chronic 
stimulation by salt loading or dehydration remains to be studied.  In neuronal 
terminals, lysosomes were found to contain recycled membranes after chronic 
stimulation (Whitaker & LaBella 1972).  Recycling of endocytosed substrates has 
been demonstrated in dendrites of other neuronal systems but not magnocellular 
neurons (Xia et al. 2009).  Further experiments involving dehydration and 
rehydration will be needed to find out whether dendritic content of lysosomes 
changes during these stimuli and whether endocytic sorting occurs in magnocellular 
dendrites, providing a local recycling pathway for plasma membrane components.  
The present study suggested that old, non-released vesicles are situated in the centre 
of dendrites indicating that regulation of vesicle pools might be similar to that found 
in bovine adrenal chromaffin cells (Duncan et al. 2003) where aged LDCVs reside in 
the centre of the cell.  Moreover, the shortage of lysosomal accumulations suggested 
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that, unlike Herring Bodies, dendrites are not specialised compartments for 
degradation but disposal of unreleased secretory vesicles occur at hot spots.  This 
further suggests that pools of aged vesicles are concentrated at these hot spots, 
making it likely that dendrites do not only contain aged, non-released vesicles, but 
may also contain a mixture of newly synthesised vesicles for release. 





Figure 2-1.  Simplified pathways to delivery to lysosomes.  Endocytosed materials, 
such as ligand-bound receptors from the plasma membrane (blue), form early 
endosomes which can sort receptors and ligands for recycling or degradation.  Early 
endosomes either mature to late endosomes or fuse to join pre-existing late 
endosomes.  Late endosomes contain hydrolytic enzymes (orange circles) which are 
responsible for protein degradation.  Late endosomes then mature to or fuse to join 
lysosomes which contain a pool of hydrolytic enzymes (orange trapezoids).  
Lysosomes are also responsible for autophagy of cell organelles and destruction of 
foreign material (e.g. bacteria phagocytosis in neutrophils and macrophages).  


















Figure 2-2.  Beam path configuration for 2-channel imaging with the confocal laser 
scanning system.  BP 500 – 550 and BP 565 – 615 filters collect emissions between 
500 – 550 nm and 564 -615 nm wavelengths and direct the emission light through to 
detection channel 1 (Ch1) and detection channel 2 (Ch2) respectively.  HFT 
√/488/543 is the main dichroic beam splitter which passes all the specified excitation 
wavelengths (488 and 543 nm) to the sample.  The mirror reflects all the light to the 
NFT 545.  The NFT 545 is the secondary dichroic beam splitter which allows 
excitation wavelengths above 545 nm to pass straight through to Ch2 and reflect 
wavelengths below 545 nm 90
o
 through to Ch1.  Emission signals are detected 
through photo multiplier tubes (PMT) and the detector gain and amplifier offset can 















Figure 2-3. Measurement of VP-eGFP intensity relative to locations of LAMP1 
immunofluorescence. (A) Schematic diagram of VP-eGFP intensity measurement.  
Red circles in the top panel = LAMP1 labelling of lysosomes; green circles in bottom 
panel = VP-eGFP. Masks of 1 µm diameter (bold circles) were drawn on images with 
the green VP-eGFP channel switched off to identify locations of LAMP1 labelling.  
These masks were then imported onto the green channel of the same image and the 
intensity of VP-eGFP at these locations was measured as spots (mean intensity/area).  
The whole dendrite in 3-D was taken into account by taking a sum of the image 
stack. The intensity of the whole dendrite was then measured for comparison (B) 
Determination of areas of interest as discussed above; one optical section is shown. 
(C) 3-D image stack converted to 2-D by the sum slices function in ImageJ where the 
sum of the pixels from the stack of images were displayed from 32-bit optical slices. 
Areas of interest described in (A) were then imported onto this image to measure 
VP-eGFP intensity. (D) VP-eGFP intensity of the whole dendrite was then obtained 
by measuring sum slices image of the whole dendrite. Scale bar = 3 µm.








Figure 2-4.  Correlation of LAMP1 labelling with VP-eGFP intensity in the dendrite.  
Full circles represent mean spot intensity – mean dendrite intensity for dendrites 
measured.  Filled box represent the mean of all the data points (error bar = ±SEM).  
Chi-squared test showed that there is a significant difference between the mean 
intensity of spots and the mean intensity of whole dendrites (p<0.001; n = 26).  This 
suggests that lysosomes were predominantly located in areas with high density of 













































Figure 2-5. LAMP1 immunofluorescence in vasopressinergic dendrite. Images are 
consecutive optical slices of 167 nm z-stepping. Red labelling is LAMP1 and green 
is VP-eGFP. Figure shows that LAMP1 staining of lysosomes was preferentially 
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3. VESICLE TRAFFICKING ALONG DENDRITIC PROFILES  
 
3.1 Introduction 
Magnocellular dendrites extend to ~200 micrometers long (Pow & Morris 1989) and 
peptides in dendrites are thought to be transported from the cell bodies where the 
Golgi apparatus (GA) is found (Morris 2005).  As discussed in Chapter 1, 
vasopressin and oxytocin are processed in the endoplasmic reticulum and packaged 
into vesicles in the GA.  Dendritic peptides are believed to travel along microtubules 
(Morris et al. 2000) in a similar fashion to peptide transport to axonal terminals.  It is 
not known whether dendritic peptide release occurs at any preferential sites along the 
dendritic membrane.  There is no evidence of active release zones in magnocellular 
dendrites and it has been found that all parts of the dendritic membranes were 
capable of exocytosis (Pow & Morris 1989).  In bovine adrenal chromaffin cells, it 
was found that vesicular age is an important factor in vesicle pool segregation 
(Duncan et al. 2003).  It is unknown whether newly synthesised vesicles are found in 
dendrites and whether there are preferential sites for storage of newly synthesised 
vesicles and for aged vesicles.  As the results indicated in Chapter 2, it is likely that 
aged vesicles occupy the centre of the dendrite leaving the periphery to newly 
synthesised vesicles.  However, it is not known whether there is a difference in 
storage along the profile of dendrites.  Newly synthesised vesicles can either be 
transported to the distal portion of dendrites, leaving aged vesicles at the proximal 
portion, or vice versa.  It is also possible for there to be no differential location for 
storage of newly synthesised and aged vesicles; i.e. it might be that vesicle storage 
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and release is homogenous along dendritic profiles with no relation to age of 
vesicles.  To test this hypothesis, fresh hypothalamic sections containing the SON 
were incubated at 20
o
C to block exit of proteins from the GA (Griffiths & Simons 
1986).  It was found in exocrine pancreatic cells that transport of secretory proteins 
through the GA is temperature-sensitive (Saraste et al. 1986).  In the same study, 
incubation of pancreatic cells at 20
o
C resulted in the trapping of secretory peptides in 
the GA.  Using microsomal fractions, it was also found that at 20
o
C, secretory 
proteins remained trapped in the endoplasmic reticulum and the GA.  Another study 
found that this blockage of exit is due to the degradation of proteins found in the 
trans-Golgi compartment (Ladinsky et al. 2002), leading to an inhibition of vesicle 
movement through the GA.  Sorting through the trans-Golgi network (TGN) is 
known to be important for peptides like vasopressin, and proteins destined for the 
regulated secretory pathway.  Temperature inhibition is reversible by incubation at 
increased temperatures (Saraste et al. 1986; Griffiths et al. 1985), making this a 
useful tool to study the dynamics of newly synthesised vesicles.  The release of GA 
exit block will generate a wave of newly packaged vesicles trafficking down 
dendritic profiles and hence, enable tracing of these newly synthesised vesicles along 
dendritic profiles.  Figure 3-1 summarises the possible outcomes of GA exit block 
and subsequent release.  In this study, hypothalamic slices of the VP-eGFP rat were 
used to study trafficking of newly synthesised vesicles. 
 
 
3.2 Material and Methods 
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3.2.1 Block of peptide release from the GA 
Sections of the hypothalamus were collected from post-natal day 7 VP-eGFP rats 
(n=8).  Neonatal rat brains were used because slice sections obtained from adult 
brains require constant oxygenation (Aitken et al. 1995), making the later incubation 
process required for GA exit block unfeasible since slices were submerged in media.  
Rats were anaesthetised with halothane or isofluorane and decapitated and their 
brains quickly removed.  Hypothalamic tissue blocks were cut by sectioning the 
brains with a vibratome in aCSF-sucrose-KOH solution (Appendix I).  The 
osmolarity of the solution was 300 mOsm/L.  The solution was gassed with oxygen 
throughout slicing.  350 µm thick coronal sections containing the SON were obtained 
from each brain.  Sections were kept in ice cold Gey’s Balanced Salt Solution 
(Sigma-Aldrich, UK) enriched with 0.5% (w/v) glucose (Sigma-Aldrich, UK).  20 
selected sections were kept in petri dishes with Gey’s solution at 4
o
C for 30 min.  
Slice sections were then transferred to pre-warmed serum-containing medium 
(Appendix I) and were either incubated at 37
o
C for 90 min (8 sections, control), 
incubated at 20
o
C for 60 min (6 sections, GA exit block), or incubated at 20
o
C for 60 
min and 37
o
C for 30 min (6 sections, release of GA exit block).  A 30 min incubation 
at 37
o
C was found to be efficient for transport of secretory proteins to the site of 
exocytosis in the presence of a secretagogue (Saraste et al. 1986).  Serum-containing 
medium was supplemented with 25 mM K
+
 which acted as stimulus for secretion in 
these experiments.  Sections were then transferred to ice cold 4% (w/v) PFA 
(Appendix I) for up to 1 hr fixation. 
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3.2.2 Indirect Immunofluorescence Labelling for Fresh Brain Sections – 
Double Label Immunofluorescence 
The fixative was removed and the tissue was washed three times for 15 min in 0.1 M 
PB (Appendix I) with 0.3% (v/v) Triton X100 (PBT).  Triton X100, a detergent, was 
used to permeabilise cell membranes for easy access for antibodies to intracellular 
antigens.  The fixed sections were then incubated in 50 mM NH4Cl in 0.1 M PB for 
10 min after which they were washed three times in 0.1 M PBT for 15 min before 
incubating in a blocking solution (10% (v/v) normal goat serum in 0.1 M PBT) for 
30 min to block non-specific binding of primary antibody to antigens in the tissue.  
Tissue sections were incubated in a primary antibody cocktail (1
o
Ab + 10% (v/v) 
serum in 0.1 M PBT) for 2 nights at 4
o
C, gently rocking.  Negative controls were 
carried out for each group by leaving out the primary antibodies, and incubating the 
samples in pre-immune serum (control: 7 sections + 1 negative control; GA exit 
block: 5 sections + 1 negative control; release of GA exit block: 5 sections + 1 
negative control).    
 
3.2.2.1 Primary Antibodies 
Neuronal marker – MAP2 
MAP2 (microtubule associated protein found in neurons) was used as a neuronal 
marker.  The polyclonal chicken IgY (Abcam) used detects all three isoforms of 
MAP2: MAP2c is present in the newborn rat brain until postnatal day 10 – 20, and is 
replaced by MAP2a which is present from postnatal day 10 onwards, MAP2b is 
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present throughout life.  MAP2a and MAP2b are both expressed in cell bodies and 
dendrites of neurons (Goedert et al. 1991), making it ideal to be used as a general 
marker for neurons.  The pre-immune IgY was used to test for MAP2 antibody 
specificity and was not found to produce any signal, while in contrast the immune 
IgY produced strong, clear staining of dendrites and perikarya of neurons 
(information provided by Abcam).  MAP2 antibody was used in 1:1000 dilution in 
this experiment.    
 
GA marker – GM130 
GM130 (BD Transduction Laboratories
TM
) is the monoclonal mouse anti cis-Golgi 
matrix protein of 130 kDa, raised against rats and used a GA marker.    Western blot 
analysis of GM130 on rat brain lysate had shown detection at 130kDa (information 
provided by BD Transduction Laboratories
TM
).  The antibody was used at 1:500 
dilution. 
 
After incubation with the primary antibodies, and pre-immune serum incubation for 
negative controls, sections were washed three times in 0.1 M PBT for 30 min to 
ensure that most of the unbound primary antibody was washed away.  A second 
blocking step with 0.2% (w/v) BSA in 0.1 M PBT for 1 hr ensures that any 
remaining non-specific binding sites were blocked.  Sections were then incubated in 
fluorophore-conjugated secondary antibody solution (2
o
Ab + 0.2% (w/v) BSA in 
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PBT + 0.3% (v/v) Triton) at 4
o
C overnight.  From this step onwards, the samples 
were protected from light.   
 
3.2.2.2 Secondary Antibodies 
All secondary antibodies used were from Molecular Probes, Invitrogen: AlexaFluor 
® 568 goat anti-mouse (λEx = 579 nm, λEm = 603 nm) and Alexa Fluor ® 633 goat 
anti-chicken (λEx = 632 nm, λEm = 647 nm).  The excitation and emission 
wavelengths are summarised in Table 1 Appendix I. 
 
After secondary antibody incubation, the secondary antibody solution was removed 
and sections were washed three times for 15 min in 0.1 M PB.  Sections were then 
mounted on microscope slides and coverslipped (coverslip thickness #1, VWR).  
Mowiol (Calbiochem) supplemented with DABCO (Sigma) was used as the 
mounting medium with a refractive index of 1.41.  Sections were left to cure at 4
o
C 
in darkness until the mounting medium had set.   
 
3.2.3 Microscopic Image Acquisition 
The Zeiss LSM510 inverted microscope was used for all imaging.  Laser excitation 
and emission filters were described in Section 2.2.3, Chapter 2.  In addition to the 
488 nm Argon and the 543 nm HeNe1 excitation lasers, a HeNe2 excitation laser λEx 
633 nm was used to excite the far red secondary antibody.  All settings for image 
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acquisition were as described in Chapter 2 except that a HFT √/488/543/633 was 
used as the main dichroic beam splitter which passes all the specified excitation 
wavelengths (488, 543, and 633 nm) to the sample.  Another HFT 633 mirror was in 
place to reflect all the excitation light above 633 nm to a long pass 650 filter to 
collect emission of over 650 nm in a third channel.  Figure 3-2 shows the settings 
used for imaging in this experiment.  All other parameters were the same as 
described in Chapter 2.   
 
3.2.4 Image Processing  
The acquired stack of images was deconvolved to as described in Chapter 2.  The 
microscopic parameters used for deconvolution were as described except that the 
excitation and emission wavelengths of the third fluorescent protein was included.   
Briefly described, the microscope type – confocal; numerical aperture – 1.4; lens 
immersion and medium refractive indices – 1.51 and 1.4; x and y sample sizes – 60 
nm; z sample size – 170 nm; excitation wavelengths – 488 nm, 543 nm, 633 nm; 
emission wavelength – 509 nm, 603 nm, 647 nm; excitation photon count – 1; 




3.3.1 Trafficking of Newly Synthesised Vesicles along Dendritic Profiles 
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Images were selected where long profiles of dendrites with no overlapping could be 
seen clearly.  Images were separated into the green (VP-eGFP), red (GM130 
staining) and blue (MAP2 staining) channels using ImageJ 
(http://rsb.info.nih.gov/ij/).  The scale of the image was calibrated using ImageJ.  The 
three channels were merged into RGB colour images and a segmented line (360 nm 
wide, diameter of approximately 2 LDCVs) was drawn from the edge of the stained 
GA down individual optical slice of dendrites where vasopressin staining was 
observed and the line selection was saved.   Measurements of individual optical 
slices were used to ensure that there were no overlapping dendritic projections 
included in the measurements.  After all the line selections were obtained, the red 
and blue channels were switched off and the original 32-bit image of the green 
channel was used.  The saved line selections were then superimposed onto the green 
channel where fluorescent intensity measurements of VP-eGFP were made for each 
line.  Fluorescent intensity was recorded for every pixel at 60 nm interval along each 
line selection, to ensure that as much information was recorded as possible.  These 
measurements were saved and the area under curve (AUC; intensity x distance) was 
calculated for each segment of 6 µm of each line to compare fluorescent intensity 
along the dendrite.  Figure 3-3 shows a diagrammatic representation of the image 
analysis and an example of line selection drawn on a representative dendrite.  
Moreover, VP-eGFP fluorescence was measured at the GA by outlining the 
immunolabelled GA and superimposing this region of interest onto the VP-eGFP 
channel, where the sum intensity of VP-eGFP of the whole cell was measured.    
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To study whether newly synthesised vesicles translocate to dendrites and whether 
there is preferential translocation of newly synthesised vasopressin vesicles along the 
profile of dendrites, 125 dendrites were analysed using the methods described above.  
Varying lengths of dendritic profiles were analysed and dendritic profiles of as long 
as 54 µm were measured.  AUC measurements were divided into 6 µm segments.   
Table 3-1 shows the number of dendrites measured for each distance in each 
treatment group.  The AUC was used to calculate the mean intensity of each 6 µm 
segment.  All measurements comparing the effects of treatment to the distances 
measured were normalised to the total fluorescence intensity of each dendrite.  Since 
data was normalised to the total fluorescence intensity, only dendrites with the same 
distances measured were chosen for comparison.  This reduces the number of 
dendrites measured in each group and hence, the three longest distances (42 µm, 48 
µm and 54 µm) were analysed.  AUC of each line measurements of the 6 µm 
segment was compared between the three treatment groups using two-way ANOVA 
comparing treatment at each segment.  Figure 3-4 shows the mean total fluorescent 
intensity of the three treatment groups.  One-way ANOVA showed that there is no 
difference in mean total fluorescence intensity measured between groups.  Figure 3-
5 shows the % fluorescence comparison between the different treatment groups of 
the three total distances measured.  There is significantly less fluorescence at 6 µm in 
the GA exit block released compared to control and GA exit block (48 µm analysis) 
and between GA exit block released and GA exit block (54 µm analysis). This 
difference is not seen with the 42 µm analysis.  At 24 µm there is a significantly 
higher % fluorescence in control compared to GA exit block.  Comparing distances 
within groups, there is a significantly higher % fluorescence at 6 µm compared to the 
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rest of the dendrite in control and GA exit block, showing that the low temperature 
did not affect vesicles already in the dendrites at the time of GA exit block.  There is, 
however, no significant difference in % fluorescence between any distance in the GA 
block released group in all three total distances analysed.  This indicates that newly 
synthesised VP-eGFP vesicles released from the GA forces a redistribution of 




The findings in this study showed that newly synthesised vesicles translocate to 
magnocellular dendrites and that there is no difference in newly synthesised 
vasopressin vesicle location throughout the distances of the dendrites measured.  As 
mentioned in the introduction of this chapter, dendrites can be up to 200 µm long and 
hence the furthest distance analysed, up to 54 µm, should be considered as the 
proximal/middle portions of dendrites.  The purpose of this study is to find out 
whether there are progressively more/less newly synthesised vesicles located along 
the profile of dendrites.  20
o
C temperature incubation blocks vesicles exit from the 
GA (Griffiths et al. 1985; Ladinsky et al. 2002) and hence, release of temperature 
block leads to release of newly packaged vesicles.  In the present study, GA exit 
block at 20
o
C incubation did not affect vesicle distribution along the profile of 
dendrites since no significant difference in immunolabelled vasopressin intensity 
compared to control was observed.  There is a significantly higher percentage of 
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vesicles at 6 µm in both control and GA exit block compared to the rest of the 
dendrite.  Portions of dendrites proximal to the cell bodies were observed to be wider 
compared to the more distal portions measured.  The higher density of vasopressin in 
these dilatations may account for the higher immunolabelled vasopressin fluorescent 
intensity measured at proximal portions of dendrites since more peptides can be 
stored in these portions.  Interestingly, this difference was not observed in dendrites 
where the GA exit block was released.  Although there were significantly less 
vesicles at 6 µm in GA exit block released compared to control and GA exit block in 
the analysis where 48 µm and 54 µm of dendrites were taken into account, this 
difference was not observed in 42 µm analysis where more dendrites were analysed.  
Difference in % fluorescence between 6 µm and longer lengths of dendrites 
measured was not observed in GA exit block released experiments.  This indicates 
that release of newly synthesised vesicles from the GA might induce a redistribution 
of vesicles at close proximity to the GA and these newly synthesised vesicles 
translocate to dendrites.  The homogenous distribution of vesicles after GA exit 
block release also indicates that there are no preferential sites of storage for newly 
synthesised vesicles.  However, a difference in % fluorescence was not observed 
between GA exit block released compared to control.  This is probably due to that 
fact that the analysis method used was not sensitive enough to pick up all newly 
synthesised vesicles that translocated to the dendrite.  This is further demonstrated by 
the fact that there is no difference in mean total fluorescent intensity between the 
three groups (Figure 3-4).   
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Another reason why there is no difference in % fluorescence between GA exit block 
release and control might be due to the fact that high K
+ 
was used in the incubation 
medium.  It was found previously in pancreatic cells that release of GA exit block by 
re-incubation of sections at 37
o
C in the presence of a secretagogue triggered 
secretion of insulin (Saraste et al. 1986).  In the present study, the incubation 
medium contains high K
+
 which has been shown to promote neuronal survival in 
explants of the hypothalamus (Shahar et al. 2004) and to stimulate dendritic peptide 
release (Ludwig et al. 2002).  Hence, one reason why no difference in vesicle 
distribution was observed along dendrites after release of the GA exit block is that 
vesicles were undergoing exocytosis during the 30 min incubation at 37
o
C.  If newly 
synthesised vesicles were preferentially released (Duncan et al. 2003), then no effect 
of vesicle re-distribution after the release of GA exit block will be observed since 
newly synthesised vesicles released from the GA will be exocytosed.  However, in 
pancreatic cells, it was found that there was a 20 - 30 min lag period of insulin 
release after cells were re-incubated at 37
o
C (Saraste et al. 1986).  Therefore, it is 
unlikely that increased exocytosis can fully account for the fact that no difference 
was found in vesicle distribution after the release of GA exit block. is a homogenous 
distribution of vesicles throughout the profiles of dendrites.  
 
One limitation to the present study is that because magnocellular dendrites contain a 
large amount of peptides, and in this case, vasopressin, it is difficult to quantify 
vasopressin content using any other method than fluorescent intensity.  Salt loading 
animals before experiments can lower vesicle content in dendrites and make 
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quantification more reliable (Tobin et al. 2004).  However, salt loading has been 
found to increase the number of newly synthesised, immature secretory granules 
(Morris & Dyball 1974).  Moreover, salt loading has been found to change the 
average diameter of dendrites (Dyball & Garten 1988; Hatton 1990).  As mentioned 
earlier, vesicle accumulation is preferential in dilatations of dendrites (Morris 2005) 
and hence, salt loading was not used in this study to minimise the vasopressin density 
for measurement.   
 
As discussed in Chapter 1, it was found that there are no active sites for peptide 
release in dendrites and all parts of the dendritic plasma membrane are capable of 
exocytosis (Pow & Morris 1989).  After exit from the GA, vesicles travel to their 
sites of secretion via microtubules (for review see (Park et al. 2009).  Hence, 
microtubule distribution is an important factor regulating distribution of newly 
synthesised vesicles.  In vitro secretion studies showed a decrease in peptide release 
from magnocellular dendrites after applying a depolarising stimuli subsequent to 
colchicine treatment which inhibits polymerisation of microtubules (Tobin & Ludwig 
2007a) suggesting the importance of microtubules in the transport of peptide-
containing vesicles in magnocellular dendrites.  The same study reported 
immunoreactivity of β-tubulin, one of the polymers that make up microtubules, in 
dendrites. However, the distribution of β-tubulin in dendrites was not discussed.  
Studies using immunohistochemistry to stain for microtubule-associated protein, an 
important component of microtubule crossbridges, has found extensive staining in 
oxytocin labelled neurons in the dendritic zone in the SON (Matsunaga et al. 1999), 
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further suggesting the presence of microtubules in dendrites.  Further experiments 
looking at the distribution of tubulin during GA exit block and release of GA exit 
block along magnocellular dendrites can be done to complement the present study. 
 
Combining the findings in this chapter with results in Chapter 2, where lysosomes 
were identified, it is likely that both newly synthesised and aged peptide vesicles are 
found in magnocellular dendrites.  However, it is still unknown whether there are 
specific mechanisms controlling peptide vesicle routing to magnocellular dendrites 
and whether the dynamics of vesicle transport and segregation of vesicle pools are 
regulated according to vesicle age.  Vesicle age cannot be studied in fixed tissue 
sections unless it is possible to distinguish newly synthesised vesicles and aged 
vesicles.  Since it is still unknown whether like newly synthesised vesicles in bovine 
adrenal chromaffin cells (Duncan et al. 2003), newly synthesised vesicles in 
magnocellular dendrites are preferentially released, it is important to identify 
vesicular age.  One method to study newly synthesised vesicles in dendrites is to 
express inducible exogenous reporter proteins targeted to vesicles (Zhang et al. 2002; 
Taupenot 2007).  If vesicle expression can be switched on/off as desired, then newly 
synthesised vesicles and aged vesicles can be identified using a “pulse-chase” 
protocol (Han et al. 1999).  The expression of the exogenous reporter protein can 
switched on for certain periods before fixation to identify newly synthesised vesicles, 
or expression can be switched off to identify aged vesicles.  Another way is to use a 
fluorescent time stamp that changes colour as it matures over time (Terskikh et al. 
2000) to label both newly synthesised and aged vesicles like that used in bovine 
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adrenal chromaffin cells as discussed in Chapter 1 (Duncan et al. 2003).  Both these 
methods will be discussed in later chapters but to carry out these experiments, first it 
is important to establish viable slice cultures of the hypothalamus (House et al. 1998) 
which is essential for pulse-chase experiments and second, because neurons are non-
dividing cells, they are difficult to transfect, making it difficult to express exogenous 
proteins.  Moreover, it is also important to establish a live cell imaging technique that 
can be used in the magnocellular system so that the dynamics of newly synthesised 
and aged vesicles and the segregation into different vesicle pools can be visualised in 
real time.  Hence, the next chapters will look at the establishment of viable 
organotypic slice cultures of the hypothalamus, a live cell imaging technique suitable 
for use in the study of vesicle release in magnocellular dendrites, transfection 
techniques that have been tested on magnocellular neurons, and generation of a range 
of constructs targeted for expression in dense core vesicles. 









Figure 3-1.  Schematic diagram showing hypothetic outcome of temperature block 
on vesicle exit from the Golgi apparatus.  (A)  Vesicle exit from GA blocked by low 
temperature (20
o
C).  Re-incubation at 37
o
C lead to release of GA exit block and: (B) 
newly synthesised vesicles preferentially transported to distal dendrite; (C) Newly 
synthesised vesicles reside at proximal potion of dendrite; or (D) Homogenous 
storage of newly synthesised and aged vesicles along dendritic profiles with no 
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Figure 3-2.  Beam path configuration for 3-channel imaging with the confocal laser 
scanning system.  BP 500 – 550 and BP 565 – 615 as described before.  HFT 
√/488/543/633 was used as the main dichroic beam splitter which passes all the 
specified excitation wavelengths (488, 543 and 633 nm) to the sample.  The HFT 633 
reflects all the excitation light above 633 nm to the long pass 650 filter and all the 
light under 633 nm to the NFT 545 filter.  The NFT 545 is the secondary dichroic 























Figure 3-4.  Mean total fluorescent intensity of dendrites measured.  There is no 
difference between treatment groups (one-way ANOVA). 




Figure 3-5.  Graph showing % fluorescence along the profile of dendrites.  % 
fluorescence is measured in 42 µm, 48 µm, and 54 µm of dendrites (A, B and C 
respectively).  In all the three lengths measured, two-way ANOVA comparing 
treatment groups at each distance showed significant difference between 6 µm and 
the rest of the dendrite in control and GA exit block only (p<0.05).  There is a 
significantly higher % fluorescence at 6 µm in control and GA exit block compared 
to GA exit block released (p<0.05) (B and C).  However, this difference was not 
observed when only 42 µm of the dendrite was measured.  Values are mean ± SEM, 
normalised to total fluorescent intensity.   




 Number of sections measured in each group 
Distance 
Measured 
Control GA exit block 
GA exit block 
released 
6 µm 39 50 47 
12 µm 39 49 46 
18 µm 35 39 39 
24 µm 29 33 29 
30 µm 22 27 19 
36 µm 17 17 12 
42 µm 11 11 7 
48 µm 8 9 5 
54 µm 6 5 4 
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4. LIVE CELL IMAGING OF DENDRITIC PEPTIDE RELEASE 
 
4.1 Introduction 
The VP-eGFP transgenic rat has provided a valuable resource for identifying 
vasopressinergic neurons in different brain areas without prior staining procedures 
(Ueta et al. 2005).  Moreover, it provides the opportunity for live cell imaging of 
vasopressinergic neurons without prior transfection or transduction.  Live cell 
imaging is a technique that had been vastly used to study the exocytotic machinery of 
neuroendocrine cell lines.  A range of different microscopic techniques have been 
used to offer deeper understanding in vesicle motility, segregation of vesicle pools, 
and dynamics of exocytosis.  (Levitan 1998; Steyer et al. 1997; Straub et al. 2000).  
Although some of these techniques, for example, Total Internal Reflection 
Microscopy (TIRFM) which images events occurring at the plasma membrane, are 
used with great success to image exocytotic/endocytotic events in neuroendocrine 
cell lines (Merrifield et al. 2002; Nofal et al. 2007), they have limited use for 
imaging vesicle release from magnocellular neurons.  TIRFM uses evanescent wave 
illumination and only illuminates within 100 nm of the specimen and hence, 
specimens imaged will have to be adhered to the cover glass that these cells were 
cultured on.  Isolated cell preparation of magnocellular neurons is largely devoid of 
dendrites, so brain slices had to be used to image dendritic release of vasopressin in 
the form of VP-eGFP.  Brain slices contain layers of different cell types and 
connective tissues hence, making them unsuitable for TIRFM imaging.  On the other 
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hand, wide field microscopy offers a simple and fast way to image fluorescence.  
However, this technique has the drawback of collecting light that is in and also out of 
focus, making it impossible to determine peptide release from a single neuron.  
Therefore, it is important to determine the appropriate microscopy technique to be 
used for live cell imaging, meanwhile, taking into consideration the preparation of 
the specimen used for imaging.  In contrast to wide field imaging, confocal imaging 
only samples from the plane of focus and hence, it is possible to identify single 
neurons.   
 
An important aspect of live cell imaging is the choice of preparation of the cells 
imaged.  As discussed above, brain slices are more appropriate for imaging dendritic 
peptide release in magnocellular neurons than isolated neurons.  Acute brain slices 
are soft and thick, and flatten under their weight on cover slips over the time course 
of imaging.  Due to these physical properties, cultured brain slices were more ideal 
for imaging purposes.  Stationary organotypic slice culture provides a means of 
keeping slice tissues alive for up to several weeks (Stoppini et al. 1991; Gahwiler et 
al. 1997) and also, slice tissues flatten and adhere to the culture interface during 
culture, making it easier to handle and reduce flattening during imaging.  The 
organotypic slice culture technique offers a way to study molecular mechanisms of 
magnocellular neurons where neurons maintain their synaptic connections as well as 
their physiological and morphological properties (House et al. 1998; Stoppini et al. 
1991; Gahwiler et al. 1997; Cho et al. 2007).  Although cultures of dissociated 
hypothalamic neurons are possible, these cultures survive best when the neurons 
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were obtained at the embryonic stage of the animal (Benda et al. 1975; Jirikowski et 
al. 1981), when these cells contain very little vasopressin and almost no oxytocin 
(Sinding et al. 1980b).  The main advantage of organotypic slice culture technique is 
that brain tissues were obtained from neonatal animals, where the magnocellular 
neurons have fully differentiated.  Moreover, neurons maintain their cytoarchitectural 
features, as well as their physiological phenotype.  Slices typically thin down to 80 – 
100 µm (House et al. 1998) which enable further manipulations like 
immunohistochemistry and live cell imaging.  All these characteristics of slice 
cultures, coupled with the use of VP-eGFP rats, made live cell imaging of 
magnocellular cell bodies and dendrites possible.   
 
While slice cultures prepared from neonatal rat brains are optimal for imaging, it is 
important to establish the physiological significance of using the SON of neonatal 
rats as a model system.  In neonatal rats, osmotic challenge had been shown to 
induce vasopressin release into the plasma (Sinding et al. 1980a).  This stimulus was 
found to deplete vasopressin content in the neurohypophysis by ~40%.  Osmotic 
challenge is known to activate neurons in both the SON and the PVN (Penny et al. 
2005).  In adult rats, magnocellular neurons of both the SON and PVN respond to 
osmotic challenge by releasing vasopressin (reviewed in (Leng et al. 1999) into the 
circulation which then acts as a vasoconstrictor and anti-diuretic agent in response to 
increased osmolality.  In the rat, oxytocin was also released after osmotic stimulation 
(Brimble et al. 1978).  The magnocellular vasopressin system is responsive by the 
time of birth (Altman & Bayer 1986; Sinding et al. 1980a).  However, direct 
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evidence for the activation of the neonatal SON in the rat in response to osmotic 
stimulation had not been shown.  In this chapter, the activation of the neonatal SON 
under osmotic challenge, and live cell imaging of VP-eGFP neurons using 
organotypic slice explants of post natal day 7 (P7) rats will be discussed.  Stimulated 
and primed vasopressin release from dendrites by thapsigargin was visualised using 
single photon laser scanning microscopy.    
 
 
4.2 Material and Methods 
4.2.1 Osmotic challenge in P7 rats 
Twelve P7 rat pups, chosen from two separate litters were used in this experiment.  
Six P7 rats were injected with hypertonic saline solution, 1 ml/100 g of 1.5 M NaCl 
(i.p.) (Giovannelli et al. 1992), the other six were used as control without injections.  
Isotonic saline injection had been shown to have no effect on Fos expression in the 
SON, compared to animals not injected (Sharp et al. 1991); hence control animals 
received no injections.  Three male and three female rats were used in each group.  
One adult rat was injected with hypertonic saline as a positive control for 
immunolabelling.  Animals were killed by decapitation 1 hr after injection, since Fos 
production should be seen 30 – 90 min after induction of vasopressin neuronal 
activity (Kawasaki et al. 2005; Sharp et al. 1991).  The hypothalami were then 
trimmed from the brain, fixed in 4% (w/v) PFA in 0.1 M PB (recipes of all solutions 
can be found in Appendix I), changed to 2% (v/v) PFA and 15% (w/v) sucrose in PB,  
 
   ____Chapter 4 Live cell imaging of dendritic peptide release 
 100
then to 30% (w/v) sucrose in 0.1 M PB (all overnight incubations at 4
O
C). The fixed 
tissue was then snap-frozen on dry ice and cut on a freezing microtome to 52 µm 
sections.  Only sections containing the SON were collected for immunohistochemical 
labelling of Fos protein.  Fos protein is derived from c-Fos, an immediate early gene, 
which is transcribed upon activation of many cell types, including magnocellular 
neurons in the hypothalamus (Berciano et al. 2002; Luckman et al. 1994; Hoffman et 
al. 1993).  The use of Fos immuno-staining as an indication of neuronal activation is 
well documented for magnocellular neurons under osmotic stimulation (Giovannelli 
et al. 1992; Hoffman et al. 1993; Sharp et al. 1991).     
 
4.2.1.1 Three-step ABC method for labelling of Fos protein 
Sections containing the SON were washed in 0.1 M PB + 0.2% (v/v) Triton X100 
(PBT) four times for 10 min.  To deactivate endogenous peroxidases, sections were 
then incubated in 20% (v/v) methanol and 1% (v/v) H2O2 in 0.1 M PB for 15 min.  
Sections were then washed in 0.1 M PBT twice for 10 min then in 0.1 M PB once for 
5 min.  To block non-specific binding of antibodies, sections were incubated in a 
cocktail of 1% (v/v) animal serum in 0.1 M PBT (blocking solution) at room 
temperature for 1 hr.  A primary antibody solution, containing the antibody against 
Fos protein, rabbit polyclonal Ab-2 Fos (Oncogene Sciences), was made up with 1% 
(v/v) animal serum in 0.1 M PBT and Ab-2 Fos in a concentration of 1:1000.  The 
primary antibody was left out in the negative control, where sections were only 
incubated in blocking solution.  Sections were incubated in either primary antibody 




   ____Chapter 4 Live cell imaging of dendritic peptide release 
 101
 
The next day, sections were washed with 0.1 M PBT for three times for 5 min then 
twice for 10 min.  During these washes, the avidin DH:biotinylated horseradish 
peroxidase complex was made up in PBT in the ratio of 1:1:3.  This complex had to 
be made up half an hour prior to use.  After washing, sections were incubated in 
biotinylated anti-rabbit immunoglobulin (Vector labs) and 30% (v/v) normal goat 
serum in 0.1 M PBT at room temperature for 1 hr.  Sections were then washed in 0.1 
M PBT three times for 5 min.  After washing, sections were incubated in the Avidin 
DH complex at room temperature for 1 hr.  Sections were then washed twice for 10 
min and then rinsed in 0.1 M sodium acetate (pH6) for 5 min. 
 
To visualise, Nickel II sulphate was dissolved in 0.2 M sodium acetate buffer 
(appendix I).  Sections were incubated in this buffer until a colour change was 
observed and the reaction was terminated by the addition of 0.1 M sodium acetate.  
Sections were then mounted on 0.5% (v/v) gelatinised slides and air dried.  Air dried 
sections were then washed in a series of ethanol solutions: 50% for 5 min, 70% for 5 
min, 90% for 5 min, 95% for 5 min, 100% twice for 10 min each, and xylene twice 
for 10 min each.  After dehydration, sections were coverslipped with DPX (VWR) 
and the mounting medium was left to cure overnight. 
 
Sections containing the SON, identified by the anatomical location in the 
hypothalamus, were viewed by a light microscope.  Ten sections containing the SON 
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were analysed per animal.  Fos immunoreactive cells were counted manually and the 
mean ±SEM for Fos counts per animal was compared between osmotically 
challenged and control groups by one way ANOVA.  All statistical tests were carried 
out using Sigma Stat.   
 
4.2.2 Organotypic slice culture 
Rat pups, 7 days old were anaesthetised with halothane or isofluorane and 
decapitated and their brains quickly removed.  Hypothalamic tissue blocks were cut 
by sectioning the brains with a vibratome in aCSF-sucrose-KOH solution (appendix 
I).  Osmolarity of solution was 300 mOsm/L.  Solution was gassed with oxygen 
throughout slicing.  Three to four 300 µm thick coronal slices containing the SON 
and part of the PVN were obtained from each brain.  Slices were kept in ice cold 
Gey’s Balanced Salt Solution (Sigma-Aldrich, UK) enriched with 5 mg/ml glucose 
(Sigma-Aldrich, UK).  Selected sections were kept in a petri dish with Gey’s solution 
at 4
o
C for 1-2 hours.  Explants were then placed on Millicell-CM filter inserts 
(Millipore, pore size 0.4 µm, diameter 30 mm) in 6-well culture dishes with 1.1 ml of 
culture medium (Stoppini et al. 1991).  Explants were incubated at 37
o
C in 5% CO2 
in a stationary manner.  Culture medium was replaced three times a week (House et 
al. 1998).  Explants were maintained for up to 14 days in vitro (DIV).  
 
Culture Media:  Serum-containing medium 
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Serum-containing growth medium was shown to help the slices to thin down to a few 
cell layers so that procedures such as live cell imaging could be done on the slices as 
whole mounts (House et al. 1998).  The serum-containing medium was composed of 
50% (v/v) Eagles basal medium (BME, Sigma-Aldrich, UK), 25% (v/v) heat-
inactivated horse serum (Harlan, UK), and 25% (v/v) Hanks balanced salt solution 
(Gibco).  The osmolarity of the medium was 320-325 mOsm/L.  Medium was 
supplemented by 0.5% (w/v) glucose, 2 mM glutamine, 25 µg/ml 
penicillin/streptomycin (House et al. 1998), 20 ng/ml ciliary neurotrophic factor 
(CNTF) (all from Sigma-Aldrich, UK), and 25 mM KCl.  It has been suggested that a 
higher KCl content increased the exocytotic capabilities of rat cerebellar granule 
neurons (Yamagishi et al. 2000).  CNTF was found to substantially increase the 
survival of both oxytocin and vasopressin magnocellular neurons in the SON in 
organotypic slice cultures by preventing programmed cell death (Rusnak et al. 2003).   
 
4.2.3 Live cell imaging 
Live cell imaging experiments were performed on organotypic slice cultures of the 
SON between 7 days in vitro (DIV7) to DIV14 when slices had adhered to 
membrane filters and flattened down.  The slices were excised from the membrane 
filter and placed inverted on a 30 mm coverslip (thickness #1) and assembled in a 
POC open perfusion adaptor (LaCon, Germany) as shown in Figure 4-1.  The 
perfusion chamber was then placed on a microscope stage heated to 37
o
C and inside 
an environmental chamber gassed with humidified air and 5.5% CO2.  A 21-gauge 
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needle was used for the outflow instead of the original outlet of the chamber.  The 
needle was connected to two outflow tubes being pumped at the same time to ensure 
constant rate of outflow.  The tissue was continuously perfused with tyrode solution 
at a rate of 0.5 ml/min, with or without stimulus.  All solutions were adjusted to pH 
7.2 and 300mOsm.  Tyrode’s solutions were warmed to 37
o
C throughout the 
experiment.  Refer to appendix I for recipes.  Figure 4-2 shows a schematic diagram 
of the perfusion set up. 
 
4.2.3.1 Timeline for image acquisition 
Thapsigargin had been shown to potentiate release of oxytocin and vasopressin after 
30 min of pre-treatment (Ludwig et al. 2002; Ludwig et al. 2005).  Hence, 
experiments were carried out at 42 min sessions.  Four groups of experiments were 
carried out: control (42 min Tyrode’s solution), potassium stimulated (30 min 
Tyrode’s + 10 min 50 mM K
+
), thapsigargin treatment (42 min 200 nM 
Thapsigargin), and thapsigargin treated, potassium stimulated (30 min Thapsigargin 
+ 10 min K
+
).  2 min was allowed for change of solution.  A schematic diagram 
showing the imaging timeline is presented in Figure 4-3.   
 
4.2.3.2 Microscopic image acquisition  
The Zeiss LSM510 inverted microscope was used for all imaging.  The 488 nm line 
of the Argon laser was used to excite eGFP which has an excitation maximum of 488 
nm and an emission maximum of 509 nm.   A HFT 488 filter was in place and the 
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excitation laser passed through two mirrors before the emitted light was collected by 
a band pass 500 – 550 filter (please refer to Figure 2-2).  The photomultiplier tube 
(PMT) settings were adjusted so that small projections from the neurons would be 
visible and were the same for all experiments.  The pinhole was adjusted to 
maximum so that the maximal emission from the specimen could be collected.  The 
laser excitation was set to 15% so that visualisation of eGFP was achievable whilst 
bleaching was kept at minimal.  Images were acquired with an x63 water immersion 
objective (NA1.2).  The lateral resolution was 216 nm for 509 nm emission 
wavelength and NA1.2.  The Nyquist sampling rate, calculated by the Nyquist 
calculator on the Scientific Volume Imaging support website, was 106 nm, 106 nm 
and 341 nm for x, y, and z sampling respectively.  Double nyquist sampling rate was 
employed to avoid under-sampling.  3-dimensional images were obtained by 
scanning the x, y –planes at 60 nm, achieved by line scanning 1024 x 1024 pixels 
with an optical zoom of 2.4, and intervals of 170 nm along the z-axis was acquired at 
the time points mentioned above.  8 bit pixel depth, line averaging of 1 (no 
averaging) and maximum scan speed were chosen for image acquisition to avoid 
photobleaching. 
 
4.2.3.3 Fluorescent image processing 
The acquired stack of images was deconvolved to remove aberrations caused by the 
intrinsic physical properties of the microscope.  The microscopic parameters used for 
deconvolution was set according to the parameters used for imaging: microscope 
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type – confocal; numerical aperture – 1.2; lens immersion and medium refractive 
indices – 1.3; x and y sample sizes – 60 nm; z sample size – 170 nm; excitation 
wavelength – 488 nm; emission wavelength – 509 nm; excitation photon count – 1; 
backprojected pinhole – maximum.  These parameters were used to calculate a 
theoretical point spread function.  Please refer to Chapter 2, section 2.2.4 for a more 




4.3.1 Osmotic challenge in P7 rats 
Figure 4-4 shows Fos expression in the SON of P7 control and osmotically 
challenged rats, and adult positive control.  The SON was identified by its anatomical 
location.  Landmark features like the 3
rd
 ventricle and the optic chiasm are also 
shown in the images.  Figure 4-5 shows the mean number of Fos positive cells per 
SON ±SEM in control and osmotically challenged P7 rats.  One way ANOVA 
followed by post-hoc Student’s t-test showed that there was significant difference 
(p<0.001) in the number of Fos positive cells between the two groups.  Marked 
increase in the number of Fos immunoreactive cells in the SON suggests activation 
of magnocellular neurons due to osmotic stimulation.  This indicates that 
magnocellular neurons in P7 rats were responsive to the osmotic challenge. 
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4.3.2 Live cell imaging 
Deconvolved images were viewed and analysed by the image analysis software, 
ImageJ (http://rsb.info.nih.gov/ij/).  The 3-D image acquired at each time point was 
then represented as a 2-D image by adding the values of each pixel through the z 
stack and displays it as a sum value.  Due to the decrease in fluorescent intensity as 
the imaging depth increased, 10 optical slices of dendrites from the centre of each 
stack were summed up for 2-D representation.  Hence, 32-bit images were analysed 
so that accurate sums were retained.  The 2-D images were created for image stacks 
collected for each time point and then aligned using the stacks shuffling plug-in 
(Thevenaz et al. 1998) to ensure that the same area was measured for each time 
point.  This allowed for measurement of fluorescent intensities in regions of interest 
by the analyse and measure functions in the software.  An example of region of 
interest measurement is shown in Figure 4-6.  Measurements made for different time 
points were done separately to indicate the amount of eGFP fluorescent gained or 
lost throughout the experiment.  
 
Figure 4-7 shows images of dendrites acquired in the live cell imaging experiments.  
One example of control, K
+
 stimulated and thapsigargin pre-treated K
+
 stimulated 
experiment is shown.  Figure 4-8A shows the changes in fluorescent intensity in 
dendrites after stimulation.  Fluorescent intensity data collected was normalised to 
data at 30 min, the time point imaged before stimulation.  Mean fluorescent 
intensities ±SEM were calculated and compared between groups using two-way 
ANOVA on repeated measures to show changes in intensities between time points 
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and between groups.  The control experiment, with no stimulation, recorded the 
extent of photobleaching and basal vesicle release.  This accounts for ~ 25% loss of 
eGFP signal.  Comparing 32 min to 42 min, there is a significant decrease in 
fluorescent intensity in dendrites in K
+
 stimulated and thapsigargin pre-treated K
+
 
stimulated groups but not in control and thapsigargin treated groups (two-way 
ANOVA, post-hoc Student’s t-test, p<0.05), showing release of VP-eGFP vesicles 
after stimulation.  Fluorescent intensity in thapsigargin pre-treated K
+
 stimulated 
group showed significant decrease compared to other groups at 42 min (p<0.05), 
suggesting that thapsigargin pre-treatment was able to potentiate further release of 
vesicles after K
+
 stimulation (a further ~ 20% release compared to K
+
 depolarisation 
alone, Figure 4-8B).   
 
To ensure that fluorescent intensity changes were due to release of VP-eGFP, 
background fluorescence decay was obtained by measuring the fluorescent intensity 
of 10 x 2 µm squared areas in the background of each image.  A single exponential 
decay function was fitted to the data.  The mean exponential decay constants (Figure 
4-8C) for each group were compared (two-way ANOVA) and showed no difference 
in rate of decay, suggesting that decrease in fluorescent intensity measured in 
dendrites were due to the release of VP-eGFP and not due to increase in fluorescent 
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4.4 Discussion 
Use of organotypic slice cultures provides several advantages to the efficacy in live 
cell imaging.  However, since cultures had to be obtained from neonatal rats, it was 
necessary to establish the physiological responsiveness of magnocellular neurons at 
that age.  Neonatal P7 rats had been shown to have a raised membrane capacitance 
and decreased membrane resistance compared to adult rats (Chevaleyre et al. 2001).  
These characteristics were correlated to an increase in dendritic ramifications.  
Despite these early differences, the membrane potential of magnocellular neurons at 
this age was shown to start to stabilise and display typical firing patterns of adult 
magnocellular neurons.  The increase in number of dendritic ramifications could 
facilitate the formation of glutamatergic synapses, as found in the dendrites of 
hippocampal neurons (Tyzio et al. 1999).  In magnocellular neurons, excitatory 
postsynaptic currents were found to be blocked by CNQX (NMDA receptor 
antagonist) around P7 – P8, suggesting glutamatergic activation (Chevaleyre et al. 
2001).  In the osmotic challenge experiments, the SON of P7 animals were shown to 
be responsive to hypertonic saline injections, suggesting activation of the 
magnocellular neurons by osmotic challenge.  Although neurons were not labelled 
for VP or OT, it is likely that the activated cells in the SON represent magnocellular 
neurons.   
 
In the present study, thapsigargin priming induced a ~ 20% potentiation of K
+
 
stimulated vasopressin release (Figure 4-8B). Compared to in vitro release 
 




 depolarisation induced a ~ 30% increase in vasopressin release after 
thapsigargin pre-treatment for 30 min compared to high K
+
 treatment alone (Ludwig 
et al. 2005).  It is worth noting that whilst the VP-eGFP gene was incorporated into 
vasopressin cells, endogenous vasopressin was still being produced.  Hence, whilst 
measurement of VP-eGFP intensity only detected release of vasopressin tagged to 
eGFP, endogenous vasopressin release would not be accounted for using this 
method.  LDCV release from the magnocellular dendrite is considered a rare event 
(Leng & Ludwig 2008).  Intracellular Ca
2+
 mobilisation caused by thapsigargin 
treatment enhanced this rare release event by recruitment of LDCV to the RRP 
(Tobin et al. 2004).  Thus, vesicle recruitment to the RRP can increase release by 20 
– 30%.  Interestingly, there were no differences in fluorescent intensity measured at 
42 min comparing high K
+
 depolarisation and control, even though there was a 
significant decrease in intensity at 42 min compared to 32 min with K
+
 stimulation 
only (Figure 4-8A).  This difference was contributed by an insignificant increase in 
fluorescent intensity in the K
+
-treated group at 32 min compared to other groups.  
This suggests that K
+
 depolarisation may cause quick vesicle mobilisation and 
vesicle pool replenishment, resulting in a higher VP-eGFP fluorescent intensity right 
after K
+
 stimulation.  Studies in the Calyx of Held synapse (Hosoi et al. 2007) and 
the synapses in the auditory brainstem (Wang & Kaczmarek 1998) found that strong 
depolarising potentials caused an influx of calcium which was essential to rapid 
vesicle recruitment to the presynaptic terminal.  It is not known whether 
magnocellular neurons display rapid vesicle recruitment after depolarisation with K
+
, 
however, vesicle recruitment in the magnocellular dendrite has previously been 
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shown using thapsigargin (Tobin et al. 2004).  It is unlikely that vesicle pools 
mobilised by thapsigargin is the same vesicle pool mobilised by high potassium 
stimulation since potassium depolarisation was unable to mobilise the thapsigargin-
sensitive vesicle pool in magnocellular dendrites (Ludwig et al. 2002).  Nevertheless, 
an ability to recruit and mobilise vesicle pools in magnocellular dendrites may 
explain the small rise in VP-eGFP fluorescent intensity at 32 min in K
+
-treated 
samples leading to a significant difference in fluorescent intensity compared to 42 
min, although VP-eGFP fluorescent intensity at both time points was not different 
between K
+
-treated and control groups.  
 
Basal release of VP-eGFP and photobleaching accounted for ~ 25% loss of eGFP 
signal.  It could be argued that usage of two-photon excitation would minimise loss 
of eGFP signal due to photobleaching since multiphoton excitation only occurs in 
one focal plane and hence, other focal planes of the cell would not be bleached 
during stack acquisition.  Reduction in photo-excitation of cells in general also 
reduces phototoxicity, which is the result of free radicals generation by laser 
excitation.  However, studies comparing cell viability between the use of one- and 
two-photon excitation in chondrocytes found that 84% of cells survived 30 min of 
continuous irradiation of 488 nm single-photon laser excitation (Bush et al. 2007).     
Moreover, photobleaching of GFP by two-photon excitation was found to be more 
enhanced compared to single-photon excitation (Chen et al. 2002) in live cell 
imaging of transfected HeLa cells.  Single-photon confocal imaging of cultured brain 
slices has also been achieved in other brain areas and cell types, e.g. endothelial cells 
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in capillaries and noradrenalinergic neurons in brainstem slices, and pyramidal cells 
in the hippocampus (Teschemacher et al. 2005). 
 
There are several problems associated with imaging live cells in slices.  Firstly, 
instability and movements in both the microscope and the tissue are the major 
problems.  A 1
o
C change in temperature of the microscope set up could account for a 
1 µm movement in the lateral or axial direction (Kasparov et al. 2002).  Therefore, it 
was important to minimise these movements by the use of environmental chambers, 
heated microscope stage, heated solutions and by taking a stack of images in the Z 
direction to make sure that the whole cell is accounted for.  Solution flow rate and 
change of solution can also affect displacement of the tissue.  An environmental 
chamber had been used to keep the temperature on the microscope stage stable.  Two 
outflow tubes had also been attached to the perfusion chamber to ensure steady flow 
of solutions.  Aside from the inherent problems encountered from the microscope set 
up, scattering of light and difference in light absorbance throughout the thickness of 
the section affect the resulting image quality.  These affect organotypic slice cultures 
to a lesser extent since cultures are made from neonatal animals which are optically 
optimal; and slice explants flatten to a few cell layers.  Nevertheless, to image whole 
neuronal cell bodies along with their dendritic projections may require imaging 
depths of tens of micrometers.  This depth of image is in itself a problem since 
fluorescence from the top of the image has less distance to travel compared to 
fluorescence from within the tissue; i.e. fluorescent intensity is stronger at the top of 
the image.  This has to be taken into consideration when quantifying fluorescent 
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intensity and hence, 10 optical slices (~1.67 µm in total) in the centre of the stack 
were selected for image analysis.   
 
Lastly, photobleaching and phototoxicity are the most important factors of concern in 
live cell imaging.  The fluorophore used in the experiments in this chapter is eGFP, 
which is a mutated (S65T) version of wild-type green fluorescent protein, GFP.  
Photobleaching in eGFP had been reported to be relatively stable (Swaminathan et 
al. 1997; Tsien 1998) making it suitable as a reporter protein in live cell imaging 
experiments.  Live cell imaging of VP-eGFP in organotypic slice cultures revealed 
significant loss of VP-eGFP within dendrites after depolarisation by 50 mM K
+
 and 
further potentiated release by depolarisation after thapsigargin pre-treatment.  This is 
in accordance with findings in in vitro experiments where isolated SON was 
stimulated and release measured with radioimmunoassays (Ludwig et al. 2002; 
Ludwig et al. 2005).  Since vasopressin release was quantified by the loss of VP-
eGFP fluorescence, it is important to establish that eGFP fluorescence was not 
affected by the treatments used.  eGFP is a class2 GFP, where two point mutations 
led to enhanced photostability, increased fluorescence and stability at 37
o
C.  eGFP is 
also pH sensitive, decreasing in fluorescent intensity at slightly acidic pH (Patterson 
et al. 1997).  To ensure that loss of eGFP fluorescence was due to vasopressin 
release, background fluorescent decay was measured.  Background fluorescence was 
caused by eGFP cells not in focus and by noise.  If the stimuli applied caused a 
decrease in eGFP emission, there would also be a significant decrease in background 
fluorescence compared to control.   Analysis of the exponential decay constants 
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demonstrated that this was not the case; i.e. there was no change in background 
fluorescence in any group at any time point.  Also, thapsigargin treatment without 
depolarisation did not cause a significant change in fluorescent intensity in dendrites, 
suggesting that thapsigargin was unable to induce a significant amount of release of 
VP-eGFP detectable by fluorescent intensity measurement and that thapsigargin 
treatment did not cause changes in properties of eGFP fluorescence. 
 
Results from the live cell imaging experiments showed that live cell imaging of P7 
organotypic slice cultures provided comparable findings as in in vitro release 
experiments.  Results from the osmotic challenge experiments also showed that 
neonatal P7 rats were suitable for use in live cell imaging experiments.  In addition, 
organotypic slice cultures are easy to handle and maintain, and could be transfected 
to induce expression of other fluorescent constructs of interest by use of biolistic 
transfection (discussed in next chapter) or viral transduction for live cell imaging 
(Teschemacher et al. 2005) providing a robust model system to study dendritic 
peptide release in magnocellular neurons.     
 


















Figure 4-1.  Perfusion chamber components.  The POC mini chamber (LaCon, 
Germany) has an observation area of 17 – 22 mm.  A slice explant was placed 
inverted on top of a 30 mm diameter cover slip (thickness #1).  The perfusion 
adaptor allowed for an open perfusion system; influx was through the inlet attached 
to the perfusion adaptor and outflow was achieved by a 21-gauge needle attached to 
two outflow tubes. 









Cover slip, 30mm 
The distance between the cover slip and the 
top of the adapter is 7.5mm. 
IN OUT 
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Figure 4-2.  Perfusion set up for live cell imaging experiments.  Solutions were 
heated up in a 37
o
C water bath and pumped in to the perfusion adaptor by a 
peristaltic pump (0.5 ml/min).  Two outflow lines were used to keep the outflow 
stable.  Solution change was achieved by a three-way tap.  The perfusion adaptor was 
placed on a stage heated to 37
o
C.  The heated stage was encased in an environmental 


























Figure 4-3.  Image acquisition timeline for live imaging.   A stack of images were 
taken at 0 min, 30 min, 32 min and 42 min.  1) Control: sections were perfused with 
Tyrode’s solution throughout; 2) 30 min Tyrode’s solution + Tyrode’s solution 
containing 50 mM K
+
 thereafter; 3) perfusion with Tyrode’s solution containing 200 
nM thapsigargin throughout; 4) perfusion with Tyrode’s solution containing 200 nM 












































Figure 4-4.  Fos expression in the hypothalamus.  A-D: postnatal day 7 (P7) 
Sprague Dawley rats; E and F: adult positive control. B, D and F (scale bar = 50 
µm) are magnified images of the SON from A, C and E (scale bar = 200 µm) 
respectively.  A and B: control; C – F: osmotically challenged, i.p. 1ml/100g 1.5 
M saline solution. 3V = 3
rd







































Figure 4-5.  Effect of osmotic challenge on Fos expression in the SON on post-natal 
day 7 (P7) Sprague Dawley rats.  Animals were divided into two groups: (1) 
osmotically challenged with 1ml/100g 1.5 M saline solution (i.p.) and (2) control.  
Values are group means ± SEM; 10 SON analysed per animal, n = 6 for each group.  
Student’s t-test showed significant difference in the number of Fos immunoreactive 
cells between control and osmotically challenged groups (p<0.001), suggesting 
activation of the SON in P7 rats after osmotic challenge.   
 
 








Figure 4-7. Live cell imaging of VP-eGFP dendrites in the SON. Images are 
examples of control, K
+
 stimulated and Tg primed K
+ 
stimulated experiments.  A 
change in fluorescent intensity indicate a change of VP-eGFP content in the 
dendrites. Images were acquired at 30’, 32’ and 42’. For K
+ 
stimulation only, control 
Tyrode’s solution was applied for 30’.  Thereafter, K
+ 
stimulation was applied. For 
Tg primed, K
+ 
stimulated experiments, control solution was replaced with Tyrode’s 
solution containing 200 nM Tg. Scale bars = 5 µm. 
 










Figure 4-8A.  Changes of fluorescent intensity in dendrites after stimulation.  All 
data were normalised to 30 min.  Intensity in the dendrite was obtained by measuring 
the mean (intensity/area) in 10 optical slices in the centre of a 3-D stack of images 
using ImageJ.  Data analysis was performed with Sigma Stat using two-way 
ANOVA on repeated measures.  A post-hoc Student’s t-test showed significant 
decreases in intensity after K
+
 stimulation and K
+
 stimulation after thapsigargin (Tg) 
priming (p=0.04 and p<0.001, n=4 and 3 respectively; comparison was made 
between 32’ and 42’).  This shows release of vasopressin by high K
+
 stimulation.  
There are no significant differences in intensity in control (n=4) and in 200 nM Tg 
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Figure 4-8B.  Changes of fluorescent intensity in dendrites after stimulation.  All 
data analysis as described in Figure 7A.  Two-way ANOVA on repeated measures 
with post-hoc Student’s t-test comparing intensity at 42’ between different groups 
showed significant decrease in intensity in Tg + K
+
 stimulated dendrites (p<0.05) 
showing that 30 min of Tg priming leads to increase release of vasopressin after 50 
mM K
+
 stimulation in dendrites. 
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Treatment 















Figure 4-8C.  Rate of fluorescence decay in image backgrounds.  Background 
fluorescence decay was obtained by measuring the fluorescent intensity of 10 x 2 µm 
squared areas in the background of each image.  Exponential decay curves were 
fitted using ImageJ.  The mean decay constants of each group are shown here.  Two-
way ANOVA comparing the decay constants of each group showed no difference 
between background fluorescent decay in all groups, suggesting that decrease in 
fluorescent intensity shown in Figure 4-8B is due to increase in vasopressin release 
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5. BIOLISTIC TRANSFECTION 
 
5.1 Introduction 
Chapter 4 described a live cell imaging model using organotypic slice explants of the 
hypothalamus of neonatal transgenic VP-eGFP rats.  To study the dynamics of 
vesicle pools and vesicle pool segregation in magnocellular dendrites, it is essential 
to distinguish between different vesicle pools.  Exogenous fluorescent proteins 
tagged to LDCV cargoes enable visualisation of vesicle pools of different age and 
hence, the regulation of these vesicle pools, by expression of a fluorescent time 
stamp (Duncan et al. 2003; Terskikh et al. 2000) or by inducible fluorescent 
expression (Han et al. 1999).  Cellular transfection offers a way of introducing 
foreign material, for example, DNA, into eukaryotic cells.  Methods available for 
cellular transfection include viral transduction (discussed in next chapter), calcium 
phosphate (Graham & van der Eb 1973) and lipid-mediated cell transfection (Felgner 
et al. 1987), electroporation (Shigekawa & Dower 1988), and biolistic transfection 
(Ye et al. 1990).  With the exception of viral transduction, these methods provide a 
cost effective and non-laborious means of targeting exogenous DNA expression in 
cells.  Of these methods, calcium phosphate co-precipitation and lipid-mediated 
transfection offer the simplest way for delivery of exogenous genetic material since 
neither of these methods require specialist equipments (Graham & van der Eb 1973; 
Felgner et al. 1987). However, these methods require delivery of the genetic material 
to the nucleus for transcription, and entry to the nucleus mostly occurs during cell 
division.  Since neurons do not divide, calcium phosphate co-precipitation and lipid-
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mediated transfection do not usually result in successful expression of exogenous 
DNA in neurons.  Electroporation delivers DNA into a cell by perturbation of the cell 
membrane via electrical pulses generated through a micropipette.  Biolistic 
transfection involves ejection of DNA-coated particles through high pressure, in 
another word, “shooting” DNA-coated “bullets” into cells.  Comparing 
electroporation and biolistic transfection, it was found that biolistic transfection 
resulted in a higher number of transfected cells (Murphy & Messer 2001) using 
cerebellar organotypic slice cultures.  Although both methods require fine tuning, 
strength and length of electrical pulse for electroporation and ejection pressure and 
DNA to particle ratio for biolistics; biolistic transfection had been successfully used 
to express exogenous genetic material in magnocellular neurons of hypothalamic 
organotypic slice cultures (Fields et al. 2003).  Hence, this chapter focuses on the 
establishment of biolistic transfection as a model to target genetic material to 
magnocellular neurons to study vesicle pool dynamics in dendrites. 
 
Biolistic transfection, also known as particle-mediated gene transfer and biological 
ballistics, is the transfer of DNA into cells by an apparatus called the gene gun 
(Biorad).  Originally, biolistics is a technique designed for gene expression in plant 
cells (Ye et al. 1990), where tungsten particles were used as bullets and were coated 
with DNA of interest.  These bullets were accelerated into plant cells by the use of 
gunpowder.  The technique was then adapted to transfect animal cells and the use of 
gunpowder was replaced by a blast of helium gas and gold particles were used as 
bullets instead.  Transfection of animal cells with the use of the gene gun was 
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achieved both in vitro (Gainer et al. 2001; Williams et al. 1991; Fields et al. 2003) 
and in vivo (Williams et al. 1991). Because gene transfer by biolistic transfection 
does not depend on the up-take of DNA during cell division, but the physical 
penetration of particles into cell membranes, it is a suitable technique to transfect 
neurons.  Gene particles were made into bullets where supercoiled plasmid DNA was 
coated onto gold particles.  One or more DNA constructs can be used in a single 
batch of bullets, allowing expression of more than one DNA construct per 
transfection.  Biolistic transfection had been effectively combined with organotypic 
slice explants of brain tissues to express foreign DNA in neurons (Arnold et al. 1994; 
Horch et al. 1999; Lo et al. 1994), and especially in vasopressin-expressing neurons 
in the hypothalamus (Gainer et al. 2001; Fields et al. 2003). 
 
In this chapter, biolistic transfection was applied to organotypic slice cultures of the 
hypothalamus.  The aim was to introduce fluorescent reporter DNA to magnocellular 
neurons so that vesicle trafficking and segregation of vesicle pools can be visualised 
by targeting fluorescent protein expression to dense core vesicles.  The age of rats 
most suitable for use for biolistic transfection was also investigated.  peGFP-N1 
(Clontech; plasmid map in Appendix II) with the immediate early promoter of 
cytomegalovirus (PCMV ie) was used as the reporter gene initially to establish the 
efficiency of biolistic transfection because peGFP-N1 is expressed in the cytoplasm 
and is extremely bright, facilitating the visualisation of successful transfection.  
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5.2 Materials and Methods 
5.2.1 Organotypic slice explants 
Hypothalamic slices were collected from postnatal day 7 (P7) and postnatal day 14 
(P14) wild type Sprague Dawley rat pups and cultured for 7 days.  300 µm coronal 
sections were collected with a vibratome in aCSF solution (Appendix I).  The 
detailed culture protocol is described in Section 4.2.2, Chapter 4. 
 
5.2.2 Biolistic transfection 
The principle of Biolistic transfection involves the blasting of plasmid DNA coated 
gold particles into cultured tissue using a gene gun (Helios Gene Gun, Biorad).  
Figure 5-1 shows a schematic diagram of biolistic transfection using the gene gun.  
Sections of the hypothalamus containing the SON were collected from neonatal wild 
type Sprague Dawley rats, and cultured as described in section 4.2.2, Chapter 4.  
Gold particles of 1.0 µm had been shown to effectively transfect neurons in 
hypothalamic slice explants (Fields et al. 2003; Gainer et al. 2001).  DNA:gold ratio 
used was 2 µg:1 mg.  All materials to be used were incubated in a desiccation 
chamber overnight.  100 µl of 0.05 M spermidine was added to the gold particles to 
help the precipitation of DNA.  Immediately after mixing, 100 µl of 1 M CaCl2 was 
added slowly onto the gold solution further aiding DNA precipitation onto the gold 
particles.  Spermidine and CaCl2 coating the gold particles are cationic and hence, 
attracts negatively charged DNA to the surface of the gold particles.  After 
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incubation at room temperature for 10 min, the mixture was centrifuged at 400rpm 
for 20 sec.  1 ml of 100% ethanol was used to wash the DNA/gold pellet twice.  The 
pellet was then re-submerged in 600 µl + 600 µl of ethanol and transferred to a 2 ml 
tube.  The gold mixture was subsequently sucked into a dry silicon tube by a syringe 
and was allowed to precipitate for 15 min.  Once the DNA/gold particles have 
precipitated onto the silicon tubing, the ethanol was pulled out, leaving the gold 
particles coating the tube.  The gold particles were then dried by a nitrogen gas 
supply for 15 min.  Individual Bullets were made by cutting the silicon tubing and 
were stored at 4
o
C with desiccating agents for up to two weeks.  
 
On the day of transfection, slice cultures were taken out from 37
o
C incubation and 
placed on a 60 mm Petri dish.  The gene gun was aimed onto the section, as 
described in Figure 5-1.  A nylon mesh was used to minimise the impact of the 
helium blast on the section.  The helium pressure used was determined by 
experiments described below.  The sections were shot at individually and quickly 
brought back to 37
o
C incubation.  Transfected sections were cultured for another 24 
hr before further immunohistochemistry was carried out. 
 
 
5.2.3 Immunohistochemistry – double label immunofluorescence 
Transfected organotypic slice explants were taken out of culture and the culture 
medium was removed.  1 ml of 4% (w/v) PFA in 0.1 M PB was added and the tissue 
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was incubated in the fixative for 1 hour.  The fixative was then removed and the rest 
of the procedure is as described in section 3.2.2, Chapter 3.  Primary antibodies were 
replaced by non-pre-immune serum to act as negative controls for immunolabelling.  
Non-transfected hypothalamic slices cultured under the same conditions as the 
transfected cultures were included for immunolabelling and act as positive controls 
for immunolabelling and negative controls for transfection. 
 
5.2.3.1 Primary Antibodies 
Vasopressin antibodies 
The vasopressin primary antibody used was either the rabbit polyclonal vasopressin 
primary antibody (Calbiochem) used at a concentration of 1:500, or PS41, a mouse 
monoclonal antibody which was a gift from Professor Harold Gainer.  The rabbit 
polyclonal vasopressin antibody had been tested by Calbiochem on rat PVN and 
SON and staining was completely eliminated by arginine vasopressin pre-treatment 
(10 µg/ml) (Calbiochem).  Information on cross-reactivity between the antibody and 
oxytocin was also provided and tests by preabsorption of the antibody with 100 
µg/ml oxytocin showed no effects on vasopressin staining.   PS41 was produced 
against vasopressin-associated neurophysin in rats (Ben Barak et al. 1985).  The 
specificity of PS41 against vasopressin-neurophysin is well described by Ben Barak 
et al. using liquid phase assays, immunoblot, and immunoprecipitation experiments.  
PS41 was pre-diluted 1:50, from the stock obtained from Prof Gainer, in 10% (v/v) 
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NGS and 0.01% (w/v) sodium azide in 0.1 M PB.  The pre-diluted antibody was kept 
at 4
o
C.  The final concentration of the PS41 antibody used was 1:1000.   
 
Oxytocin antibodies 
In some experiments, oxytocin primary antibodies were used in addition to 
vasopressin primary antibody to identify all magnocellular neurons in the SON.  The 
mouse monoclonal anti-oxytocin antibody, PS38, was a gift from Prof Harold 
Gainer.  PS38 is directed against oxytocin-associated neurophysin and its specificity 
was also characterised by liquid phase assays, immunoblot, and immunoprecipitation  
(Ben Barak et al. 1985).   
 
Neuronal marker – MAP2 
MAP2 (microtubule associated protein found in neurons) was used as a neuronal 
marker.  The polyclonal chicken IgY (Abcam) used detects all three isoforms of 
MAP2: MAP2c is present in the newborn rat brain until postnatal day 10 – 20, and is 
replaced by MAP2a which is present from postnatal day 10 onwards, MAP2b is 
present throughout life.  MAP2a and MAP2b are both expressed in cell bodies and 
dendrites of neurons (Goedert et al. 1991), making it ideal to be used as a general 
marker for neurons.  The pre-immune IgY was used to test for MAP2 antibody 
specificity and was not found to produce any signal, while in contrast the immune 
IgY produced strong, clear staining of dendrites and perikarya of neurons 
(information provided by Abcam).  
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Glial cells marker – anti-GFAP 
Anti-glial fibrillary acidic protein (GFAP; Sigma) rabbit polyclonal antibody was 
used to identify glial cells in organotypic slice cultures.  GFAP encodes for 
intermediate filament protein in astrocytes.  Anti-GFAP antibody was used at 1:400 
final concentration. 
 
After incubation with the primary antibody, and pre-immune serum incubation for 
negative controls, sections were washed three times in 0.1 M PBT for 30 min to 
ensure that most of the unbound primary antibody was washed away.  A second 
blocking step with 0.2% (w/v) BSA in 0.1 M PBT for 1 hour ensures that any 
remaining non-specific binding sites were blocked.  Sections were then incubated in 
fluorophore-conjugated secondary antibody solution (2
o
Ab + 0.2% (w/v) BSA in 
PBT + 0.3% (v/v) Triton) at 4
o
C overnight.  From this step onwards, the samples 
were protected from light.   
 
5.2.3.2 Secondary Antibodies 
All secondary antibodies used were from Molecular Probes, Invitrogen: Alexa Fluor 
® 568 goat anti-mouse, Alexa Fluor ® 568 goat anti-rabbit, and Alexa Fluor ® 633 
goat anti-chicken.  The excitation and emission spectra, and the emission filters used 
for confocal imaging are shown in Table 1 Appendix 1. 
  Chapter 5 Biolistic transfection 
133 
 
After secondary antibody incubation, the secondary antibody solution was removed 
and sections were washed three times for 15 min in 0.1 M PB.  Sections were then 
mounted on microscope slides and coverslipped (coverslip thickness #1, VWR).  
Mowiol (Calbiochem) supplemented with DABCO (Sigma) was used as the 
mounting medium with a refractive index of 1.41.  Sections were left to cure at 4
o
C 
in darkness until the mounting medium had set.   
 
5.2.4 Image acquisition 
5.2.4.1 Widefield fluorescence image acquisition 
Widefield fluorescent images were acquired with the LeicaDMR upright light 
microscope using either the Hamamatsu ORCA HR digital camera, acquired by 
OpenLab (Improvision), or using the Leica DFC490 digital camera, acquired by the 
Leica Application Suite V2.7.  Images acquired with the Hamamatsu camera were 
obtained with a band pass 450 – 490 nm excitation filter and a long pass 515 nm 
emission filter for visualisation of green fluorescence, and band pass 515 – 560 nm 
excitation and long pass 590 nm emission filters for visualisation of red fluorescence.  
Images acquired with the Leica DFC490 camera were obtained with Fitc 488 nm and 
Texas Red 568 nm excitation filters and band pass 516 – 556 nm and 604 – 644 nm 
emission filters to visualise green and red fluorescence respectively. 
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5.2.4.2 Confocal image acquisition 
Confocal images were acquired using the Zeiss LSM510 inverted microscope.  eGFP 
was excited with the 488 nm line of the Argon laser, emission collected through a 
band pass 500 – 550 nm filter.  Alexa Fluor 568 staining was excited with the 543 
nm HeNe1 laser and emission collected through a band pass 565 – 615 nm filter.  
Alexa Fluor 633 staining was excited with the 633 nm HeNe2 laser and emission 
collected with a long pass 650 nm filter.  Filter settings are summarised in Figure 3-
2, Chapter 3.  The pinhole was adjusted to 1 Airy unit for all channels for confocal 
imaging.  Images were acquired with an x63 oil immersion objective (NA1.4).  3-
dimensional images were obtained by scanning the x, y –planes at 60 nm, achieved 
by line scanning 1024 x 1024 pixels with an optical zoom of 2.4, and intervals of 170 
nm along the z-axis was acquired to avoid under sampling.  8 bit pixel depth, line 
averaging of 1 (no averaging) and maximum scan speed were chosen for image 
acquisition to avoid photobleaching.  All 3-D images were deconvolved to remove 
background noise (Huygens Deconvolution Software, SVI).  Please refer to section 




5.3.1 Organotypic slice culture – P7 vs. P14 
Empirical experiments were carried out to determine the age of neonatal rats suitable 
to be used in organotypic slice culture for biolistic transfection studies.  Figure 5-2 
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(A) and (B) show two organotypic slice explants both cultured for 7 days, one 
obtained from a P7 rat pup and the other obtained from a P14 rat pup.  The sections 
were stained for vasopressin and visualised using by the Alexa Fluor 568 antibody as 
described above.   Figure 5-2 C shows a transcardially perfused section of the 
hypothalamus from an adult (200 – 300 g) VP-eGFP transgenic rat (transcardial 
perfusion was described in Chapter 2).  Green signals were from vasopressin eGFP 
cells in the SON. Comparing the morphology of the SON between the three ages, the 
SON in P14 rats closely resembled that of an adult rat.  Vasopressinergic neurons in 
the P14 slice culture are more spread out in the SON (Figure 5-2 B), similar to the 
anatomy of the SON of an adult rat (Figure 5-2 C).  Vasopressinergic neurons in the 
P14 slice culture have also migrated towards either side of the optic chiasm (not 
shown in figure) resembling the location of the SON in adult rats.  Therefore, P14 
rats were chosen for biolistic transfection experiments. 
 
5.3.2 Transfection efficiency – optimisation of transfection pressure 
Using eGFP as the reporter gene, optimisation of helium pressure used was carried 
out on P14 organotypic slice cultures of non-VP-eGFP rats. The peGFP-N1 plasmid 
localises in the nucleus and produces an enhanced green fluorescent protein.  This 
allowed easy identification of cells that had been transfected with peGFP-N1.   
 
Slice explants were shot at 120 psi (827.4 kPa), 160 psi (1103.2 kPa), 180 psi 
(1241.2 kPa) and 200 psi (1379 kPa) (n=4 slices per pressure) to determine the best 
  Chapter 5 Biolistic transfection 
136 
pressure of helium gas to use for transfection of magnocellular neurons.  In a 
separate experiment, slice explants were shot at 50 psi (344.75 kPa) and 60 psi 
(413.7 kPa) (n=3 slices per pressure).  Two slices from each experiment were not 
transfected and were used as positive controls for immunohistochemistry.  Slices 
were fixed >20 hr after transfection in 4% (w/v) PFA and immunolabelled for 
vasopressin and oxytocin (PS41 and PS38, both raised in mouse) and MAP2 (raised 
in chicken) for identification of neurons, and in particular magnocellular neurons.  
Secondary antibodies used were Alexa Fluor 588 goat anti-mouse and Alexa Fluor 
633 goat anti-chicken.   
 
10 x63 images were taken of slices from each transfection pressure used using the 
confocal microscope.  The transfection efficiency, i.e. the number of cells transfected 
per section, of the different transfection pressures used is shown in Figure 5-3B.  
One way ANOVA comparing the number of transfected cells showed that there were 
significantly more cells transfected at 160 psi compared to all other pressures used 
except to 180 psi (p<0.05, Student’s t-test).  The transfection efficiency for the 
number of neurons, i.e. transfected cells expressing green fluorescent and labelled 
with MAP2, was also counted (Figure 5-3C).  There was no significant difference in 
the number of neurons transfected between the different pressures used (one-way 
ANOVA).  160 psi was chosen as the transfection pressure in further experiments.  
An example of a transfected neuron labelled with MAP2 is shown in Figure 5-4.  
The transfection efficiency of neurons was calculated to be 7% of the total number of 
cells transfected.  Immunofluorescence labelling of VP and OT was carried out on 
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the same sections and no magnocellular neurons were found to be transfected.  
Hence, further experiments were carried out where sections were either labelled with 
MAP2, VP/OT or GFAP antibodies to investigate the cell types transfected (Section 
5.3.3). 
 
5.3.3 Transfection of neurons, magnocellular neurons, and non-neuronal cells 
15 hypothalamic sections from four P14 pups were collected and cultured for 1 day 
in vitro (DIV) before transfection.  Sections were fixed <20 hr after transfection and 
were immunolabelled for VP/OT (PS41 and PS38) and MAP2 or GFAP.  Figure 5-5 
shows a representative example of the SON after transfection (red = VP/OT; blue = 
MAP2).  Mixing of PS41 and PS38 antibodies allows visualisation all transfected 
magnocellular neurons alongside staining with MAP2. Figure 5-6 shows a 
transfected magnocellular neuron, stained for vasopressin/oxytocin (red) and MAP2 
(blue), transfected with the peGFP-N1 plasmid (green).  This shows that the biolistic 
technique was successful in transfecting magnocellular neurons (transfection 
efficiency = 1.8% of the total number of cells transfected).  There are also other non-
neuronal cell types not stained for MAP2 which were also transfected with the 
biolistic technique.  Figure 5-7 shows eGFP expression (green) in sections stained 
for GFAP (red) an astrocyte marker.  Although no astrocytes were found to express 
the peGFP-N1 plasmid, other cell types such as fibroblasts-like cells and 
oligodendrocytes were found to be transfected.  Figure 5-7 (A) and (B) show 
putative fibroblasts and Figure 5-7 (C) shows a putative oligodendrocyte expressing 
the peGFP-N1 plasmid.  Although optimisation of the biolistic transfection technique 
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did result in the transfection of magnocellular neurons, the number of neurons 




Stationary organotypic slice culture is an ideal system to study magnocellular 
neurons due to the conservation of the topography of the hypothalamus in these 
cultures.  Using organotypic slice cultures from the hypothalamus of neonatal rats, 
magnocellular neurons can be easily identified through immunohistochemical 
labelling with vasopressin and oxytocin antibodies.  In vitro slice cultures also allow 
for post-culture transfection of cells of interest without the use of in vivo viral 
transduction or transgenic models.  Brain cultures had been prepared from foetal 
(Jiao et al. 1993) to mature rats (Xiang et al. 2000).   To determine the age which is 
most suitable for organotypic slice culture from the hypothalamus, P7 and P14 rats 
were used.  Slices were obtained from the hypothalamus and cultured under the same 
conditions for seven days.   At the end of culture, slice tissues were fixed and 
labelled for vasopressin staining.  Comparing cultured slices labelled for vasopressin 
and slices obtained from an adult VP-eGFP rat (Figure 5-2), the SON from P14 
animals showed a closer morphological resemblance to that of the adult rat than P7 
animals.  Hence, P14 rats were chosen for further transfection experiments. 
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Biolistic transfection had been used as an approach to transfect hard-to-transfect, or 
non-dividing cells (e.g. neurons) as an alternative to viral transduction to express 
foreign DNA in these cell types (Fields et al. 2003; Lo et al. 1994).  A range of 
different helium pressures used for transfection on cultured neuronal cells had been 
reported: 100 psi for cultured hippocampal and cerebellar neurons (Wellmann et al. 
1999); 175 psi for dorsal root ganglion explants (O'Brien et al. 2001); 180 psi for 
hypothalamic slice cultures (Fields et al. 2003).  It is evident that the higher the 
transfection pressure used, the deeper the penetration of particles into the brain 
slices, but also, the lower the survival rate of cells (O'Brien et al. 2001).  Hence, it 
was essential to determine the optimal helium pressure to be used in experiment.  All 
pressures used were successful in transfection, and 160 – 180 psi was found to 
transfect with the highest efficiency, although there was no significant difference in 
the number of neurons transfected with the pressures used.   
 
The transfection efficiency of neurons was found to be 7% of the total number of 
cells transfected using 160 psi transfection pressure, transfection efficiency in 
magnocellular neurons was much lower at ~ 1.8%.  Several measures could be taken 
to improve transfection efficiency, for example, by adjusting the diameter of gold 
particle used, and by adjusting the DNA:gold ratio.  However, gold particle diameter 
of 1 µm and DNA:gold ratio of 2 µg:1 mg had been successfully used to transfect 
magnocellular neurons in hypothalamic slice cultures before (Fields et al. 2003).  
Another aspect which could improve transfection efficiency is the use of younger 
animals for culture.  Fields et al. (Fields et al. 2003) had successfully transfected 
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magnocellular neurons using slices from postnatal day 6-8 rats cultured for up to 15 
days in vitro.  In fact, several studies have used early postnatal rat pups for biolistic 
transfection in different brain areas with success (Lo et al. 1994; Wellmann et al. 
1999; Thomas et al. 1998).  However, other studies had successfully transfected 
cortical neurons in slice culture prepared using P12 – P14 rats (Tao et al. 1998; 
Arnold & Clapham 1999), suggesting that age is not the factor that determines 
transfection efficiency.  Whilst survival of cells after transfection is an important 
factor in transfection efficiency, and it is known that cultures prepared from younger 
rats survive better, it was demonstrated (Figure 5-6) that cultures prepared from P14 
rats survived biolistic procedure, even though transfection efficiency was low.  
Nevertheless, cell death after particle bombardment is an important limiting factor to 
transfection efficiency in neurons.  It had been shown that localised cell death occurs 
as soon as after the biolistic transfection process (Raju et al. 2006; Young, III et al. 
1999).  Another factor that strongly affected the transfection efficiency is the length 
of culture.    Organotypic slice cultures were found to contain a dense layer of glial 
cells over the surface of the slice tissue (personal observation), hence favouring 
transfection of glial cells on the surface of the explant as demonstrated in Figure 5-7.  
The development of a glial cell layer over the surface of cultured organotypic slices 
had been shown in cultured slices from other brain areas (Coltman & Ide 1996) and 
can be prevented by the omission of animal serum in the culture media (Czapiga & 
Colton 1999).  On the other hand, it is possible to target gene expression to 
specifically to neurons.  In hypothalamic slice culture, the nerve-specific enolase 
promoter had been shown to target gene expression to neurons and the vasopressin 
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promoter had been shown to target expression specifically to vasopressinergic 
neurons (Gainer et al. 2001). 
 
Although it is possible to target gene expression specifically to specific neuronal 
phenotypes, and despite the fact that the biolistic technique was successful in 
transfecting neurons and magnocellular neurons, the low and random transfection 
efficiency achieved with biolistic transfection means that a very high number of 
samples would be required to achieve the initial aim of this experiment to label 
vesicles and look at the behaviour vesicle pools under different stimuli.  Another 
major concern deeming this transfection technique unsuitable for the studying of 
vesicle behaviour is the scattering of gold particles which reflected laser excitation 
across the tissues transfected.  It was realised that the scattered gold particles closely 
resembled large dense core vesicles and because gold particles were excited by all 
the excitation lasers used, emission was collected from all three emission channels, 
rendering it impossible to differentiate between large dense core vesicles and gold 
particles.  Since the aim of this project is to study the distribution of dense core 
vesicles in magnocellular dendrites, it is unfeasible to progress with biolistic 
transfection to label these vesicles.  
 
Other methods available for transfection of neurons as discussed at the beginning of 
this chapter include calcium phosphate and lipid-mediated cell transfection, 
electroporation, and viral transduction.  All of these methods, except for viral 
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transduction, would not be suitable for the use with organotypic slice cultures due to 
low transfection efficiency and the growth of a dense glial cell layer on the surface of 
slice tissues, preventing access of transfection agent to the neurons underneath.  Viral 
transduction, on the other hand, has several advantages including high transfection 
efficiency in all cell types including neurons.  Hence, the next chapter of this thesis 
will discuss the development of a suitable viral transduction system for the use in 
hypothalamic slice culture. 




Figure 5-1.  Schematic diagram of biolistic transfection of organotypic slice culture 
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Figure 5-2.  Organotypic slice 
cultures P7 vs. P14.  (A) P7  
culture and (B) P14 culture stained 
for vasopressin by indirect double 
immunofluorescence labelling.  
The yellow staining in these 
images shows vasopressin cells 
present in the SON.  (C) 
Transcardial perfused section of 
the hypothalamus from adult (200 
– 300g) VP-eGFP rat.  Green 
signal represents vasopressin in the 
SON.  Images were acquired with 
the Hamamatsu camera (excitation 
band pass 450 – 490 nm filter and 
a long pass 515 nm emission filter 
for (C), and band pass 515 – 560 
nm excitation and long pass 590 
nm emission filters for (A) and 
(B).  The morphology of the SON 
in the P14 slice culture (B) closely 










  Chapter 5 Biolistic transfection 
145 
 
  Chapter 5 Biolistic transfection 
146 
 
  Chapter 5 Biolistic transfection 
147 
 
  Chapter 5 Biolistic transfection 
148 
 






Fluorescent protein expression in 
LDCVs and viral transduction
Chapter 6 Fluorescent protein expression in LDCVs and viral transduction  
150 
 




Viral transduction is well known for its use to target gene expression in hard to 
transfect cells and its high transfection efficiency (Slack & Miller 1996; Washbourne 
& McAllister 2002).  Gene targeting using viral transduction techniques has 
improved dramatically by reducing cytotoxicity and the cost in production.  Non-
viral transfection techniques offer much lower production cost and can transfer 
genetic material of almost any size to the target cell.  However, as seen in Chapter 5, 
in non-dividing cells like neurons, non-viral transfection techniques offer 
disappointing transfection efficiency.  Viral transduction had been successfully used 
to express genes of interest in different neuronal cell types (Ehrengruber et al. 2001; 
Keir et al. 1999; Ridoux et al. 1995; Vasquez et al. 1998).  Another important factor 
to consider is that expression of virally transduced genes typically occurs 1-7 days 
after transduction, depending on the type of cells targeted and the type of virus used 
(Ridoux et al. 1995).  Successful transduction of magnocellular neurons in 
organotypic slice cultures of the hypothalamus (Keir et al. 1999) and in vivo 
transduction of magnocellular neurons (Vasquez et al. 2001) using adenoviral gene 
transfer has been previously reported .  
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Several different types of recombinant viral vectors are currently used for gene 
delivery in research each possessing different levels of cytotoxicity, transduction 
efficiency, maximal size of insert, onset of protein expression, etc (reviewed in 
(Washbourne & McAllister 2002).    Hence, there is not one virus that is suitable for 
use in every system.  Most recently, the success of adenovirus and adeno-associated 
virus-mediated gene transfer in magnocellular neurons had been demonstrated 
(Vasquez et al. 2001; Keir et al. 1999; Cho et al. 2007).  The virus chosen for 
expression of exogenous proteins in magnocellular neurons in this study is the 
replication-incompetent adenovirus with human adenoviral type5 (Ad5) genome 
(Adeno-X
TM
 Expression Systems, Clontech).  The adenovirus is modified for 
recombination and used to target exogenous protein expression since large portions 
of the Early Regions 1 (E1) and 3 (E3) of the viral genome had been deleted to 
enable accommodation of larger DNA insert (up to 8kb) and also, making it unable 
to replicate itself unless grown in cell lines which expressed the Ad5 Early Regions 
(i.e. HEK 293 cells that stably express the Ad5 E1 genes are used for propagation of 
viral particles after recombination).  Adenovirus particles infect cells by interaction 
of the adenovirus fibre antigen with proteins found on cell membranes (Lonberg-
Holm & Philipson 1969).  Adenoviruses are endocytosed by host cell membranes 
and this endocytosis is clathrin-dependent (Meier & Greber 2003).  After successful 
entry into the cell, the adenoviral particles dissociate from endosomes.  Soon after 
dissociation from endosomes, the capsids, along with other viral structures, 
disassemble and release the recombinant DNA, in addition to the viral genome, to the 
infected cell cytoplasm and these gain entry to the nucleus through nuclear pores for 
replication (Greber et al. 1993).   




To target fluorescent protein expression in LDCVs, the pre-pro-atrial natriuretic 
factor (ppANF) was chosen to be tagged to the fluorescent reporter protein.  ppANF 
has been found to target reporter proteins to LDCVs (Duncan et al. 2003; Wiegand et 
al. 2003; Burke et al. 1997).  Moreover, release of co-packaged peptides was not 
found to be affected by ppANF expression (Shields et al. 1990).  The three reporter 
constructs chosen are: the ppANF-Timer (to be used as a fluorescent time-stamp), 
and ppANF-tdTomato and ppANF-eGFP (see Appendix II for plasmid maps and 
sequences).  All three constructs will be used for inducible fluorescent protein 
expression as described below.  tdTomato (Shaner et al. 2004) is a dimeric mutant of  
DsRed (Campbell et al. 2002),  a red fluorescent protein derived from the coral of the 
Discosoma genus, which is an obligate tetramer.  The tetramerisation of DsRed often 
results in the aggregation of the fluorescent protein in cellular compartments (Lauf et 
al. 2001).  This aggregation is overcome in the tdTomato protein which forms 
dimers.  tdTomato is also 160% as bright as DsRed and the half time for the protein 
to mature is 1 hr as opposed to ~10 hr for DsRed (Shaner et al. 2004). This increased 
brightness offers an opportunity for live cell imaging, where increased laser 
excitation to illuminate dim fluorescence often leads to cell death.  Moreover, at the 
early maturation of the DsRed protein, the fluorophore emits in the green spectrum 
and slowly matures to emit in the red.  The slow maturation time of DsRed meant 
that traces of green fluorescence could be detected long after transfection or 
transduction.  The much shorter maturation time of tdTomato made it superior as a 
red fluorescent protein.  On the other hand, the slow maturation of DsRed gave rise 
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to another mutant, the fluorescent Timer DsRed-E5, which will be known as Timer 
from now on.  The fluorescent Timer was first described by Terskikh et al. (Terskikh 
et al. 2000).  The slow maturation of the fluorescent timer protein is characterised by 
the time that is required for the protein to fold and tetramerise requiring > 16 hr – 
acting as a time stamp.  It has been used in bovine adrenal chromaffin cells to study 
segregation of vesicle pools according to age (Duncan et al. 2003; Wiegand et al. 
2003).   Hence, this study will use the Timer protein as a time-stamp on LDCVs, 
investigating the segregation of vesicle pools according to age.  In addition to the 
fluorescent time-stamp, utilisation of an inducible expression system targeting 
fluorescent reporter proteins to LDCVs will allow “pulse-chase” experiments to be 
carried out where fluorescent protein production is induced or stopped at different 
time points (Han et al. 1999).  The tetracycline/doxycycline inducible system had 
been chosen for this study.  In the tet-on system, binding of tetracycline/doxycycline 
to the reverse tetracycline repressor protein downstream of the silent minimal 
immediate early promoter of cytomegalovirus (PminCMV) induces transcription of 
reporter proteins.  In the tet-off system, binding of tetracycline/doxycycline to the 
tetracycline repressor protein switches off transcription of the gene of interest 
downstream.  When target cells, in this case magnocellular neurons are infected with 
constructs containing the TRE and a (reverse) tetracycline repressor protein, 
transcription of the reporter gene is turned on (tet-on system) or off (tet-off system) 
by the addition of tetracycline or doxycycline.  This system also ensures that all cells 
which received doxycycline switch transcription on/off at the same time.  The 
tetracycline repressor protein (TetR) works by negatively regulating the genes of 
interest in the absence of tetracycline.  In the Adeno-X
TM
 Expression System 1 
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(Clontech), TetR is fused with an activation domain found in the Herpes simplex 
virus (VP16 protein) (Triezenberg et al. 1988).  Fusion of VP16 to TetR converts the 
repressor element of TetR to an activator in the absence of tetracycline/doxycycline, 
the resulting fusion gene is called the tetracycline-controlled transactivator (tTA) 
(Gossen & Bujard 1992) found in the Tet-off system (Figure 6-1).  In the Tet-on 
system, the regulatory protein is a reverse TetR fused to VP16 making the reverse 
tetracycline-controlled transactivator (rtTA) (Gossen & Bujard 1995), resulting in 
activation of transcription in the presence of tetracycline/doxycycline (Figure 6-1).  
The PCMVie promoter does not enhance transcription unless tTA or rtTA binds the 
TRE upstream of the promoter.  Hence, for successful expression of the gene of 
interest, the regulatory and response virus has to be co-infected.  Figure 6-2 shows 
an overview of recombinant virus construction and subsequent infection of target 
cells, using the Tet-on virus as an example. 
 
In addition to the time-stamp labelling LDCVs, either by the fluorescent Timer or the 
inducible fluorescent proteins, expression of LDCV targeted fluorescent constructs 
can be used in conjunction with live cell imaging, where ppANF-tdTomato can be 
imaged together with VP-eGFP expressing magnocellular neurons in organotypic 
slice cultures of the hypothalamus. Dendrites of VP-eGFP magnocellular neurons are 
easily identified by green fluorescence (Chapter 4) and vesicles expressing the 
ppANF-tdTomato protein after viral transduction can be identified as red 
fluorescence.  Using the inducible construct, ppANF-tdTomato can be expressed for 
different lengths of time before imaging to visualise the dynamics of vesicles of 
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different age.  On the other hand, transduced magnocellular neurons can be fixed 
before imaging, allowing the use of immunohistochemical labelling and the 
expression of ppANF–Timer or ppANF-eGFP constructs to study segregation of 
vesicle pools. As discussed above, the targeting of fluorescent reporter proteins to 
LDCVs requires tagging of the fluorescent construct to ppANF.  Generation of 
ppANF-tagged fluorescent constructs enables direct visualisation of LDCVs.  
Previous studies in LDCV dynamics and vesicle pool segregation, mostly carried out 
in clonal cell lines, provided insights of LDCV dynamics in endocrine neurons.  
Hence, clonal cells (PC12 and N2a) were transfected with ppANF-tagged fluorescent 
construct to examine fluorescent protein targeting.  Expression of a fluorescent time 
stamp, via a fluorescent protein that changes its emission over time or an inducible 
expression system, in magnocellular neurons provides an important tool to study 
vesicle pool segregation in magnocellular dendrites. 
 
 
6.2 Materials and Methods 
Generation of viral particles containing the desired constructs regulated by an 
inducible promoter required several steps of subcloning: 1) To generate ppANF-
tagged reporter constructs, 2) To insert the ppANF-tagged construct into a shuttle 
vector that contains recombination sites for transferring into the viral vector, 3) To 
produce recombinant virus with the inducible ppANF-tagged construct, 4) To 
produce viral particles utilising HEK293 cell culture.  Figure 6-3 shows an overview 
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of the whole procedure from the generation of ppANF-tagged constructs to the 
generation of viral particles.  To generate a Tet-on expression system, ppANF-tagged 
constructs were inserted into a shuttle vector containing the Tet-responsive promoter 
– pTRE-shuttle2 vector (Clontech).  This shuttle vector also contains unique 
recombination sites which are compatible with two unique recombination sites in the 
viral vector.  To generate a Tet-off expression system, ppANF-tagged constructs 
were inserted into the pDNR-CMV donor vector (Clontech) which contains two loxP 
sites that are recognised by a specific recombination enzyme, Cre recombinase.  Cre 
recombinase catalyses the cleavage of loxP sites and the subsequent recombination 
of these sites.  Thus, cre-loxP recombination enables genes inserted between the loxP 
sites to be transferred to a special Adeno-X acceptor virus, also containing loxP sites 
and a Tet-responsive promoter. The ppANF-eGFP plasmid was a gift from Dr. Rolly 
Wiegand, University of Edinburgh (Wiegand et al. 2003) and ptdTomato (Shaner et 
al. 2004) was a gift from Dr. Colin Rickman, University of Edinburgh.  The pTRE-
shuttle2, pDNR-CMV donor vector, and pTimer constructs were available from 
Clontech.   
 
6.2.1 Construction of inducible ppANF-eGFP, ppANF-tdTomato and ppANF-
Timer 
Subcloning was carried out by PCR amplification of a cDNA fragment encoding the 
rat ppANF (Seidman et al. 1984), ligation of insert DNA to vector DNA, purification 
and amplification, and finally ligation to the viral vector DNA.  All these procedures 
are described in detail in the sections below.  This section describes the insert DNA 
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fragments amplified, the vectors used and the restriction sites used for subcloning of 
each plasmid.  The selected restriction sites used for each construct ensured that the 
insert DNA was in the same reading frame as the vector DNA. 
 
ppANF-Timer 
PCR was used to introduce two unique restriction sites, HindIII and AgeI, to the 
ppANF fragment of ppANF-eGFP.  ppANF-Timer was produced by subcloning the 
ppANF (insert, 466 bp) fragment from ppANF-eGFP into the pTimer vector 
(Clontech) which contains unique HindIII and AgeI restriction sites.  Figure 6-4A 
shows a plasmid map for ppANF-eGFP and Figure 6-4B shows a plasmid map for 
ppANF-Timer.  Restriction sites for subcloning were also shown. 
 
pTRE-ppANF-eGFP 
The pTRE-shuttle2 (Clontech) vector contains the tetracycline response element 
coupled to the PCMVie promoter and a multiple cloning site where the DNA of interest 
can be inserted.  NheI and EagI are unique restriction sites in the pTRE-shuttle2 
vector and were used for subcloning the ppANF-eGFP insert.  NheI and EagI sites 
were introduced to the 5’ and 3’ end of ppANF-eGFP (1.2 kb) via PCR 
amplification.  Figure 6-4C shows a plasmid map for pTRE-shuttle2 and Figure 6-
4D shows the plasmid map for pTRE-ppANF-eGFP and the restriction sites used. 
 




pTRE-ppANF-tdTomato was produced by replacing the eGFP sequence from pTRE-
ppANF-eGFP with a tdTomato sequence.  A tdTomato fragment (1.4 kb) was 
amplified by PCR and AgeI and EagI restriction sites were introduced.  AgeI and 
EagI are unique restriction sites found in pTRE-ppANF-eGFP and were used for 
insertion of tdTomato.  Figure 6-4E shows a plasmid map for pTRE-ppANF-
tdTomato and the restriction sites used.  
 
pTRE-ppANF-Timer 
The ppANF-Timer fragment (1.15 kb) of the ppANF-Timer construct was amplified 
by PCR and subcloned into the pTRE-shuttle2 vector via the unique NheI and EagI 
restriction sites.  Figure 6-4F shows the plasmid map for pTRE-ppANF-Timer and 
the restriction sites used. 
 
pTRE-Timer 
pTimer (687 bp) was amplified via PCR where a NheI restriction site was introduced 
to the 5’ end of the Timer DNA and the EagI site at the 3’ end was included in the 
amplification.  The amplified Timer fragment was subcloned via the NheI and EagI 
sites of the pTRE-shuttle2 vector.  Figure 6-4G shows the plasmid map for pTRE- 
Timer and the restriction sites used. 
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pDNR- ppANF-eGFP  
ppANF-eGFP (1.2 kb), containing unique HindIII and XbaI sites on the 5’ and 3’ 
ends of the insert DNA fragment respectively, was inserted into pDNR-CMV donor 
vector, also containing the same unique restriction sites.  Figures 6-4 H and I show 




pTRE-ppANF-tdTomato was used as a template for PCR amplification of ppANF-
tdTomato (1.9 kb) where HindIII and XbaI sites were introduced to the 5’ and 3’ 
ends of the ppANF-tdTomato fragment respectively.  The amplified ppANF-
tdTomato was then inserted into the pDNR-CMV donor vector.  Figure 6-4 J shows 
the plasmid map of pDNR-ppANF-tdTomato. 
 
6.2.2 Amplification of DNA fragment by PCR 
Before a DNA fragment was subcloned into a vector, the DNA fragment was 
amplified by polymerase chain reaction (PCR).  Typical conditions used for PCR are 
summarised in Tables 6-1 and 6-2.  PCR is a technique that uses a Taq polymerase 
to expand short stretches of oligonucleotides, primers, which bind to specific 
sequences of DNA as designed.  Because of the different temperature cycles 
employed, which include a denaturation cycle at 95
o
C to separate double stranded 
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DNA, the enzyme could extend a piece of DNA multiple times, resulting in an 
amplified fragment.   
 
Primers, short stretches of oligonucleotides, were required for PCR because Taq 
polymerase can only add new nucleotides to an existing strand of oligonucleotide.  A 
forward primer reads from 5’ to 3’ from the sense strand and a reverse primer reads 
the anti-sense strand from the vector DNA.  Forward primers were designed so that 
they were complementary to the beginning of the DNA fragment and reverse primers 
were complementary to the c-terminal of the fragment.  Primers could also be 
designed so that specific sequences of restriction sites could be introduced to the 
DNA fragment amplified.  Hence, when primers anneal to complementary DNA, the 
DNA sequence amplified will include the added restriction sites.  This allows for 
introduction of specific restriction sites that are compatible with the restriction sites 
available in the multiple cloning site of the vector DNA.  Compatible restriction sites 
allow for ligation between two pieces of DNA that are digested by the same enzyme 
(Figure 6-5).  Primers were bought from VHBio or Invitrogen and Taq polymerase 
from Promega.  The sequences of primers used to amplify DNA fragments for 
subcloning of each construct are listed in Table 6-3. 
 
6.2.3 Separation and purification of DNA fragments by electrophoresis and gel 
extraction 
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The amplified DNA fragment was transferred directly from PCR to a 1% (w/v) 
agarose gel (appendix I) supplemented with SYBR Safe
TM
 gel stain (10000 X) for 
visualisation.  A DNA ladder (1kb plus ladder, Invitrogen) was loaded alongside 
sample DNA and the fragments were separated by electrophoresis at 100 – 140 mV 
for 30 min to 45 min in TBE buffer (Appendix I).  DNA fragments were visualised 
under UV light and were excised from the agarose gel and purified with the Qiaquick 
Gel Extraction Kit (Qiagen) or the PureLink Quick Gel Extraction System 
(Invitrogen) following the suppliers’ instructions.  DNA was eluted from the silicon 
membrane with 30 µl of ddH2O. 
 
6.2.4  Ligation of vector DNA and insert 
Purified DNA fragments and their respective vectors were digested with restriction 
enzymes to create compatible ends for ligation.  Conditions for a typical restriction 
digest are shown in Table 6-4.  Reactions were typically incubated at 37
o
C 
overnight.  Products of overnight digestions were loaded on 1% (w/v) agarose gel in 
TBE buffer for electrophoresis.  DNA fragments of the correct sizes were then 
excised from the agarose gel and purified by gel extraction (section 6.2.3).  
Restriction enzymes were from NEB, Promega, or Fermentas. 
 
Four ligation reactions and two control ligations were usually performed.  Vector and 
insert DNA were used at different ratios to optimise the success in DNA ligation.  If 
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100 ng of vector DNA was used each time, the amount of insert DNA required for 








So if the vector:insert ratio to be used is 3:1, then the amount of insert DNA required 












The vector: insert ratios typically used for ligation are 3:1, 1:1, 1:3 and 1:10.  Two 
control ligations were carried out: vector + ligase (Promega) without insert, and 
vector without ligase or insert.  The typical reaction conditions for ligation reactions 
are shown in Table 6-5.  The first control ligation was performed in the absence of 
the insert to find out the amount of self-ligated vectors.   In the second control 
ligation, the insert and T4 DNA ligase (Promega) were omitted to determine the 
amount of vector not digested by either enzyme.  Reaction mixtures were incubated 
at room temperature for 15 min and then at 4
o
C for at least 3 hr.  
 
6.2.5 Amplification of plasmid DNA by E. coli 
Constructs with ligated DNA were amplified by bacterial cell culture.  E. coli can be 
chemically treated so that the bacteria are competent to acquire DNA that is 
introduced to them (Chen & Dubnau 2004).  E. coli that has been treated is known as 
competent cells and the process by which they take up DNA introduced to them is 
known as transformation (described below).  Vector DNA used for subcloning 
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contain antibiotic resistant genes and hence, E. coli that has been transformed by the 
DNA constructs introduced can be grown on agar dishes containing selective 
antibiotics.  E. coli that has not acquired constructs with antibiotic resistance does not 
grow.  Single colonies of E. coli were selected to grow in culture.  Every E. coli in 
the culture now contains the desired construct and hence, the construct is amplified.  
The detailed protocols for preparation and transformation of competent cells are 
described below. 
 
6.2.5.1  Preparation of competent cells 
Scrapings of frozen XL-10 Gold cells (Stratagene) were incubated in 3ml LB 
medium (recipe: Appendix I) overnight at 37
o
C, with shaking.  The 3 ml culture was 
used to inoculate 250ml LB medium containing 20mM sterile MgSO4 the following 
day.  Cells were grown until the optical density of the cell suspension was between 
0.4 – 0.6, measured at 600 nm.  The bacterial culture was then pelleted at 4500 x g 
for 5 min at 4
o
C and re-suspended in ice cold 100 ml TFB1 (recipe in appendix I).  
The suspension was subsequently incubated on ice for 5 min and pelleted at 4500 x g 
for 5 min (4
o
C).  The cell pellet was re-suspended in 10ml TFB2 (recipe Appendix I) 
and incubated on ice for 30 min.  Cells were then aliquoted into 1.5ml pre-chilled 
eppendorf tubes (200 µl/tube) and snap frozen in a dry ice – isopropanol bath and 
stored at -70
o
C.  Each batch of competent cells was transformed with 0.1 ng of DNA 
to determine the transformation efficiency (the transformation protocol is found in 
the next section).  The number of single colonies resulting from this transformation 
was counted and the transformation efficiency was calculated as the number of 
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colonies transformed per µg of DNA.  Only cells which had a transformation 
efficiency of 10
6
 colony forming unit/µg of DNA were used. 
 
6.2.5.2 Transformation of competent cells 
Frozen competent cells were brought up from -70
o
C on ice and allowed to thaw for 5 
min.  100 µl of competent cells were then aliquoted to pre-chilled polypropylene 
tubes (100 µl competent cells per transformation).  10 µl of ligation reaction product 
was added to each tube of competent cells, including control reactions.  Cells were 
then returned to ice and incubated for 30 min.  After the 30 min incubation, cells 
were heat-shocked at 42
o
C for 90 sec.  Cells were immediately returned to ice for 2 
min after heat shock.  900 µl of pre-chilled LB was added to each 100 µl of cells and 
incubated at 37
o
C for 1 hr, shaking.  After the 1 hr incubation, cells were pelleted at 
4000 x g for 5 min and re-suspended in 100 µl of LB.  The whole suspension was 
then plated on 1.5% (w/v) Agar plates (recipe Appendix I) containing the respective 
antibiotics and cultured overnight at 37
o
C.  As mentioned above, vector DNA 
contains antibiotic resistance genes (see Figure 6-4 for antibiotic resistance markers 
present in each plasmid), usually kanamycin or ampicillin, so that by culturing 
bacteria in the presence of selective antibiotics, only colonies that express the 
antibiotic resistance gene, and hence the gene of interest, could be selected.   
Single colonies were counted for each ligation ratio the following day and the plate 
with the most colonies was selected.  Well-separated single colonies were picked for 
culturing in 5ml LB at 37
o
C overnight, with shaking.  DNA grown in these 5 ml 
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cultures can be extracted by miniprep plasmid DNA purification (section 6.2.6) and 
confirmation of the desired constructs was carried out before they were amplified 
any further. 
 
6.2.6  Miniprep plasmid DNA purification protocol 
Plasmid DNA purification was either performed by the Qiaprep Miniprep (Qiagen) 
or PureLink™ Quick Plasmid Miniprep Kit (Invitrogen) following the suppliers’ 
instructions.  All centrifugation steps were carried out on a microcentrifuge at 14000 
x rpm.  Briefly, bacterial cells containing the desired DNA were cultured in 5 ml LB 
medium overnight.  Cells were then pelleted, lysed in an alkaline buffer and bacteria 
chromosomal DNA, proteins and cellular debris were precipitated, leaving plasmid 
DNA dissolved in a high concentrated salt solution.  This solution is then passed 
through a silica membrane which absorbs plasmid DNA at high salt concentration 
and elutes at low salt concentration.  30 µl of either water or TE buffer, supplied with 
the miniprep kit, was added directly onto the silica membrane and incubated at room 
temperature for 1 min before centrifuging for 1 min to elute the DNA from the 
membrane.  The DNA obtained was either stored at -20
o
C or used immediately for 
restriction digest analysis to confirm the presence of the desired DNA construct.  
Digestion with unique restriction sites gives specific bands of known length and 
hence, helps identify the DNA fragments in the constructs. 
 
6.2.7 Sequence confirmation 
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Purified plasmid DNA was sent to Cogenics, UK for sequence analysis.  A pair of 
primers (forward and reverse) was designed to read from the vector into the insert 
through the two subcloning sites.  A forward and a reverse primer were designed to 
read DNA sequences in an opposite direction of each other, the extended sequence 
crosses path and hence, the DNA sequence to be confirmed was read twice.  To 
sequence longer fragments, several forward and reverse primers were designed so 
that all reading frames were overlapped.  Sequencing results were aligned to the 
predicted DNA sequence using Vector NTI from Invitrogen.  Only DNA sequences 
that had been confirmed and which contain the correct sequences would be used for 
further subcloning or transfection studies. 
 
6.2.8 Maxiprep plasmid amplification protocol 
After the plasmid sequence had been confirmed, a maxi-preparation of the plasmid 
was made.  Single colonies from competent cells transformed with the miniprep 
DNA that had been sequenced were picked for 5 ml culture in LB medium 
containing the selective antibiotic for 8 hours and then transferred to a 250 ml LB 
culture overnight with selective antibiotics.  Subsequently, a maxi preparation was 
carried out with either the PureLink HiPure Maxi Plasmid Prep (Invitrogen) or the 
HiSpeed Plasmid Maxi Kit (Qiagen).  All procedures were carried out according to 
the manufacturers’ instructions.  The DNA concentration obtained from the maxi 
preparation was checked with a spectrophotometer reading at 260 nm.  The 
concentration of DNA was calculated based on the fact that 50 µg of DNA has an 
absorbance of 1 when measured at 260 nm.  Hence, the optical density measured 
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multiplied by 50 and the dilution factor of the diluted DNA will give the 
concentration of the DNA measured.  Restriction digests were carried out to further 
confirm the presence of the desired constructs.   
 
6.2.9 N2a and PC12 cell culture and transfection of recombinant constructs 
Neuroblastoma 2a cells, also called N2a cells, were established by R.J. Klebe and 
F.H. Ruddle.  N2a cells are tumour cells and are originated from a strain A albino 
mouse.  N2a cells are endocrine cells which had been found to produce a range of 
peptides, vasopressin being one of them (Bamberger et al. 1995).  Moreover, N2a 
cells release peptides via the regulated secretory pathway (Noel et al. 1989) and 
hence, these cells were used to test recombinant DNA constructs to study expression 
of fluorescent proteins in LDCVs.  The pheochromocytoma cell line, PC12 cells 
(Greene & Tischler 1976), derived from the rat adrenal medulla is a popular 
neuroendocrine cell line used to study peptide vesicle release. PC12 cells used in this 
study were a gift from Dr Colin Rickman and were cultured on coverslips at 70% 
confluency, ready for transfection (section 6.2.9.4). 
 
6.2.9.1 N2a culture 
N2a cells were stored in cell freezing media (appendix I) at -196
o
C (liquid nitrogen).  
Cells were brought up from liquid nitrogen storage and thawed quickly in a 37
o
C 
water bath.  DMSO in the freezing medium was washed away by pre-warmed N2a 
culture medium (appendix I) and cells were pelleted at 250 x g for 5 min.  Cells were 
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then grown in fresh culture medium at 37
o
C, 5.5% CO2.  The N2a culture was then 
expanded by splitting cells at 80 – 90% confluency. 
 
6.2.9.2 Expanding N2a culture 
The growth medium was removed and the N2a cells which were adherent to the 




 which inhibit the trypsin reaction.  Trypsin-EDTA (Sigma) was used to 
detach adherent cells from the culture flask.  Cells were incubated in trypsin-EDTA 
for 1 to 2 min until sheets of cells were visibly detaching when the flask was 
agitated.  To detach all the cells from the culture flask, the flask was rapped sharply 
several times on the side.  To quench the activity of the trypsin, culture medium 
containing 10% (v/v) foetal calf serum was added and then cells were split into 
different tissue culture flasks in a suitable volume. 
 
6.2.9.3 Cell freezing 
Expanded N2a cells were frozen for storage for future use.  Adherent cells were 
removed as described in section 2.6.1.2 and diluted in N2a culture medium 
containing 10% (v/v) foetal calf serum.  Cells were then pelleted at 250 x g for 10 





cells/ml and aliquoted into freezing vials.  To freeze cells, the aliquots were held on 
ice for 5 min, and then stored in an isopropanol bath at -70
o
C overnight.  The next 
day, cells were transferred to liquid nitrogen for long term storage. 




6.2.9.4 Transfection of single cells 
Lipofectamine
TM
 2000 (Invitrogen), was used to introduce plasmid DNA into N2a or 
PC12 cell culture to test the expression of ppANF-tagged constructs.  N2a cells 
originally cultured in tissue culture flasks were transferred onto cover glasses of 
thickness #1 and were transfected at a confluency of 80 – 90%.  PC12 cells were 
grown on coverslips ready for transfection at a confluency of ~70%.  Before 
transfection, the DNA of interest was diluted in 100 µl of DMEM (Gibco) without 
serum.  The DNA:Lipofectamine
TM
 2000 ratio was 1 µg:3 µl.  For cultures grown in 
a 12-well culture dish, 4 µl of Lipofectamine
TM
 2000 was diluted in 100 µl of 
DMEM (Gibco) without serum or antibiotics.  The mixture was incubated at room 
temperature for 5 min.  After the 5 min incubation, the DNA mixture and the 
Lipofectamine
TM
 2000 mixture was combined and incubated at room temperature for 
20 min.  200 µl of the transfection mixture was then added to each well containing 
the cells and 1 ml of culture medium which was then mixed gently by rocking the 
culture dish back and forth.  The cells were then incubated at 37
o
C, 5.5% CO2 for at 
least 16 hr after transfection before fixing in 4% (w/v) PFA for immunofluorescence 
labelling. 
 
2.6.9.5 Double immunofluorescence labelling for adhering single cell cultures 
Immunocytochemistry for N2a cells and PC12 cells is similar to that carried out for 
free floating sections described in section Chapter 2.  All steps carried out were at 
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room temperature on a gently rocking platform unless otherwise stated.  First, the 
culture medium was removed and cells were washed for 10 min twice with 0.1 M 
PBS.  Cells were then fixed with 4% (w/v) PFA for 30 min.  The PFA was then 
washed by rinsing with 0.1M PBS for 10 min twice.  50 mM NH4Cl was used to 
quench background fluorescence and free aldehyde groups by incubating cells in 
NH4Cl-PBS for 10 min.  NH4Cl was then removed and the cells were washed twice 
for 10 min with 0.1 M PBS.  The cell membranes were then permeabilised with 0.5% 
(v/v) Triton X100 in 0.1 M PBS for 15 min.  The triton solution was then removed 
and the cells were washed with 0.1M PBS for 10 min twice.  Non-specific binding 
was blocked by incubating cells in a block solution of 10% (v/v) pre-immune animal 
serum, 0.2% (v/v) Tween-20 (Sigma) in 0.1 M PBS for 30 min.  The block solution 
was then removed and cells were incubated in a 1
o
Ab cocktail made up in block 
solution overnight at 4
o
C.  After incubation in the 1
o
Ab, cells were washed in a wash 
solution containing 0.2% (v/v) Tween-20 in 0.1 M PBS three times for 45 min.  A 
2
o
Ab cocktail was made up in the block solution described above and cells were 
incubated in the 2
o
Ab solution of 2 hr.  After incubation in 2
o
Ab, cells were washed 
three times for 45 min with wash solution after which, cells were rinsed with 0.1 M 
PBS for 10 min twice.  Cells were then mounted onto glass microscope slides in 
Mowiol (Appendix I) and the mountant was left to cure in darkness before imaging. 
 
6.2.10 Construction of recombinant adenoviral vectors 
Constructs confirmed to have the correct sequences were subcloned into either the 
Adeno-X System 1 viral DNA (Clontech) to create the Tet-on expression system or 
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the LP-Adeno-X-TRE System 2 viral DNA (Clontech) to create the Tet-off 
expression system.  All procedures for subcloning were carried out as described in 
section 6.2.1 unless otherwise stated.  Plasmid maps of pAdeno-X and pLP-Adeno-
X-TRE can be found in Figure 6-6A and 6-6B. 
 
6.2.10.1 Construction of recombinant adenoviral DNA for Tet-on expression system 
Recombinant pTRE-shuttle2 vectors were digested by the endonucleases PI-SceI and 
I-CeuI.  Adeno-X System 1 viral (pAdeno-X) DNA was pre-linearised with PI-SceI 
and I-CeuI so that once the recombinant pTRE-shuttle2 vectors were digested, it was 
ready for ligation.  The gene of interest is subcloned into a shuttle vector and the 
recombinant shuttle vector is inserted into the viral vector via PI-SceI and I-Ceu sites 
(Mizuguchi & Kay 1998). All digestion and purification steps were carried out 
according to the Adeno-X
TM
 Tet-Off® & Tet-On® Expression System 1 User 
Manual (Clontech).  Briefly, a double digest of 3 hr at 37
o
C using PI-SceI and I-CeuI 
was carried out on recombinant pTRE-shuttle2 vectors.  3 – 5 µl of the reaction 
product was analysed on a 1% (w/v) agarose gel as described in section 6.2.3 except 
that DNA fragments were not excised from the agarose gel.  After confirmation that 
the reaction product gave the right band sizes, the rest of the reaction product was 
purified using the Qiaquick Gel Extraction Kit (Qiagen) following the 
manufacturer’s instruction.  In this case, the reaction product was not incubated at 
42
o
C to dissolve the agarose gel since the reaction product was dissolved in solution.  
After purification of the linearised recombinant pTRE-shuttle2 vectors, ligation with 
the pre-linearised pAdeno-X DNA was carried out using T4 ligase as described in 
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section 6.2.4.  The ligation product was purified by adding 1 x TE Buffer (pH 8.0) to 
a final volume of 100 µl and 100 µl of phenol:chloroform:isoamyl alcohol (25:24:1) 
(Sigma Aldrich) to the ligation reaction to remove salts in the ligation buffer and 
proteins including the T4 ligase.  The solutions were mixed and then separated by 
centrifugation at 14000 rpm for 5 min at 4
o
C.  The top aqueous layer which contains 
the DNA was removed and transferred to a clear eppendorf tube.  To this tube, 400 
µl of 95% (v/v) ethanol and 1/10 volume 3 M NaOAc was added to precipitate the 
DNA.  This solution was transferred to a -20
o
C freezer for an incubation of 10 min to 
help visualisation of the final purified DNA.  The solution was then centrifuged at 
14000 rpm for 5 min at 4
o
C to pellet the DNA.  The supernatant was removed and 
discarded and the DNA pellet was washed with 300 µl of 70% (v/v) ethanol.  This 
was then spun again at 14000 rpm for 2 min.  The ethanol was removed and the 
DNA pellet was left to dry at room temperature for 15 min.  The DNA was then 
dissolved in 15 µl of sterile H2O.  The purified ligation product was then digested 
with SwaI, a restriction site found between the I-CeuI and PI-SceI sites in the 
pAdeno-X DNA (Figure 6-6A), to linearise non-recombinant, self-ligated pAdeno-X 
DNA.  The restriction digest product was then purified using the 
phenol:chloroform:isoamyl alcohol method described above.  After the DNA pellet 
was dried, it was dissolved in 10 µl of sterile H2O which was then used to transform 
competent E. coli bacterial cells as described in section 6.2.5.2.  Bacterial cells were 
cultured in the presence of 100 µg/µl ampicillin, since the pAdeno-X vector contains 
the ampicillin resistance gene.  Single colonies were used to inoculate a 5 ml culture, 
which were then grown for <24 hr at 37
o
C, shaking.  Cultures were then purified to 
obtain a mini-scale DNA preparation following the instructions in the Adeno-X
TM
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Tet-Off® & Tet-On® Expression System 1 User Manual (Clontech).  The purified 
recombinant pAdeno-X DNA was then analysed by PCR using a set of primers 
provided by Clontech (Adeno-X Forward and Reverse PCR Primers).  These primers 
were designed to confirm the presence of recombinant pTRE-shuttle2 DNA in the 
recombinant pAdeno-X DNA.  The forward primer binds to a sequence upstream of 
the I-CeuI site in the pAdeno-X DNA, whilst the reverse primer binds to a sequence 
downstream of the I-CeuI site of the recombinant pTRE-shuttle2 DNA.  This is 
explained in Figure 6-7.  The presence of inserted recombinant pTRE-shuttle2 DNA 
in the recombinant pAdeno-X DNA would produce a band of 287 bp which was 
analysed on a 1% (w/v) agarose gel after PCR.  The PCR reaction mix used was as 
shown in Table 6-1 and the reaction conditions are found in Table 6-6.  PI-SceI and 
I-CeuI restriction digests were also carried out to verify the presence of insert DNA 
in the recombinant pAdeno-X vector. 
 
6.2.10.2 Construction of recombinant adenoviral DNA for Tet-off expression 
system 
Inserts subcloned into the pDNR-CMV vector were used to generate the Tet-off 
expression system.  The pDNR-CMV vector contains two loxP sites used for Cre-
loxP recombination.  Cre recombinase is an enzyme which mediates recombination 
of DNA sequences at loxP sites.  The pLP-Adeno-X-TRE contains one loxP site and 
act as the acceptor vector.  The reaction was carried out according to the Clontech 
Adeno-X
TM
 Expression Systems 2 user manual where 1 µl of 200 ng recombinant 
pDNR-CMV vector and 1 µl of Cre recombinase (supplied with the Adeno-X 
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Expression Systems 2 kit) were added to 18 µl of Adeno-X LP TRE reaction mix 
containing Cre reaction buffer and BSA.  Briefly, the reaction was incubated at room 
temperature for 15 min and then Cre recombinase was inactivated at 70
o
C for 5 min.  
Transformation of E. coli was carried out to amplify the recombinant viral DNA.  
Electrocompetent cells were used for transformation instead of the chemically 
competent cells described in section 6.2.5 for efficient transformation 
(transformation efficiency for XL10 Gold is ≥5 × 109 cfu/µg pUC18 control DNA 
(Stratagene)).  Electrocompetent cells were purchased from Clontech (EZ10 
ElectroCompetent cells; transformation efficiency = 10
10
 cfu/µg pUC19 control 
DNA) and each transformation was carried out with 40 µl of cells, 1.5 µl of Adeno-X 
LP TRE reaction mix at a voltage of 1.75 kV, 25 µF capacitance in a 0.1 cm cuvette 
(according to manufacturer’s protocol) using the Biorad Gene Pulser II to deliver the 
pulse.  Electroporated cells were then transferred to 960 µl of SOC medium 
(Appendix I) for 1 hr incubation at 37
o
C, shaking at 200 rpm.  Cells were then 
pelleted and resuspended in 100 µl of SOC medium.  The cell suspension was then 
plated out on sterile LB agar containing 7% (w/v) sucrose and 30 µg/ml 
chloramphenicol dissolved in 100% ethanol.  pDNR-CMV vectors contain 
chloramphenicol resistance gene in the expression cassette between the loxP sites 
and the sucrase gene downstream the two loxP sites for negative selection 
(expression of the sucrase gene leads to inability of cells to grow in sucrose).  Hence, 
chloramphenicol selected for recombinant pLP-Adeno-X-TRE constructs and 
sucrose selected against recombinant pDNR-CMV constructs that did not form 
recombinants with pLP-Adeno-X-TRE.  Cultures on LB agar were grown for 30 hr at 
37
o
C.  When colonies were grown, they were used to inoculate 20 µl of sterile H2O 
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each where 10 µl were then used to inoculate 5 ml of LB medium with 100 µg/ml 
ampicillin (ampicillin resistant gene found in pLP-Adeno-X-TRE) and 30 µg/µl 
chloramphenicol.  The rest of the 10 µl was used to carry out colony PCR screening.  
The PCR reaction mix used was as shown in Table 6-1 except that DNA was 
replaced with 10 µl of bacterial cell suspension.  The forward and reverse primers 
used were supplied by Clontech (Adeno-X LP CMV Primer Mix) and the reaction 
conditions are found in Table 6-6.  The PCR reaction products were then separated 
on a 1% (w/v) agarose gel and a 660 bp band was expected.  XhoI digests were also 
carried out as suggested by Adeno-X
TM
 Expression Systems 2 user manual to verify 
the presence of insert DNA in the recombinant pLP-Adeno-X-TRE vector. 
 
6.2.10.3 Miniscale preparation of recombinant Adeno-X DNA 
Since the plasmid size of recombinant Adeno-X DNA is >10kb, miniscale 
preparation of DNA could not be carried out using either the Qiaprep Miniprep 
(Qiagen) or PureLink™ Quick Plasmid Miniprep Kit (Invitrogen).  Miniscale 
preparations of recombinant pAdeno-X DNA and pLP-Adeno-X were performed by 
resuspension of pelleted bacterial cell cultures (2ml) in 150 µl of resuspension buffer 
P1 (see appendix I).  150 µl of lysis buffer P2 and neutralisation buffer N3 were then 
added to the mixture.  After addition of buffer N3, the DNA sample was incubated 
on ice for 5 min.  The DNA sample was then centrifuged at 4
o
C at 14000 rpm for 5 
min.  DNA was purified using phenol:chloroform:isoamyl alcohol as described in 
section 6.2.10.1 and dissolved in 15µl of buffer TE. 
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6.2.11 HEK 293 cell culture 
The Human Adenovirus 5-transformed Human Embryonic Kidney (HEK) 293 cell 
line stably expresses the Ad5 Early Regions 1 (E1) genes that are essential for the 
replication and transcription of Adeno-X viral DNA.  This is because the E1 region 
of wild-type adenovirus has been deleted from the Ad5 genome in the Adeno-X viral 
DNA to restrict the cytopathic activity of the adenovirus.  Hence, HEK 293 cells 
were used to package and propagate the recombinant adenoviral vectors.  The cell 
culture protocol for HEK 293 cells is as described in section 2.6 for N2a cells.  
However, instead of DMEM with 10% (v/v) foetal calf serum, HEK 293 cells 
(Invitrogen) were first cultured in CD 293 medium (Invitrogen) without serum for up 
to 3 passages and then switched to DMEM with 10% (v/v) foetal calf serum 
according to the cell culture guidelines provided by invitrogen.  The thawing, 
expansion and freezing of HEK 293 cells were exactly the same as those described 
for N2a cells in section 6.2.9. 
 
6.2.11.1 Transfecting HEK 293 cells with recombinant Adeno-X DNA 
After confirmation of the presence of the insert of interest in the Adeno-X vector by 
PCR, the recombinant Adeno-X DNA was digested with PacI at 37
o
C for 2 hr to 
linearise the recombinant plasmid.  After PacI restriction digestion, the recombinant 
pAdeno-X DNA was purified by phenol:chloroform:isoamyl alcohol purification as 
described in section 6.2.10.1.  PacI linearised DNA was dissolved in 10 µl of sterile 
water and stored at -20
o
C until used for HEK 293 cells transfection. 




HEK 293 cells were plated in a 25 cm
2
 tissue culture flask the day before the 
transfection to allow the cells to reach 50-70% confluency.  Each 25 cm
2
 flask of  
HEK 293 cells was transfected with 10 µl of PacI digested Adeno-X recombinant 
DNA using Lipofectamine
TM
 2000 (Invitrogen) as described in section 6.2.9.  When 
HEK 293 cells expressed recombinant Adeno-X DNA, cells become cytopathic.  
This cytopathic effect, where cells round up and detach from the tissue culture flask, 
takes place one to two weeks after transfection.  Cells were then detached from the 
tissue culture flask by mechanical disruption without using trypsin and transferred to 
a 15 ml conical tube.  The suspension was centrifuged at 1500 x g for 5 min at room 
temperature and the pellet was then resuspended in 500 µl sterile PBS.  The cells 
were lysed with three consecutive freeze-thaw cycles where the cells were frozen in a 
dry ice/isopropanol bath and then thawed in a 37
o
C water bath.  Care was taken to 
not let the cells reach 37
o
C.  The cells were vortexed after each thaw.  After the third 
cycle, the cell debris was pelleted by a brief centrifugation and the supernatant, 
which now contained the viral particles, was stored at -20
o
C.   
 
A fresh 25 cm
2
 flask of HEK 293 cells was infected by the viral particles produced in 
the previous step by adding the lysate directly to the culture medium.  If cytopathic 
effects were not evident within a week, the cells were detached from the 25cm
2
 flask 
by mechanical disruption, and the cells were lysed to infect a fresh culture of HEK 
293 cells.  When more than 50% of cells had detached from the flask, cells were 
lysed using the method described above.  This is the primary amplification stock and 
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the presence of the recombinant pAdeno-X DNA was verified by PCR as described 
in sections 6.2.10.1 and 6.2.10.2. 
 
6.2.11.2 Amplifying recombinant adenovirus 
To prepare high-titre stocks of the recombinant adenovirus, HEK 293 cells were 
plated in 75 cm
2
 flasks and grown to 50 – 70% confluency and infected with primary 
amplification stock at a multiplicity of 1 – 5 pfu/cell suspended in 5 ml growth 
media.  Cells were incubated at 37
o
C for 90 min before 10 ml of fresh growth 
medium was added.  Cells were cultured at normal growth conditions until 
cytopathic effects were evident.  Cells were then lysed according to the protocol 
described in section 6.2.11.1. 
 
6.2.11.3 Determining viral titre with end-point dilution assay 
HEK 293 cells were grown in a 96-well plate the day before the assay.  Each well 
contained approximately 10
4
 cells in 100 µl of growth medium.  The next day, a 
1:100 dilution of the amplified viral particles was made and using this as a stock, 





100 µl of diluted virus were added to each well.  This is summarised in Figure 6-8. 
 
Cells were grown under normal growth conditions, without changing the culture 
medium, for 10 days.  After which, cytopathic effects were evaluated from each well 
and the viral titre was calculated by counting the number of cytopathic effects 
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positive wells for each dilution divided by 10.  The sum of the fractions of cytopathic 
effects positive wells, x, was used in the following formula to calculate the viral titre 






6.3.1 Exogenous fluorescent protein expression in LDCVs 
ppANF fusion protein is known to be expressed in LDCVs (Burke et al. 1997).  To 
verify whether the ppANF-eGFP construct, used as a template for the amplification 
of the ppANF fragment for subcloning of other constructs, was indeed able to target 
eGFP expression to LDCVs, PC12 cells were transfected using Lipofectamine 2000 
(Invitrogen).  Cells were incubated at 37
o
C overnight after transfection and fixed in 
4% (w/v) PFA for immunostaining.  PC12 cells were stained for chromogranin A 
(goat anti-chromogranin A antibody, 1:250 dilution, Santa Cruz Biotechnology, inc), 
a peptide found in LDCVs (Curry et al. 1991; Mahata et al. 1992).The secondary 
antibodies used were AlexaFluor donkey anti-goat 568 (1:500; Invitrogen) as 
described in previous chapters.  ppANF-eGFP expression was excited with the 488 
nm laser line and chromogranin A labelling excited with 568 nm laser.  Images were 
acquired on the Zeiss Axiovert LSM510 laser scanning confocal microscope as 
described in previous chapters. 
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Figure 6-9 shows a PC12 cell transfected with the ppANF-eGFP construct and 
stained for chromogranin A.  Colocalisation analysis was carried out by the 
Colocalisation Threshold plugin in ImageJ where the threshold for each channel was 
set automatically according to Costes’ method (Costes et al. 2004).  Comparing the 
Pearson’s correlation coefficient for the two channels, ppANF-eGFP and 
chromogranin A staining, there is a significant difference (p<0.006, n=10/group) 
between control, where cells did not express ppANF-eGFP, and ppANF-eGFP-
expressing cells.  Colocalisation of ppANF-eGFP expression and chromogranin A 
staining shows that ppANF-eGFP was indeed targeted for expression in LDCVs.  
However, only partial colocalisation of ppANF-eGFP was observed with 
chromogranin A staining.  This reflects the fact that chromogranin A staining did not 
label all dense core vesicles and that ppANF-eGFP was expressed in vesicles where 
chromogranin A failed to label. 
 
6.3.2 Expression of ppANF-Timer and pTRE-ppANF-Timer 
The ppANF-Timer construct was chosen to study the segregation of newly 
synthesised and aged vesicles since the Timer fluorophore matures and changes 
colour over 16 hr.  The ppANF-Timer was generated by subcloning an amplified 
fragment of ppANF DNA, using ppANF-eGFP as a template, by PCR.  Figure 6-
10B shows the PCR amplification product of between 400 and 500 bp, which is 
expected of ppANF amplification (486 bp).  Through PCR amplification, a HindIII 
restriction site and a AgeI restriction site were introduced to the 5’ and 3’ end of the 
ppANF fragment respectively and subcloned into unique HindIII and AgeI sites 
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found in the pTimer vector.  The product of ppANF and pTimer ligation was 
amplified by maxi preparation of the plasmid and the product was digested by 
HindIII and AgeI to confirm the presence of ppANF in the construct.  Figure 6-10C 
shows two DNA fragments of 3.27 kb and 461 bp as a result of HindIII and AgeI 
double digest, confirming the presence of the pTimer vector and ppANF insert.  The 
ppANF-Timer construct was further analysed by sequence analysis (Cogenic), 
confirming that no base pair mutations were introduced through the subcloning 
process.   
 
ppANF-Timer was then used to generate the inducible pTRE-ppANF-Timer 
construct by subcloning ppANF-Timer into the pTRE-shuttle2 vector (Clontech) 
where the Timer protein production can be switched on at selected time points to 
assure a controlled period time for expression.  Figure 6-10D shows a 1.21 kb DNA 
fragment of ppANF-Timer amplified by PCR.  The ppANF-Timer DNA amplified 
consists of a NheI site at the 5’ end of the fragment and a EagI site at the 3’ end.  
These sites were used to insert ppANF-Timer into the pTRE-shuttle2 vector.  Figure 
6-10E shows restriction digests of pTRE-ppANF-Timer after amplification of 
ligation products of pTRE-shuttle2 and ppANF-Timer.  NheI and EagI double digest 
produced 4.4 kb and 1.16 kb fragments which were the band sizes expected for the 
digested vector and the ppANF-Timer insert.  Single digests using NheI and EagI 
were also carried out and produced bands of DNA of 5.5 kb.  An undigested 
supercoiled DNA sample was ran alongside digests as control to ensure that the 
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restriction enzymes used were effective.  Sequence analysis was carried out for the 
pTRE-ppANF-Timer construct confirming the correct sequence of DNA present. 
 
A double transfection with pTRE-ppANF-Timer and pTet-on containing the reverse 
tetracycline repressor protein (Figure 6-1), using 1 µg/ml doxycycline to induce 
expression, was then carried out on N2a cells.  Figure 6-11 shows an N2a cell 
expressing the pTRE-ppANF-Timer.  Since ppANF targets fluorescent protein 
expression to LDCVs, a punctate expression of green and red fluorescence was 
expected, similar to eGFP expression in Figure 6-9.  However, Timer protein 
expression was concentrated in “clumps” and was not seen throughout the cell.  This 
aggregation of Timer protein is similar to the previously identified aggregation of 
DsRed in the ER (Lauf et al. 2001).  Figure 6-10F shows the amplification of 
pTimer by PCR and Figure 6-10G shows pTRE-Timer restriction digests by NheI 
and EagI after the ligation of amplified pTimer to pTRE-shuttle2 vector. DNA 
fragments of 680 bp from the PCR amplification of pTimer was observed and NheI 
and EagI double digest produced DNA fragments of 4.4 kb and 680 bp, confirming 
the presence of the Timer insert in pTRE-shuttle2.  Figure 6-12 shows an N2a cell 
transfected with pTRE-Timer and pTet-on.  Expression of pTRE-Timer was induced 
by 1 µg/ml doxycycline.  As seen in Figure 6-12, Timer protein not tagged to 
ppANF was expressed throughout the cell cytoplasm and emitted in both green and 
red, as expected over >16 hr of maturation.   It has been reported previously that 
untagged DsRed protein, like untagged eGFP, did not show aggregation in cellular 
compartments (Lauf et al. 2001).  Hence, expression of Timer with the ppANF tag 
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hampered the correct cellular localisation of the fluorophore.  Since this study 
wanted to look at the segregation of vesicle pools by age, the unability to express the 
Timer protein in LDCVs made it unfeasible to continue the use of this fluorophore 
further. 
 
6.3.3 Expression of pTRE-ppANF-eGFP and pTRE-ppANF-tdTomato 
ppANF-eGFP was amplified by PCR and inserted into the pTRE-shuttle2 vector via 
the NheI and EagI sites.  tdTomato, as mentioned above, is 160% as bright as the 
conventional DsRed and matures within 1 hr, leaving no traces of green 
fluorescence.  More importantly, the dimeric tdTomato does not form aggregates in 
cellular compartments.  tdTomato was amplified using PCR to introduce a NheI and 
an EagI site to the 5’ and 3’ ends of the tdTomato DNA fragment.  The amplified 
tdTomato was then inserted to the pTRE-ppANF-eGFP construct via the NheI and 
EagI sites to produce pTRE-ppANF-tdTomato.  Figure 6-13 shows the PCR 
amplification products of ppANF-eGFP (1.2 kb) and tdTomato (1.4 kb), and 
restriction digests using NheI and EagI of the pTRE-shuttle2 and ppANF-eGFP 
ligation product, and the pTRE-ppANF- and tdTomato ligation product.   NheI and 
EagI double digest of pTRE-ppANF-eGFP produced DNA fragments of 4.4 kb and 
1.2 kb, confirming the presence of ppANF-eGFP in the pTRE-shuttle2 vector.  NheI 
and EagI double digest of pTRE-ppANF-tdTomato produced DNA fragments of 4.4 
kb and 1.9 kb, confirming that tdTomato was inserted into the pTRE-ppANF- vector. 
 
Chapter 6 Fluorescent protein expression in LDCVs and viral transduction  
184 
 
pTRE-ppANF-eGFP and pTRE-ppANF-tdTomato were expressed in PC12 cells via 
double transfections of the recombinant constructs and pTet-on, using 1 µg/ml 
doxycycline for induction of expression.  Figure 6-14A shows PC12 cells expressing 
the pTRE-ppANF-eGFP and the pTRE-ppANF-tdTomato plasmids.  PC12 cells were 
immunolabelled with Chromogranin A and a Golgi apparatus marker (mouse anti-
GM130, BD laboratories, described in Chapter 3) was used to label the Golgi 
apparatus.  Expression of both plasmids produced punctate expression of fluorescent 
proteins, as expected for ppANF targeting to LDCVs.  Moreover, colocalisation 
analysis showed that like ppANF-eGFP expression (Figure 6-9), expression of 
ppANF-tdTomato colocalised with the expression of the dense core vesicle marker, 
chromogranin A (Figure 6-14B; p<0.001) (Curry et al. 1991; Mahata et al. 1992), 
indicating that expression of both ppANF-tagged constructs were targeted to LDCVs.  
In this study, negative controls were carried out where transfected cells were not 
incubated in doxycycline.  No expression of either constructs was observed. 
 
An analysis of pTRE-ppANF-tdTomato expression at different time points was 
carried out on transfected PC12 cells to visualise segregation of vesicle pools at 
different time points.  PC12 cells were double transfected with pTRE-ppANF-
tdTomato and pTet-on with 1 µg/ml doxycycline at time 0.  pTRE-ppANF-tdTomato 
expression was observed as early as 4 hr post-transfection.  Cells were then fixed 8 
hr, 16 hr and 24 hr after doxycycline was added to the medium and immunolabelled 
with GM130.  Image stacks were acquired of PC12 cells expressing the pTRE-
ppANF-tdTomato protein using the same imaging parameters as described (Chapter 
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3) and the sum fluorescent intensity (Chapter 2, section 2.2.5) of pTRE-ppANF-
tdTomato expression in deconvolved images was obtained.  pTRE-ppANF-tdTomato 
expression was measured in the GA, cell centre and cell periphery (the outer 1 µm of 
the cells).  The areas measured were cut out so that expression of pTRE-ppANF-
tdTomato in the GA, for example, was not taken into measurement of the other cell 
areas.  Figure 6-15 shows analysis of pTRE-ppANF-tdTomato expression in 
different cell areas at different time points normalised to the pTRE-ppANF-tdTomato 
expression in the GA.  There was significantly higher expression in the GA 
compared to the rest of the cells at all time points (p<0.05, two-way ANOVA, post-
hoc Student’s t-test).  There were no differences between pTRE-ppANF-tdTomato 
expression between the cell centre and cell periphery at any time points and no 
difference at expression at the cell centre and the cell periphery between any time 
points.  There is a significant increase in pTRE-ppANF-tdTomato expression in the 
cell centre at 24 hr compared to 8 hr.  Since cells were not stimulated for vesicle 
release, this indicates that non-released LDCVs accumulate after 24 hr and reside in 
the cell centre.  This study showed that aged vesicles reside in the centre of PC12 
cells, in accordance to the finding that aged, non-released vesicles were found in the 
centre of bovine adrenal chromaffin cells (Duncan et al. 2003).  Moreover, this study 
shows that pulse-labelling of inducible ppANF-tagged  fluorescent protein 
expression can be used to study vesicle pool segregation according to age. 
 
6.3.4 Generation of pAdeno-X constructs 
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Mini-scale preparation of recombinant pAdeno-X constructs were analysed using the 
Adeno-X Forward and Reverse PCR Primers and I-CeuI/PI-SceI double restriction 
digest to confirm the presence of recombinant pTRE- inserts.  PCR analysis (Figure 
6-7) showed that both recombinant pAdeno-X constructs produced an amplified 
fragment of 287 bp, as would be expected (Figure 6-16A).  Further PCR analysis 
using the Adeno-X Forward PCR Primer which binds upstream to the I-CeuI site of 
pAdeno-X viral DNA, and a reverse primer which binds to the insert ppANF-eGFP 
or ppANF-tdTomato DNA, respectively, also produced amplified DNA fragments of 
the expected band sizes (Figures 6-16B and C).  HEK 293 cells were then 
transfected with pAdeno-X viral DNA to produce viral particles.  Cells infected with 
recombinant pAdeno-X constructs were lysed and their lysates collected for PCR 
analysis.  Despite the positive PCR analysis of recombinant viral DNA (Figure 6-
16A – C), PCR analysis of viral stock using the Adeno-X Forward and Reverse PCR 
Primers did not show the presence of the expected 287 bp fragment.  Further 
restriction analysis by double digestion with I-CeuI and PI-SceI did not produce 
DNA fragments of the expected sizes (2.8 kb and 32.67 kb for pAdeno-X-TRE-
ppANF-eGFP and 3.5 kb and 32.67 kb for pAdeno-X-TRE-ppANF-tdTomato).  
Single digests with either enzyme produced DNA bands similar to undigested DNA 
in the case of pAdeno-X-TRE-ppANF-eGFP, indicating that either the restriction 
enzymes were compromised, or the I-CeuI and PI-SceI restriction sites were 
compromised (Figure 6-16D).  Double digestion of pAdeno-X-TRE-ppANF-
tdTomato revealed that the construct was cut by I-CeuI whilst PI-SceI was 
unsuccessful (Figure 6-16D). 




I-CeuI and PI-SceI double digests were carried out on pTRE-ppANF-eGFP and 
pTRE-ppANF-tdTomato to find out whether the I-CeuI and PI-SceI restriction sites 
were compromised and whether both enzymes were efficient in the conditions used.  
Figure 6-17A shows that both I-CeuI and PI-SceI cut pTRE-ppANF-eGFP and 
pTRE-ppANF-tdTomato into bands of 2.8 kb and 2.8 kb, and 2.8 kb and 3.5 kb 
respectively, indicating that both enzymes were efficient in restriction digest under 
the conditions used.  Further restriction analysis of pAdeno-X-TRE-ppANF-eGFP 
and pAdeno-X-TRE-ppANF-tdTomato using NheI and EagI showed that the 1.2 kb 
and 1.9 kb inserts were present in the pAdeno-X construct respectively (Figure 6-
17B).  However, the full length of the pAdeno-X DNA did not appear to be present.  
Adding up the band sizes of the NheI/EagI double digest of pAdeno-X-TRE-ppANF-
eGFP found the plasmid size to be approximately 7 to 8 kb, which was a lot less than 
the 35.46 kb expected.  The two constructs were subsequently sent away for 
sequence analysis and it was confirmed that although the I-CeuI sites were intact in 
both constructs, the PI-SceI sites were missing, as well as a large portion of the 
pAdeno-X viral DNA.  Care was taken during the transformation of E. coli with 
recombinant Adeno-X DNA to amplify the recombinant constructs to prevent 
damage and recombination of Adeno-X constructs.  XL-10 Gold cells (Stratagene) 
are recombination deficient, and colonies expressing the recombinant pAdeno-X 
constructs were picked <24 hr after transformation for miniprep cultures which were 
used the same day to inoculate maxiprep cultures.  Maxiprep cultures were grown 
overnight for <24 hr hours before maxi DNA preparation was carried out.  Cultures 
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expressing recombinant pAdeno-X constructs were always used fresh and never 
stored at room temperature or at 4
o
C, minimising damage to Adeno-X DNA.  Hence, 
it was concluded that the pAdeno-X DNA was originally damaged and Clontech had 
since replaced our pAdeno-X Tet-on expression system with the pLP-Adeno-X-TRE 
Tet-off expression system. 
 
6.3.5 Expression of pDNR-ppANF-eGFP and pDNR-ppANF-tdTomato 
pDNR-CMV donor vector (Clontech) was used to subclone ppANF-eGFP and 
ppANF-tdTomato into the inducible pLP-Adeno-X-TRE construct.  Firstly, ppANF-
eGFP was inserted into pDNR-CMV via the unique HindIII and XbaI restriction sites 
present in both ppANF-eGFP and pDNR-CMV vectors.  HindIII and XbaI sites were 
also introduced to ppANF-tdTomato via PCR amplification (Figure 6-18A).  After 
ligation of the pDNR-CMV vector with the insert DNA, mini-preparations of the 
constructs were carried out.  HindIII and XbaI restriction digests on the mini-preps 
confirmed the presence of ppANF-eGFP (1.2 kb) and ppANF-tdTomato (1.9 kb) in 
the constructs (Figures 6-18B and C).  These positive constructs were then sent for 
sequence analysis which confirmed the presence of insert DNA between the HindIII 
and XbaI sites (Cogenics). 
 
N2a cells were transfected with pDNR-ppANF-eGFP and pDNR-ppANF-tdTomato 
to test for fluorescent protein expressions in these constructs.  Figures 6-19A and B 
show the expression of pDNR-ppANF-eGFP in green and pDNR-ppANF-tdTomato 
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in red respectively, confirming that these constructs could be used for further pLP-
Adeno-X-TRE subcloning. 
 
6.3.6 Generation of pLP-Adeno-X-TRE constructs 
pLP-Adeno-X-TRE DNA was ligated to pDNR-ppANF-eGFP and pDNR-ppANF-
tdTomato via Cre recombination.  The recombinant DNA was then used to transform 
electrocompetent cells using the procedures described in section 6.2.10.1 above.  The 
transformed cells were then cultured for 1 hr at 37
o
C and then used to inoculate 
sucrose/chloramphenicol agar, which was further cultured for 24 hr at 37
o
C.  Colony 
PCR was performed on selected colonies picked from the agar plates using Adeno-X 
LP CMV Primer Mix (section 6.2.10.1).  Figures 6-20A and B show the results of 
PCR analysis of pLP-Adeno-X-TRE-ppANF-eGFP and pLP-Adeno-X-TRE-ppANF-
tdTomato respectively.  Both analyses generated a band of 660 bp, which is 
consistent with the presence of the pDNR insert in the pLP-Adeno-X-TRE vector.  
Further analysis using the XhoI restriction enzyme showed that pLP-Adeno-X-TRE-
ppANF-eGFP had a missing band at the expected 5.0 kb, which was where the insert 
DNA should be (Figure 6-20C).  XhoI restriction analysis of pLP-Adeno-X-TRE-
ppANF-tdTomato generated all the expected bands (14.5, 8.0, 5.8, 3.6, 2.5, and 1.4 
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Targeting of fluorescence to LDCVs allows direct visualisation of peptide release 
and vesicle pool segregation.  ppANF, a peptide of 152 amino acids, had been shown 
to target fluorescent protein expression to LDCVs in PC12, bovine adrenal 
chromaffin cells and pituitary lactotrophs (Han et al. 1999; Ng et al. 2002; Stenovec 
et al. 2004; Duncan et al. 2003).  Results from ppANF-eGFP transfection of PC12 
cells had shown that eGFP expression was colocalised with chromogranin A staining 
(Figure 6-9), indicating that ppANF successfully targeted fluorescent protein 
expression to LDCVs.  In this study, a fluorescent time stamp was tagged to ppANF 
for LDCV targeting.  The fluorescent time stamp had been successfully used as an 
indication of vesicle age since the Timer fluorescent protein changes emission from 
green to red as it matures over time (Terskikh et al. 2000).  Hence, over a time 
course, vesicles older than 16 hr emit in the red spectrum and newly synthesised 
vesicles emit in the green.  However, the fluorescent time stamp also has complicated 
folding properties as it matures.  The Timer protein matures and oligomerises into a 
tetramer for fluorescent emission, similar to the maturation process in DsRed (Wall 
et al. 2000).  Previous studies have reported that untagged DsRed expressed in the 
cytoplasm and did not aggregate (Lauf et al. 2001).  In this study, targeting of Timer 
to LDCVs was shown to have the same effect.  As the results in section 6.3.2 have 
shown, tagging of the fluorescent Timer to ppANF resulted in aggregation of the 
fluorophore in perinuclear compartments, likely to be the ER (Figure 6-11).  Similar 
to untagged DsRed expression untagged fluorescent Timer expression, was observed 
throughout the cytoplasm of N2a cells (Figure 6-12).  This demonstrates that 
oligomerisation of the ppANF-Timer protein had resulted in aggregation of the 
fluorophore (Figure 6-11).  Since ppANF tagged to eGFP or tdTomato, both form 
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dimers, resulted in correct targeting of the fluorophores to LDCVs, Timer expression 
had hampered ppANF targeting.  Nevertheless, the fluorescent Timer had been 
shown previously to be successfully targeted to LDCVs in bovine adrenal chromaffin 
cells (Duncan et al. 2003) by tagging to ppANF.  Hence, further experiments to tag 
the Timer protein to ppANF with differing lengths of linking bases which provide 
more flexibility for the  oligomerisation of the Timer protein (Wall et al. 2000) might 
to crucial to expression of Timer protein in LDCVs.  A study analysing the different 
mutants of the DsRed protein had found that mutants with different “free space”, 
based on crystal structure analysis, around the fluorophore resulted in different 
maturing properties of the protein (Terskikh et al. 2002).  It was hypothesised that 
aggregation of the Timer protein is due to electrostatic attraction between the 
negatively charged surface of the protein and the positively charged N-terminal.  
Mutation at the N-terminal of the Timer protein resulted in a non-aggregating form 
of the protein (Yanushevich et al. 2002).  Therefore, it is crucial in future 
experiments to alter the linking region of ppANF and Timer and also to mutate the 
N-terminus of the Timer protein for efficient expression of the fluorescent protein. 
 
Meanwhile, the inducible ppANF-tdTomato construct generated was shown to be 
efficient in pulse-chase labelling of newly synthesised and mature LDCVs.  The Tet-
on expression system involved subcloning fluorescent proteins into a vector with a 
tetracycline response element which upon binding of the tetracycline to the rtTA, 
activates transcription of the fluorescent proteins.  Two fluorescent reporter proteins 
were chosen – eGFP which emits green and tdTomato which emits red.  Figure 6-14 
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showed expression of the pTRE-ppANF-eGFP and pTRE-ppANF-tdTomato 
constructs in PC12 cells and colocalisation of fluorescent protein expression with 
chromogranin A staining.  This shows that both fluorescent proteins were targeted to 
LDCVs and both inducible constructs are suitable for studying the dynamics of 
LDCVs.  “Pulse-chase” expression of pTRE-ppANF-tdTomato had shown that there 
was a significant difference between mean fluorescent intensity in the GA compared 
to other cell areas at all time points measured, indicating that transfected cells were 
actively synthesising ppANF-tdTomato at all time points.  Moreover, there was a 
significant increase in mean fluorescent intensity in the cell centre at 24 hr after 
induction of pTRE-ppANF-tdTomato expression compared to 8 hr.  Since no 
stimulant was used in the culture medium, vesicles not released as a result of basal 
activity were retained in the cells, making up the reserve pool of vesicles.  A 
significantly higher mean fluorescent intensity in the cell centre at 24 hr suggested 
that non-released aged vesicles join the reserve pool in the cell centre, in agreement 
to the vesicle pool arrangement found in bovine adrenal chromaffin cells (Duncan et 
al. 2003). 
 
To express these constructs in magnocellular neurons, these constructs had to be 
inserted into the Adeno-X viral genome for transduction.  The Tet-on expression 
system involved subcloning the recombinant pTRE-shuttle vector into pre-linearised 
Adeno-X DNA.  However, Figures 6-16D and E and 6-17 showed that the PI-SceI 
sites of both pAdeno-X-TRE-ppANF-eGFP and pAdeno-X-TRE-ppANF-tdTomato 
were compromised.  Further sequence analysis confirmed that the PI-SceI site was 
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absent.  The pAdeno-X is a large plasmid, >32 kb, making it vulnerable to damage 
and recombination.  The vulnerability to damage of the pAdeno-X plasmid was taken 
into consideration and  hence, each incubation step from transformation of 
recombinant deficient E. coli to the growth of bacterial cultures was carried out in < 
24 hr succession to the previous step.  Taking all the precautions taken into account, 
one explanation of the absence of portions of Adeno-X DNA and the PI-SceI site 
was that the Adeno-X DNA was damaged prior to subcloning and transformation.  
Clontech technical support had also agreed that the Adeno-X DNA was damaged and 
the company has replaced our Adeno-X
TM
 Tet-On® Expression Systems 1 with the 
Adeno-X
TM
 Expression Systems 2 containing pLP-Adeno-X-TRE vector. 
 
The reporter genes chosen for the Adeno-X
TM
 Expression Systems 2 were ppANF-
eGFP and ppANF-tdTomato.  Subcloning of the two reporter constructs into the 
pDNR-CMV donor vector was shown to be successful in Figure 6-18B and C.  
Transfection of pDNR-ppANF-eGFP and pDNR-ppANF-tdTomato in N2a cells had 
also shown expression of the two constructs (Figure 6-19).  Cre-loxP-mediated 
recombination was carried out to insert the gene of interest from the pDNR-
constructs to the pLP-Adeno-X vector.  Restriction digests with XhoI restriction 
enzyme had confirmed that the presence of the insert and pLP-Adeno-X-TRE vector 
in the pLP-Adeno-X-TRE-ppANF-tdTomato construct.  Further sequence analysis 
also confirmed that the loxP sites used for recombination were intact, making this 
construct a strong candidate for inducible expression of ppANF-tdTomato protein in 
magnocellular neurons.  Transduction of magnocellular neurons with adenovirus is 
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known to be an efficient means of exogenous protein expression.  Adenovirus has 
low cytotoxicity, an important factor to consider in samples to be used in live cell 
imaging experiments.  In addition, the tet-on and tet-off systems offer the 
opportunity to label newly synthesised and mature LDCVs by the addition of 
doxycycline, hence eliminating the use of the complicated Timer protein, and also 
ensuring that fluorescent protein expression ceases at the same time within each 
sample studied.  Generation of viral particles containing the pLP-Adeno-X-TRE-
ppANF constructs will inevitably be a big step forward in targeting fluorescent 
protein expression in LDCVs of magnocellular neurons and controlling fluorescent 
expression will allow pulse chase study of vesicle release in magnocellular dendrites.  
 




Figure 6-1.  Adeno-x Tet-Off and Tet-on system.  Transcription is turned off/on by 
the addition of doxycycline.  PCMV = cytomegalovirus promoter; (r)tetR = (reverse) 
tetracycline repressor protein; VP16 = c-terminal activation domain of Herpes 
simplex virus; (r)tTA = (reverse) tetracycline-controlled transactivator; TRE = 
tetracycline response element; PminCMV = minimal immediate early promoter of 
cytomegalovirus; Tc = tetracycline; Dox = doxycycline.  Diagram adapted from 
Adeno-X
TM
 Tet-Off® & Tet-On® Expression System 1 User Manual. 
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Figure 6-2.  Overview of recombinant adenovirus construction and infection.  The 
gene of interest was subcloned into the pTRE-shuttle2 vector via the multiple cloning 
site (MCS).  Insert DNA, bearing the restriction sites compatible with restriction sites 
in the MCS, and pTRE-shuttle2 vector were digested creating compatible restriction 
sites for ligation to create recombinant pTRE-shuttle2 vectors.  pTRE-shuttle2 
vectors contain PI-SceI and I-CeuI restriction sites compatible with those found in 
the pAdeno-X viral vector and can be subcloned via these sites by T4 ligation.  
Recombinant pAdeno-X vectors were then amplified via transformation and culture 
of bacterial cells.  Amplified viral DNA was linearised by PacI digestion and HEK 
293 cells were infected with viral DNA to add packaging of viral particles.  
Recombinant viral particles can then be used to infect target magnocellular cells 
along with Tet-on regulatory virus for inducible expression of the gene of interest.   
Figure adapted from Adeno-X
TM
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Figure 6-3.  Overview of the generation of inducible ppANF-tagged constructs to the 
generation of viral particles using the Adeno-X
TM
 Expression System 1 (Clontech).   
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Figure6-4.  Plasmid maps of ppANF tagged fluorescent constructs and inducible 
constructs showing the promoters, proteins expressed, restriction sites used for 
subcloning, antibiotic resistant markers, and the sizes of the constructs.  Vector maps 
generated with Vector NTI (Invitrogen). 






Figure 6-5.  PCR amplification and introduction of restriction sites.  Compatible 
sites with the vector DNA, where the amplified DNA would be subcloned into, were 
chosen, in this example, AgeI and EagI.  Restriction digests result in non-paired 
oligonucleotides producing sticky ends for ligation.  Ligation involves the use of T4 
ligase, where sticky ends from the same restriction digests are joined together.  
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Figure 6-6.  A) Plasmid map of pAdeno-x containing two inverted terminal repeats, 
the ampicillin resistance gene, PacI sites for linearization of viral vector, and the PI-
SceI and I-CeuI sites for subcloning of recombinant pTRE-shuttle2 vectors.  B) 
Plasmid map of pLP-Adeno-X-TRE containing similar features as (A) plus the TRE 
located upstream of the minimal cytomegalovirus promoter (PminCMV).  Together, the 
TRE and PminCMV makes up the PhCMV -1 which is silent when the tTA is activated in 
the presence of tetracycline.  pLP-Adeno-X-TRE also contains a loxP site for Cre-
loxP recombination with recombinant pDNR-CMV vectors.  Both plasmid maps 
show positions of restriction sites and the size of the Adeno-X vectors.  Figures 
adapted from Adeno-X
TM
 Expression System 1 and Adeno-X
TM
 Expression Systems 

































Figure 6-7.  Confirmation of recombinant pAdeno-x-ppANF-DsRed1-E5 ligation 
and transformation by PCR screening.  Figure adapted from Adeno-X
TM
 PCR 
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Figure 6-8.  Determining viral titre with the end-point dilution assay.  HEK 293 cells 
were plated in a 96-well plate for 10 days.  The recombinant virus was diluted from a 





100 µl of diluted virus was added to each well containing HEK 293 cells.  Negative 
controls were carried out by adding virus-free media to cells.  Shaded circles 
represent cell growth and circles marked with C represent cytopathic effect of cells 
seen in each well.  The number of wells containing cells with cytopathic effect was 
noted for each dilution used.  Figure adapted from Adeno-X
TM
 Tet-Off® & Tet-On® 
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Figure 6-10.  Gel images from electrophoresis of PCR amplification products of 
ppANF, ppANF-Timer and pTimer and restriction digest of ppANF-Timer, pTRE-
ppANF-Timer and pTRE-Timer.  A) DNA ladder (Invitrogen) labelled with band 
sizes in bp.   B) PCR amplification of ppANF (486 bp).  C) Restriction digest of 
ppANF-Timer using HindIII (H) and AgeI (A); sizes of DNA fragments shown are 
3.27 kb and 461 bp; confirming the presence of ppANF in the pTimer vector.  D) 
PCR amplification of ppANF-Timer (1.21 kb).  E) Restriction digests of pTRE-
ppANF-Timer – N/E = NheI/EagI double digest, N = NheI single digest, E = EagI 
single digest, s.c. = supercoiled undigested DNA.  Single digests show band sizes of 
5.58 kb and double digest shows band sizes of 4.4 kb and 1.16 kb, confirming the 
presence of ppANF-Timer in the pTRE-shuttle2 vector.  F) PCR amplification of 
pTimer (680 bp).  G) Restriction digests of pTRE-Timer using NheI and EagI.  
Single digests show band sizes of 5.1 kb and double digest shows band sizes of 4.4 
kb and 680 bp, confirming the presence of pTimer in the pTRE-shuttle2 vector. 
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Figure 6-13.  Gel images from electrophoresis of PCR amplification products of 
ppANF-eGFP and tdTomato and restriction digest of pTRE-ppANF-eGFP, pTRE-
ppANF-tdTomato.  A) PCR amplification of ppANF-eGFP (1.2 kb).  B) PCR 
amplification of tdTomato (1.4 kb).  C and D) Restriction digest of pTRE-ppANF-
eGFP and pTRE-ppANF-tdTomato using NheI (N) and EagI (E); sizes of DNA 
fragments shown are 4.4 kb and 1.2 kb for pTRE-ppANF-eGFP; and 4.4 kb and 1.9 
kb for pTRE-ppANF-tdTomato confirming the presence of both ppANF-eGFP and 
ppANF-tdTomato inserts in the pTRE-shuttle2 vector.  N/E = NheI/EagI double 
digest, N = NheI single digest, E = EagI single digest, s.c. = supercoiled undigested 
DNA.   
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Figure 6-14B.  Colocalisation between ppANF-tdTomato and chromogranin A.  
Mean Pearson’s correlation coefficients of control (non-transfected cells) and pTRE-
ppANF-tdTomato transfection. Student’s t-test showed a significant difference 
between control and ppANF-tdTomato colocalisation with chromogranin A ; 
p<0.001, n=10. 
 



































Figure 6-15.  pTRE-ppANF-tdTomato expression in the GA, cell centre and cell 
periphery in transfected PC12 cells.  Cells were transfected for 8 (n = 7), 16 (n=10) 
and 24 hr (n=8).  There are significant differences in pTRE-ppANF-tdTomato 
expression between the GA of all time points compared to the cell centre and the cell 
periphery.  pTRE-ppANF-tdTomato expression in the cell centre at 24 hr was 
significantly higher than expression at 8 hr (p<0.05, two-way ANOVA, post-hoc 
Student’s t-test).  There were no significant differences in other cell areas at the 
different time points. 











Figure 6-16.  Analysis of pAdeno-X-TRE-ppANF-eGFP and pAdeno-X-TRE-
ppANF-tdTomato.  A) PCR analysis of pAdeno-X-TRE-ppANF-eGFP and pAdeno-
X-TRE-ppANF-tdTomato using pAdeno-X Forward and Reverse PCR Primers, 
DNA fragment amplified – 287 bp.  B and C) PCR analysis of pAdeno-X-TRE-
ppANF-eGFP and pAdeno-X-TRE-ppANF-tdTomato using pAdeno-X PCR forward 
primer and a reverse primer binding directly to the insert DNA.  B) Reverse primer 
binding to the c-terminal of the ppANF fragment in pAdeno-X-TRE-ppANF-eGFP, 
DNA fragment amplified – 1.2 kb.  C) Reverse primer binding to the c-terminal of 
the tdTomato fragment in pAdeno-X-TRE-ppANF-tdTomato, DNA fragment 
amplified – 2.7 kb. D) P/I = PI-SceI/I-CeuI double digest, P = PI-SceI single digest 
and I = I-CeuI single digest, s.c. = undigested supercoiled DNA.  P/I double digest 
should generate two DNA fragments for each plasmid: 2.8 kb and 32.67 kb for 
pAdeno-X-TRE-ppANF-eGFP and 3.5 kb and 32.67 kb for pAdeno-X-TRE-ppANF-
tdTomato.  Single digests showed that I-CeuI restriction enzyme worked on pAdeno-
X-TRE-ppANF-tdTomato pAdeno-X-TRE-ppANF-eGFP and PI-SceI did not digest 
either construct since DNA fragments observed were similar to undigested 
supercoiled DNA. 
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Figure 6-17.  A) Restriction analysis of pTRE-ppANF-eGFP and pTRE-ppANF-
tdTomato with I-CeuI and PI-SceI.  I/P = I-CeuI and PI-SceI double digest, I = I-
CeuI single digest, P = PI-SceI single digest and s.c. = undigested supercoiled DNA.  
Double digest of pTRE-ppANF-eGFP produced two bands at 2.79 kb and 2.85 kb, 
and single digests produced bands at 5.6 kb.  Double digest of pTRE-ppANF-
tdTomato produced two bands, one at 2.8 kb and one at 3.5 kb.   These band sizes 
confirmed the presence of ppANF-eGFP and ppANF-tdTomato within the I-CeuI 
and PI-SceI sites of pTRE-shuttle2 vector, both restriction enzymes were successful 
at digest, and both restriction sites were intact in the recombinant pTRE-shuttle 
vectors.  B) Restriction analysis of pAdeno-X-TRE-ppANF-eGFP and pAdeno-X-
TRE-ppANF-tdTomato with NheI and EagI.  N/E = NheI and EagI double digest, N 
= NheI single digest and E = EagI single digest.  pTRE-ppANF-tdTomato NheI/EagI 
double digest was included as a positive control of the double restriction digest.  
NheI and EagI digests of pAdeno-X-TRE-ppANF-eGFP revealed the total size of the 
recombinant pAdeno-X DNA to be between 7 and 8 kb.  Meanwhile, a ~ 2 kb and a 
band higher than 12 kb were seen in NheI and EagI digests of pAdeno-X-TRE-
ppANF-tdTomato. 









Figure 6-18.  Analysis of pDNR-ppANF-eGFP and pDNR-ppANF-tdTomato.  A) 
PCR amplification of ppANF-tdTomato, DNA fragment amplified – 1.9 kb. B) 
HindIII (H) and XbaI (X) double digest of pDNR-ppANF-eGFP showing band sizes 
of 1.2 kb and 5.6 kb.  C) H/X double digest of pDNR-ppANF-tdTomato showing 
band sizes of 1.9 kb and 5.6 kb.  S.c. = undigested supercoiled DNA.   
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Figure 6-20.  Analysis of pLP-Adeno-X-TRE-ppANF-eGFP and pAdeno-X-
LPTRE-ppANF-tdTomato.  A and B) Colony PCR analysis of pLP-Adeno-X-TRE-
ppANF-eGFP (A) and pAdeno-X-LPTRE-ppANF-tdTomato (B) using Adeno-X LP 
CMV Primer Mix.  DNA fragments amplified – 660 bp.  C and D) XhoI restriction 
digests (X) of pAdeno-X-LPTRE-ppANF-eGFP (C) and pAdeno-X-LPTRE-ppANF-
tdTomato (D).  DNA fragments expected (kb) – pAdeno-X-LPTRE-ppANF-eGFP: 
14.5, 8.0, 5.0, 3.6, 2.5, 1.4, 0.6; pAdeno-X-LPTRE-ppANF-tdTomato – 14.5, 8.0, 
5.8, 3.6, 2.5, 1.4, and 0.6.  s.c. = undigested, supercoiled DNA. 




PCR Mix Sample (µl) Negative Control (µl) 
Final 
Concentration 
PCR Buffer 10 10 1x 
d’NTPs 1 1 0.2mM @ 
MgCl2 4 4 2mM 
Forward Primer (µM) 5 5 0.2 – 0.3 µM 
Reverse Primer (µM) 5 5 0.2 – 0.3 µM 
DNA (1ng/µl) 1 - 1ng/50µl 
Taq Polymerase 0.25 0.25 1.25u 
H2O 23.75 24.75 - 
Total Volume 50µl 
Table 6-1. Typical reaction mix for PCR.   
 
 
PCR cycles Temperature Duration No. of Cycles 
Denaturation 95
o
C 2 min 1 
Denaturation 95
o
C 1 min 
32 Annealing 64
o
C 30 sec 
Elongation 72
o
C 1 min 30 sec 
Elongation 72
o
C 5 min 1 
Hold 4
o
C Indefinite - 
Table 6-2. PCR Cycles for the amplification of DNA fragment. 






Forward primers Reverse primers 















Table 6-3.  Primers used in PCR amplification of DNA fragments for subcloning.  Forward and reverse primers listed in 5’ to 3’ for each 
DNA fragment amplified. 








DNA (1 µg/µl) 30 5 1 1 1 
Enzyme 1 1 1 1 - - 
Enzyme 2 1 1 - 1 - 
10x Digestion Buffer  4 2 2 2 2 
H2O 4 11 16 16 17 
Total Volume 40 20 

















1 1 1 1 1 1 
Insert DNA (1.4 
kb, 33ng/µl) 
0.3 1 4.5 8.9 - - 
T4 ligase 1 1 1 1 1 - 
2x Ligation 
Buffer  
5 5 6.5 10.9 5 5 
H2O 2.7 2 - - 3 4 
Total Volume 10 10 13 21.8 10 10 
Table 6-5.  Conditions for a typical ligation reaction. 
 




PCR cycles Temperature Duration No. of Cycles 
Denaturation 94
o
C 2 min 1 
Denaturation 94
o
C 1 min 
32 Annealing 64
o
C 30 sec 
Elongation 68
o
C 1 min 30 sec 
Elongation 68
o
C 5 min 1 
Hold 4
o
C Indefinite - 












It is known that dendritic peptide release is temporally and functionally different 
from axonal terminal release (Ludwig et al. 2002).  However, the mechanism 
regulating this difference in peptide release is not fully understood.  The present 
study investigated the mechanism of dendritic peptide release by studying the 
regulation of vesicle pools in dendrites.  Intracellular mobilisation of calcium is 
known to recruit vasopressin-containing vesicles to the periphery of the plasma 
membrane (Tobin et al. 2004), suggesting the recruitment of a reserve vesicle pool 
for release.  In peptide-releasing bovine adrenal chromaffin cells, newly synthesised 
vesicles were found to be preferentially recruited to the readily releasable pool whilst 
aged vesicles made up the reserve pool (Duncan et al. 2003; Wiegand et al. 2003), 
suggesting vesicular age is an important factor for vesicle pool regulation.  It is not 
known whether magnocellular dendrites contain vesicle pools functionally different 
depending on age, and it is not known if there are specific mechanisms governing the 
routing of vesicles to dendrites.  
 
 
7.1 Vesicle pools and routing 
The segregation of different LDCV vesicle pools in axonal terminals and in 
endocrine cell lines are well documented.  These vesicle pools were found to be 
functionally different from each other where depolarisation of the cell membrane 
  Chapter 7 Discussion 
221 
initially triggers the release of the RRP and prolonged depolarisation triggers release 
of the RP (Horrigan & Bookman 1994; Voets et al. 1999).  Previous morphological 
studies found that lysosomes are present in magnocellular dendrites (Morris & 
Dyball 1974), which suggests the existence of the machinery for degradation of aged 
organelles, including unreleased LDCVs in these parts of the neurons.  The present 
study found that lysosomes in magnocellular dendrites are significantly correlated 
with high vasopressin density, suggesting that lysosomes in magnocellular dendrites 
have important functions in the degradation of vasopressin LDCVs.  Lysosomes 
were found to be located in the centre of dendrites, suggesting that they are ideally 
positioned to handle aged, non-released LDCVs.  Although lysosomes were found in 
magnocellular dendrites and were found to be correlated with high vasopressin 
density, it was not known whether dendrites are important compartments for 
degradation like the Herring bodies found in neuronal terminals (Heap et al. 1975; 
Krsulovic et al. 2005).  If dendrites were compartments of degradation; i.e. a 
compartment filled with aged vesicles ready to be degraded, then aged vesicles may 
be specifically routed to dendrites.  However, using low temperature to block vesicle 
exit from the GA revealed that newly synthesised vesicles do translocate to dendrites 
indicating that dendrites contain a mixture of newly synthesised vesicles and aged 
vesicles and that vesicle routing to magnocellular dendrites is not dependant on 
vesicle age.  Since dendrites are structures of ~200 µm in length, it is interesting to 
find out whether newly synthesised vesicles translocate to specific parts of dendrites.  
If newly synthesised vesicles were specifically translocated to any portion of the 
dendritic profile, this might suggest that different portions of a dendrite have 
different release properties.  Tracking of newly packaged vesicles from the GA along 
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the profile of dendrites suggested that there was no difference in the distribution of 
newly assembled vesicles from the GA.  This suggests that release properties are 
similar in all parts of a dendrite.  Although dendrites measured in this study only 
represent the proximal to middle portion of the full lengths of dendrites, this result 
agreed with the finding that all parts of the dendritic membranes were capable of 
exocytosis (Pow & Morris 1989) and no active zones for release were found.  Hence, 
if newly synthesised vesicles were preferentially recruited for readily releasable pool 
secretion, there is no difference in preferential release throughout the length of 
dendrites.   
 
In bovine adrenal chromaffin cells, the divalent cation barium was found to 
preferentially release vesicles from the reserve vesicle pool and possibly the non-
releasable pool (Seward et al. 1996; Duncan et al. 2003) indicating that barium was 
able to activate a distinct release pathway specific to vesicles in the reserve pool. 
Reserve pool vesicles in magnocellular dendrites are known to potentiate stimulus-
dependent release (Ludwig et al. 2002); however, whether vesicles from the reserve 
pool can also be preferentially released from magnocellular dendrites and hence has 
differential functions to RRP vesicles is unknown.     In contrast, Ba
2+
 was found to 
be unable to stimulate reserve vesicle pool or non-releasable pool release from 
neurohypophysial terminals (Seward et al. 1996).  The model proposed by Heap et 
al. 1975 and later extended by Krsulovic et al. 2005 suggested that in the neural lobe, 
the RRP vesicles are found in endings and RP vesicles are segregated in specialised 
swellings and Herring bodies where there is a lower chance for re-recruitment for 
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release.  Since dendrites do not contain the specialised compartmentalisation found 
in the neural lobe, it would be interesting to find out whether RP vesicles have 
distinct release mechanisms as found in chromaffin cells.  Meanwhile, LDCVs found 
in the Herring bodies represent aged vesicles which cannot be recruited for release 
(Krsulovic et al. 2005).  Aged LDCVs in the neural lobe are known to undergo 
continuous proteolysis (Nordmann & Labouesse 1981) and contain less hormones 
than newly synthesised vesicles either due to continual proteolysis or leakage 
through vesicular membrane (Nordmann & Morris 1984).  It is not known whether 
dendrites also contain a non-releasable pool of vesicles.  If aged vesicles with 
different peptide content can be recruited for release, will there be functional 
differences between release of newly synthesised and aged vesicles?  Nevertheless, 
presence of newly synthesised vesicles and lysosomes in dendrites ensures plasticity 
in response to change in demands for dendritic peptide release.   
 
 
7.2 New tools for studying dendritic peptide release 
Organotypic slice cultures are known for their advantages in the preservation of 
differentiated neurons where synaptic connections are maintained in the process of 
culture.  Moreover, they allow for pharmacological and gene transfer 
experimentations.  In the present study, live cell imaging of dendritic peptide release 
was successfully carried out using organotypic slice cultures of the hypothalamus of 
neonatal VP-eGFP rats.  Although vasopressin is known to be present in the 
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hypothalamus before birth (Sinding et al. 1980b), systemic activation of the SON in 
neonatal rats has not been shown.  The activation of the SON after systemic osmotic 
challenge found in this study proves the physiological significance in using neonatal 
rats for further studies.   
 
Several problems were encountered using brain slices for live cells imaging.  Firstly, 
instability and movements in both the microscope and the tissue are the major 
problems.  A 1
o
C change in temperature of the microscope set up could account for a 
1 µm movement in the lateral or axial direction (Kasparov et al. 2002).  Therefore, it 
was important to minimise these movements by the use of environmental chambers, 
heated microscope stage, heated solutions and by taking a stack of images in the Z 
direction to make sure that the whole cell is accounted for.  An environmental 
chamber had been used to keep the temperature on the microscope stage stable.  
Solution flow rate and change of solution can also affect displacement of the tissue.  
Hence, two outflow tubes had been attached to the perfusion chamber to ensure 
steady flow of solutions.  Aside from the inherent problems encountered from the 
microscope set up, scattering of light and difference in light absorbance throughout 
the thickness of the section affect the resulting image quality.  These affect 
organotypic slice cultures to a lesser extent since cultures are made from neonatal 
animals which are optically optimal; and slice explants flatten to a few cell layers.  
Nevertheless, to image whole neuronal cell bodies along with their dendritic 
projections may require imaging depths of tens of micrometers.  This depth of image 
is in itself a problem since fluorescence from the top of the image has less distance to 
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travel compared to fluorescence from within the tissue; i.e. fluorescent intensity is 
stronger at the top of the image.  This has to be taken into consideration when 
quantifying fluorescent intensity and hence, 10 optical slices (~1.67 µm in total) in 
the centre of the stack were selected for image analysis.  Lastly, photobleaching and 
phototoxicity are the most important factors of concern in live cell imaging.  The 
fluorescence used in the live cell imaging experiments is eGFP, which is a mutated 
(S65T) version of wild-type green fluorescent protein, GFP.  Photobleaching in 
eGFP had been reported to be relatively low (Swaminathan et al. 1997; Tsien 1998) 
making it suitable as a reporter protein in live cell imaging experiments.  Live cell 
imaging of VP-eGFP in organotypic slice cultures revealed significant loss of VP-
eGFP within dendrites after depolarisation by 50 mM K
+
 and further potentiated 
release by depolarisation after thapsigargin pre-treatment.  This is in accordance with 
findings in in vitro experiments where isolated SON was stimulated and release 
measured by radioimmunoassays (Ludwig et al. 2002; Ludwig et al. 2005).  The live 
cell imaging protocol established further confirmed the findings that thapsigargin 
was able to potentiate dendritic vasopressin release subsequent to high K
+
 
stimulation.  Since the amount of VP-eGFP loss found in the live cell imaging 
experiments was comparable to the percentage of vasopressin release found in in 
vitro experiments (please refer to Chapter 4), live cell imaging using organotypic 
slice explants proves to be a robust model to study dendritic peptide release. 
The experimental models established allow for targeted gene transfer to be carried 
out in conjunction with live cell imaging to study the segregation of vesicle pools in 
magnocellular dendrites.  Non-dividing cells, such as neurons, are known to be 
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difficult to transfect using standard transfection techniques.  The biolistic technique 
had been shown to be successful in transfecting magnocellular neurons (Thomas et 
al. 1998).  The present study also showed that biolistic transfection is an effective 
method to transfect magnocellular neurons.  Although the number of neurons 
transfected using this technique is relatively low, compared to the total number of 
cells transfected, it is possible to target gene expression to neurons by driving gene 
expression with neuronal specific promoters (Thomas et al. 1998), hence reducing 
the total number of transfected cells and allowing better identification of transfected 
neuronal cells.  However, the major problem encountered with biolistic transfection 
in this study is the light reflection caused by scattered gold particles used as “bullets” 
for transfection.  Since gold particles are scattered throughout the tissue, and the 
amount of reflected light varies (personal observation), it is difficult to judge the 
actual size of the particles.  This study focuses on the dynamics and segregation of 
vesicle pools in magnocellular dendrites and hence, gold particle reflection which 
resembles fluorescently labelled LDCVs, made this technique unsuitable for further 
optimisation and use for further studies. 
 
Therefore, to express exogenous fluorescent reporter proteins in LDCVs to study the 
release of different vesicle pools, the adenoviral transduction system was used.  The 
adenoviral system chosen was an inducible system whereby expression of exogenous 
reporter proteins can be switched on/off by addition of doxycycline.  To confirm that 
ppANF-tagged reporter proteins were expressed in LDCVs, N2a cells were 
transfected and then immunolabelled for chromogranin A expression.  Colocalisation 
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analysis showed that ppANF-tagged reporter proteins were expressed in LDCVs.    
The fluorescent time-stamp pTimer had also been tested for expression in LDCVs.  
However, the fluorescent Timer did not produce desirable expression when tagged to 
ppANF.  This had further been analysed by subcloning the non-ppANF tagged 
pTimer DNA into the inducible pTRE-shuttle vector for expression.  N2a cells 
transfected with pTRE-Timer expressed red and green fluorescence as expected.  
Since pTimer tagged to ppANF did not result in expression in LDCVs, two other 
fluorophores were chosen for expression: ppANF-eGFP and ppANF-tdTomato.  
Expression of these two constructs, subcloned into the inducible pTRE-shuttle vector 
when co-transfected with pTet-on, resulted in fluorescent expression in LDCVs.  
Studies on vesicle segregation using double transfected PC12 cells (pTRE-ppANF-
tdTomato and pTet-on) showed that pulse labelling experiments were able to label 
different vesicle pools after 24 hr, proving that pulse-labelling was efficient in 
identifying vesicle pools.  Although this study started out with using the pAdeno-X 
coupled to the tet-on system, the pAdeno-X DNA was found to be damaged (Figures 
6-16 and 6-17); hence, the viral system was replaced with the pLP-Adeno-X-TRE 
tet-off system.  Adenovirus-induced transduction coupled with the tTA had been 
previously shown in cultured hippocampal neurons (Harding et al. 1997; Ralph et al. 
2000) and since expression of exogenous proteins can be switched off simply by 
adding doxycycline to the culture medium, the LP-Adeno-X-TRE virus is an ideal 
candidate to be used for pulse chase labelling experiments in magnocellular 
dendrites.  Subcloning of ppANF-eGFP and ppANF-tdTomato into a donor vector, 
pDNR-CMV vector, ensured the correct insertion of ppANF-eGFP and ppANF-
tdTomato into the pLP-Adeno-X-TRE vector.  The use of ppANF-eGFP as a reporter 
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gene allows for pulse-chase labelling where magnocellular neurons can be identified 
by immunolabelling.  In addition, the use of ppANF-tdTomato as a reporter gene 
allows for pulse-chase labelling experiments to be carried out in conjunction with 
live cell imaging of magnocellular dendrites from VP-eGFP rats.  Furthermore, the 
inducible adenoviral constructs can be used in in vivo transduction of magnocellular 
neurons where expression of reporter proteins have been demonstrated by injection 
of adenoviral constructs directly into the SON or via retrograde uptake of the 
adenovirus by injection of the neural lobe (Vasquez et al. 1998; Vasquez et al. 2001).  
In vivo transduction allows pulse-chase labelling to be carried out in intact infected 
animals where visualisation of vesicle pool segregation in magnocellular dendrites 
can be carried out on perfusion fixed brain sections.  Live cell imaging of 
magnocellular dendrites can also be achieved by culturing sections of the 
hypothalamus of VP-eGFP rats infected with inducible ppANF-tdTomato.  The 
induction of viral constructs containing the TRE-coupled promoter in vivo has been 
achieved by simply adding doxycycline to drinking water (Lee et al. 2005).  Hence, 
the successful production of the pLP-Adeno-X-TRE-ppANF-tdTomato construct 
brought us one step closer to the visualisation of vesicle pool segregation in 
magnocellular dendrites. 
 
7.3 Future directions 
With the successful production of adenoviruses containing the pLP-Adeno-X-TRE-
ppANF-tdTomato construct, LDCVs in magnocellular neurons can be labelled.  
Preferential release by recruitment of specific pools, for example barium recruitment 
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of the reserve/non-releasable pool (Seward et al. 1996; Duncan et al. 2003) can also 
be studied to investigate the functional difference of vesicle pools.  In vivo injection 
of the inducible viral constructs can be combined with physiological assays or 
visualisation techniques to study release mechanisms of different vesicle pools.  
Infection of magnocellular vasopressin neurons prior to salt loading, whilst 
terminating reporter protein expression at different time points, will provide an 
understanding to the functional significance of different vesicle pools in 
magnocellular dendrites.    
 
On the molecular level, although there is evidence that SNARE-associated proteins 
are involved in dendritic peptide release in magnocellular neurons: synaptotagmin, 
SNAP-25 and syntaxin (Schwab et al. 2001), VAMP/synaptobrevin (de Kock et al. 
2003), and α-SNAP (Morris et al. 2000); immunolabelling revealed that VAMP2, the 
major VAMP isoform found in magnocellular nerve terminals (Jurgutis et al. 1996), 
was absent in magnocellular dendrites (Ludwig et al. 2006).  Hence, magnocellular 
dendrites use a different isoform of VAMP compared to axon terminals to regulate 
exocytosis.  In dopaminergic neurons, botulinum toxin B, which cleaves VAMP, 
inhibited exocytosis from dopaminergic nerve terminals but not from the somato-
dendritic compartment, leading to speculation that different VAMP isoforms can be 
present in terminals and in the soma/dendrites.  A possible VAMP isoform, VAMP4, 
has been found to be upregulated in the SON after a hypoosomolar challenge 
(Mutsuga et al. 2005), indicating that VAMP4 may have important functions in 
dendritic peptide release.  Identification of specific VAMP isoforms found in 
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magnocellular dendrites will allow specific targeting of dendritic peptide release via 
expression of dominant negative genes or siRNA.  Expression of a dominant 
negative form of VAMP had been shown in chromaffin cells to result in reduced 
exocytotic events (Sorensen et al. 2002).  Meanwhile, targeting of siRNA to 
magnocellular neurons has also been achieved in vivo (Jensen et al. 2008).  
Identification of other SNARE-associated proteins is also important in decoding the 
molecular mechanisms of dendritic peptide release.  Munc18, which binds syntaxin 
at its closed conformation to prevent SNARE complex formation (Nicholson et al. 
1998; Han et al. 2009; Rickman & Duncan 2010), and Ca
2+
-dependent activator 
protein (CAPS 1) which plays an important role in exocytosis downstream of vesicle 
docking (Fujita et al. 2007), have both been reported in magnocellular dendrites 
(Ludwig et al. 2006).    
 
Furthermore, membrane capacitance measurements showed evidence that 
endocytosis occurs in the somata/dendrites of magnocellular neurons (Soldo et al. 
2004; de Kock et al. 2003).  The endocytotic machinery in magnocellular 
soma/dendrites has not been investigated in detail.  The development of a fixable 
membrane dye, FM1-43FX (green) and FM4-64FX (red) (Invitrogen), provides a 
means to study endocytosis and vesicle recycling in magnocellular dendrites in slice 
preparation where the cytoarchitecture of dendrites is retained.  In hippocampal 
neurons, LDCV recycling and kiss-and-run exocytosis of peptide-vesicles had been 
demonstrated in soma and dendrites (Xia et al. 2009).  Kiss-and-run exocytosis has 
also been demonstrated in LDCVs in nerve terminals in posterior pituitary 
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preparations (Klyachko & Jackson 2002).  In pancreatic β cells, kiss-and run 
exocytosis of LDCVs was shown to release small molecules such as ATP that is co-
packaged with insulin (MacDonald et al. 2006).  It is not known whether vesicle 
recycling and kiss-and-run exocytosis occurs in magnocellular dendrites.  Uptake of 
the FM dye in dendrites will demonstrate endocytosis, whereas, subsequent 
stimulation protocol to look at release of the membrane dye will suggest whether 
magnocellular dendrites contain recycling vesicles.  In addition, neurons containing 
VP-eGFP can be employed to study kiss-and-run exocytosis in dendrites where 




Dendritic peptide release from magnocellular neurons serves as an important source 
of peptides in the brain.  Dendritic release of vasopressin and oxytocin has been 
shown to be important in autoregulation and paracrine control of neuronal activity.   
Peptides found in the CSF are believed to be released from dendrites and hence, 
dendritic peptide release has been implicated in the regulation of behaviour (Ludwig 
& Leng 2006).  The temporal and functional difference between dendritic and axon 
terminal peptide release in magnocellular neurons indicate differences in the 
mechanisms regulating release in these two compartments.  The finding that newly 
synthesised LDCVs translocate to dendrites suggests that dendritic peptide release 
can be up- or down-regulated independent of axon terminal release.  Moreover, 
dendrites also contain their own resources for degradation, indicating that dendrites 
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are self-sufficient compartments for the destruction of aged organelles.  The live cell 
imaging technique established will be invaluable in studying the regulation LDCV 
release in a system where homologous cell lines are unavailable.  Furthermore, 
inducible reporter proteins targeted to LDCVs are essential to label different vesicle 
pools.  In vivo or in vitro viral transduction with targeted proteins for expression in 
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aCSF-sucrose-KOH solution 
• 220 mM sucrose 
• 1.2 mM KCl, 10 mM HEPES 
• 10 mM glucose 
• 1.2 mM KH2PO4 
• 2 mM MgCl2 
• 2.5 mM CaCl2 
• pH to 7.4 with 1M KOH 
• Check osmolarity = 300 mOsm/L 
 
Agarose, 1% (w/v) 
• 50 ml TBE buffer (see below for recipe) 
• 0.5 g agarose 
• Microwave till agarose dissolves 
• Cool solution under cold water 
• Add 5 ul of Sybrsafe (Invitrogen) for DNA visualization under UV light 
 
Buffer N3 
• 5 M KOAc 
• Autoclave and store at 4oC 
 
Buffer P1 
• 25 mM Tris-HCl (pH 8.0) 
• 10 mM EDTA 
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• 50 mM glucose 
• Autoclave and store at 4oC 
 
Buffer P2 
• 0.2 M NaOH 
• 1% (v/v) SDS 
 
Buffer TE 
• 10 mM Tris-HCl (pH 8.0) 
• 1 mM EDTA 
 
Cell freezing media 
• DMEM (Gibco) 
• 10% (v/v) Foetal calf serum (Harlan) 
• 5% (v/v) DMSO (Sigma) 
 
Cryoprotectant solution 
• 20% (v/v) glycerol 
• 30% (v/v) ethylene glocol 
• 0.2 M PBS  
• Titrate to pH 5.5 
 
Gelatine solution for subbing slides 
• Heat up distilled H2O 
• 5 g/L gelatine 
• Let solution cool 
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• Add 0.5 g/L chromic potassium sulphate 
• Filter solution before use 
 
Hep-Saline solution (Heparinised saline) 
• 9 g/L NaCl 
• 0.129 g/L Heparin 
 
LB; Luria-Bertani, medium 
• 10 g tryptone  
• 5 g yeast extract  
• 5 g NaCl  
• 1 L water  
• pH 7.5 
• Autoclave 
 
LB Agar  
• 1 L of LB medium (pH 7.5)  




• 4.76 ml glycerol (density 1.26 g/L) 
• 2.4 g Mowiol 4-88 (Calbiochem) 
• 12 ml distilled water 
• 12 ml 0.2M Tris pH 8.5  
• Warm up to 50oC for 2 hours 
• Aliquot into 50 ml centrifuge tubes 
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• Centrifuge at 2000 rpm for 15 min, save supernatant 
• Add 0.72 g DABCO (1,4 diazabicyclo [2,2,2]-octane) 
• Aliquot into 10 ml in 15 ml conical tubes  
• Store at -20oC  
 
N2a culture medium 
• DMEM (with L-Glutamine, 4500 mg/L D-Glucose, 110 mg/L Sodium Pyruvate, 
Gibco) 
• 10% (v/v) Foetal cal serum (Harlan) 
• 1:50 Pen/Strep/Neo (Sigma)  
 
Nickel II sulphate solution for Fos immunohistochemistry 
• 100ml of 0.2M sodium acetate buffer 
• 5g nickel II sulphate  
• 0.8g glucose 
• 0.16g ammonium chloride 
• 50mg DAB is added to 98ml dH20 
• 0.006g glucose oxidase type VII-s (Sigma G7016) was added immediately prior 
to use 
 
4% (w/v) PFA in 0.1 M PB(S) 
• 4 % (w/v) Paraformaldehyde  
• 0.2 M PB or PBS 
• distilled H2O 
• Heat up distilled H2O 
• Add paraformaldehyde 
• Dissolve paraformaldehyde with 10 M NaOH 
• Add equal volume of 0.2 M PB(S) 
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• Titrate to pH 7.4 when cooled 
 
Phosphate buffer (PB) 0.1M 
• 11.5 g/L Na2HPO4 
• 2.964 g/L NaH2PO4.2H2O 
• Make up in distilled H2O 
• Titrate to pH 7.4 
 
Phosphate buffered saline (PBS) 0.1M 
• 11.5 g/L Na2HPO4 
• 2.964 g/L NaH2PO4.2H2O 
• 8.5 g/L NaCl 
• Make up in distilled H2O 
• Titrate to pH 7.4 
 
Serum-containing medium 
• 50% (v/v) Eagles basal medium (BME, Sigma-Aldrich, UK) 
• 25% (v/v) heat-inactivated horse serum (Harlan, UK) 
• 25% (v/v) Hanks balanced salt solution (Gibco) 
• 0.5% (w/v) glucose (Sigma-Aldrich, UK) 
• 2 mM glutamine (Sigma-Aldrich, UK) 
• 25 µg/ml penicillin/streptomycin (Sigma-Aldrich, UK) 
• 20 ng/ml ciliary neurotrophic factor (CNTF) (Sigma-Aldrich, UK) 
• The osmolarity of the medium was 320-325 mOsm/L 
 
SOC medium 
• 0.5% (w/v) yeast extract 
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• 2% (w/v) Tryptone 
• 10 mM NaCl 
• 2.5 mM KCl 
• 10 mM MgCl2 
• 10 mM MgSO4 
• 20 mM Glucose 
 
TBE buffer (1M Tris, 1M Boric Acid, 20mM EDTA) 
• 24.22 g Tris  
• 12.366 g boric acid  
• 1.489 g EDTA  
• Adjust pH to 8.3. QS to 2 liters. Autoclave. 
 
TFB1 
• 30 mM potassium acetate 
• 10 mM CaCl2 
• 50 mM MnCl2 
• 100 mM RbCl2 
• 15% (v/v) glycerol 
• Adjust pH to 5.8 with 1 M acetic acid 
• Filter sterilise with Millipore vacuum filter (0.22 um pore size) 
 
TFB2 
• 10 mM MOPs 
• 75 mM CaCl2 
• 10 mM RbCl2 
• 15% (v/v) glycerol 
• Adjust pH to 6.5 with 1 M KOH 
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• Filter sterilise with Millipore vacuum filter (0.22 um pore size) 
 
Tyrode solutions 
Control tyrode solution 
• 121 mM NaCl 
• 5 mM KCl 
• 1.2 mM NaH2PO4
.
2H2O 
• 2.4 mM CaCl2
.
2H2O 
• 1.3 mM MgCl2
.
6H2O 
• 10 mM D-glucose 
• 5 mM HEPES 
• 26 mM NaHCO3 
 
50mM KCl solution 
• 76 mM NaCl 
• 50 mM KCl 
• 1.2 mM NaH2PO4
.
2H2O 
• 2.4 mM CaCl2
.
2H2O 
• 1.3 mM MgCl2
.
6H2O 
• 10 mM D-glucose 
• 5 mM HEPES 
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Table 1.  Excitation and emission maxima of secondary antibodies used for indirect 




















 Excitation Maximum (nm) Emission Maximum (nm) 
Alexa Fluor 488 495 519 
Alexa Fluor 568 578 603 
Alexa Fluor 633 632 647 
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Figure 1. Fluorescence spectra of fluorophores used (Alexa Fluor 488, 568 and 633 
antibody conjugates and green fluorescent protein).  Spectra graphs generated with 
Fluorescence SpectraViewer, Invitrogen 
(http://www.invitrogen.com/site/us/en/home/support/Research-Tools/Fluorescence-
SpectraViewer.html). 
Alexa Fluor 488 
antibody conjugate
Alexa Fluor 633 
antibody conjugate
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Abstract 
The magnocellular neurones of the supraoptic nucleus (SON) and paraventricular 
nucleus (PVN) are capable of neuropeptide release from their axon terminals and 
dendrites.  In magnocellular axon terminals, swellings known as Herring bodies are 
responsible for the degradation of aged, unreleased peptide vesicles.  Peptide vesicles 
that have entered Herring bodies cannot be re-recruited for release and degradation in 
Herring bodies is carried out by the large amounts of lysosomes found in them.  
Interestingly, Herring bodies were found to be extremely dynamic and plastic 
structures which increase in number during dehydration and decreases during 
rehydration.  Dendrites of the magnocellular neurones contain a large proportion of 
the neuronal peptide content.  Swellings similar to Herring bodies found in axon 
terminals have not been reported in dendrites.  In the present study, 
immunofluorescent labelling of lysosomes in dendrites expressing vasopressin (VP) 
endogenously tagged to eGFP (VP-eGFP) showed that there are “hot spots” for 
degradation in magnocellular dendrites.  Lysosomes were found to be preferentially 
located where there was a high density of VP-eGFP expression.  Further analysis 
found that lysosomes were mostly found in the centre of dendrites.  Previous studies 
in endocrine cell lines reported that aged, unreleased vesicles reside in the centre of 
cells.  The central localisation of lysosomes in dendrites indicates a role for 
degradation of aged, unreleased vesicles in dendrites. 
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Introduction 
The magnocellular neurones of the SON and PVN have been widely used as a 
model system to study neuroendocrine peptide release due to the fact that these 
neurones exclusively release large amounts of two peptide hormones VP and 
oxytocin (OT).  VP and OT are released into the circulation via the pituitary gland in 
the neural lobe where VP and OT exert their peripheral functions.  Magnocellular 
neurones also release peptides from their dendrites and this release is different to that 
from the pituitary in that peptides largely remain in the CSF and act on the brain.  
However, the major difference found between peptide release from axon terminals in 
the pituitary and peptide release from dendrites in the brain is that release from axon 
terminals and dendrites can be differentially stimulated and occurs via different 
mechanisms (1,2).  This led to the acknowledgement that axon terminals and 
dendrites of the magnocellular neurones are different compartments where release of 
neuroactive substances can be differentially regulated.  To better understand the 
mechanisms governing the difference in peptide release between axon terminals and 
dendrites of magnocellular neurones, it is essential to investigate differences in 
peptide handling between these two compartments.  
The neurosecretory axons in the neural lobe is made up of different 
compartments consisting of undilated segments, endings and swellings (3).  Peptide 
vesicles were proposed to arrive at the endings through the undilated segments, and 
become stored in the swellings if they were not released (3,4).  A specialised 
compartment, known as the Herring body, was found to be filled with lysosomes (5) 
and was found to be the site of degradation for aged, non-released peptide vesicles 
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(4).  Neurosecretory vesicles that have entered the Herring body cannot be re-
recruited for release, suggesting that Herring bodies are specialised compartments for 
degradation of cellular organelles.  A dehydration regime showed large amounts of 
peptide vesicles residing in Herring bodies and a dehydration-rehydration protocol 
showed reduced amounts of Herring bodies associated with axon terminals indicating 
that Herring bodies are also dynamic and plastic.  In comparison, dendrites are 
morphologically different to axon terminals and no specialised bodies had been 
reported in association with dendrites (6).   
A large amount of peptides is stored within the dendritic compartment.  In the 
case of VP, 95% of the VP content in VP-ergic neurones is contained within the 
dendrites (7,8), indicating that dendrites are important compartments for peptide 
storage and release.  High potassium depolarisation applied to the SON, which 
exclusively contains cell bodies and dendrites, for 10 -15 min released ~2.5% of 
oxytocin vesicles (1), and 30 min microdialysis in the SON of suckling rats released 
~10% of oxytocin vesicles from the somato-dendritic compartment (9,10).  Hence, a 
large amount of peptide vesicles in dendrites are not released.  Non-released vesicles 
age and will eventually be degraded. In hippocampal neurones, degradation was 
found to occur only in cell bodies.  Endocytosis had been shown to occur throughout 
the length of hippocampal dendrites but evidence of lysosomes were only found in 
cell bodies (11).  In contrast, evidence of lysosome staining had been seen in 
magnocellular dendrites (6).  There is also evidence of both endocytosis (12) and 
autophagy (13) in magnocellular dendrites, indicating that magnocellular dendrites 
are actively involved in membrane recycling and the disposal of aged/damaged 
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organelles.  Moreover, since magnocellular dendrites act as a major storage 
compartment of peptide vesicles, they may also be important sites for degradation. 
Since special swellings/bodies for degradation were not found in 
magnocellular dendrites, the organisation of degradation sites in the dendritic 
compartment is not known.  Recently, a transgenic rat line was established where 
endogenous VP was tagged with eGFP fluorescent protein (VP-eGFP) (14) which 
enables visualisation of endogenous VP without prior staining.  Staining of 
lysosomes in brain sections containing VP-eGFP hence enabled correlation analysis 
of lysosomal localisations with endogenous VP.  The aims of this study were to 
investigate the physiological significance of lysosomes in magnocellular dendrites 
and the organisation of these degradation sites in magnocellular dendrites.   
 
Materials and Methods 
Indirect Immunofluorescence Labelling for Free-floating Sections 
Four adult male transgenic VP-eGFP rats (200 – 300 g), were anaesthetised with 
sodium pentobarbitone and transcardially perfused with heparin-containing saline 
and then 4% paraformaldehyde.   Rats were then decapitated and their brains 
removed and stored in post-fix solutions (15% sucrose w/v in 4% 
paraformaldehyde).  Sections were stored in cryoprotective solution (30% sucrose 
w/v in 0.1 M PB).  Immunofluorescence labelling was performed on cryostat cut 52 
µm sections containing the SON.  Briefly, sections were washed three times for 10 
min in 0.1 M PBS on an orbital rotation and then incubated in 50 mM NH4Cl for 10 
min.  Sections were washed again three times in 0.1 M PBS.  Non-specific antibody 
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binding was prevented by incubating brain sections in a blocking solution which 
contains 0.1 M PBS, 0.3% (v/v) Triton X100, and 10% (v/v) pre-immune goat serum 
for 30 min at room temperature.  The primary antibody used to label lysosomes is the 
mouse monoclonal IgG raised against lysosomal associated membrane protein 1 
(LAMP-1, LY1C6, Santa Cruz Biotechnology, Inc.).  Primary anti-LAMP1 antibody 
was added to the blocking solution at 1:50 dilution (4 µg/ml) and sections were 
incubated in the primary antibody cocktail at 4
o
C overnight.  Negative controls were 
carried out by replacing primary antibody incubation with pre-immune serum 
incubation.  The next day, the primary antibody was washed off three times in 0.1 M 
PBS for 10 min before incubation in secondary antibody solution containing 
AlexaFluor 568 (1:500 dilution, Invitrogen) made up in blocking solution at 4
o
C 
overnight.  Sections were washed three times 10 min and mounted onto gelatinised 
slides, air dried and embedded with mowiol (Calbiochem) mounting medium and 
coverslipped.  The mounting medium was left to cure overnight protected from light 
and sections were imaged once the medium was dry. 
 
Microscopic Image Acquisition 
The Zeiss LSM510 inverted microscope was used for all imaging.  The 488 nm line 
of the Argon laser was used to excite eGFP that has an excitation maximum of 488 
nm and an emission maximum of 509 nm.   A dichroic beam splitter, HFT 488, was 
in place and the excitation laser passed through two mirrors before the emitted light 
was collected by a band pass 500 – 550 filter.  The helium-neon 1 (HeNe1) laser line 
(excitation wavelength 543 nm) was used to excite the AlexaFluor 568 staining 
  Appendix II – Hot spots for degradation in dendrites of magnocellular neurones 
xvii 
(excitation maximum 578 nm, emission maximum 603 nm).  The photomultiplier 
tube (PMT) settings and laser powers were kept exactly the same for all samples.  
Images were acquired by sequential scanning to avoid bleed through of emitted light 
from either channel.  An x63 oil immersion objective (NA1.4) was used.  Images 
were acquired close to double Nyquist sampling rate to avoid under sampling 
(Nyquist calculator available at www.svi.nl).    3-dimensional images were obtained 
by scanning the x, y –planes at 60 nm, achieved by line scanning 1024 x 1024 pixels 
with an optical zoom of 2.4, and intervals of 170 nm along the z-axis.  8 bit pixel 
depth, line averaging of 1 (no averaging) and maximum scan speed were chosen for 
image acquisition to avoid photobleaching. 
 
Image Processing  
The acquired stack of images was deconvolved to remove aberrations caused by the 
intrinsic physical properties of the microscope.  Deconvolution of images was 
achieved by use of the Huygens Essential software (Scientific Volume Imaging, NL, 
www.svi.nl) available in the IMPACT imaging facility in our centre.  The Huygens 
deconvolution software restores convolution in images taken by removing blurring 
caused by diffraction of light and noise introduced by the microscope photomultiplier 
tube.  Image restoration is based on the iterative application of a maximum 
likelihood estimate algorithm where the point spread function – the smallest 
fluorescent single point object that can be resolved in 3 dimensions by the 
microscopic parameters used, is used to calculate and reassign out-of focus light 
signals to the point of origin (15).   
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The microscopic parameters used for deconvolution was set according to the 
parameters used for imaging: microscope type – confocal; numerical aperture – 1.4; 
lens immersion and medium refractive indices – 1.51 and 1.4; x and y sample sizes – 
60 nm; z sample size – 170 nm; excitation wavelengths – 488 nm, 543 nm; emission 
wavelength – 509 nm, 603 nm; excitation photon count – 1; pinhole = 1 Airy unit.  
These parameters help the deconvolution software to calculate a theoretical point 
spread function used.  A signal to noise ratio is used in the software to control the 
sharpness of the restoration result of the image and can be calculated as the square 
root of the brightest intensity in the image divided by the average intensity of a single 
photon hit caused by photon noise.  Generally, the lowest signal to noise ratio, 3, was 
employed, assuming a very noisy image, so that no background noise would be 
enhanced by deconvolution.  Because of the calculations involved in deconvolution, 
8 bit unsigned images were converted to 32 bit float images. 
 
Image Analysis 
Dendrites were imaged according to the protocol described above.  Images were 
selected where long profiles of dendrites with no overlapping could be seen clearly.  
Lysosomes were located by going through optical sections in the z direction to 
ensure that stained lysosomes analysed were not from presynaptic terminals but 
occurred within the dendrites.  Images were separated into the green (eGFP signal) 
and red (LAMP-1 staining) channels using ImageJ (http://rsb.info.nih.gov/ij/).  
Correlation analysis, but not colocalisation analysis, was carried out because lytic 
activity in the lysosome could change eGFP excitation and/or emission or simply 
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deform the eGFP fluorophore.  Emission of green fluorescent protein is also highly 
pH sensitive (16).  Hence, the low pH, pH 4.5, found in lysosomes will greatly 
reduce the fluorescent intensity of eGFP.   Moreover, correlation analysis will give 
an idea of whether lysosomes are located where there is a high density of vasopressin 
eGFP vesicles.  After all the areas of interest were obtained, the red channel was 
switched off and the original 32-bit image of the green channel was used for a 
“SUM” projection of the image where pixel intensities were summed up in each 
column of pixels in the z-stack using ImageJ to take into account the whole dendrite 
in 3 dimension.  The saved areas of interest were then superimposed onto the green 
channel Please refer to Figure 1 for a diagrammatic representation of the image 
analysis and an example of areas of interest drawn on a representative dendrite.  
To find out whether lysosomes are located in the centre of dendrites, the 
width of dendrites where lysosomes were situated was measured.  The midpoint of 
the dendrite was calculated and the locations of lysosomes were expressed as % 
displacement from midpoint. 
 
Statistics 
To compare whether lysosomal locations are preferentially situated where 
there is a high density of vasopressin-containing vesicles, the difference between the 
mean spots VP-eGFP fluorescent intensity and the whole dendrite VP-eGFP 
fluorescent intensity was obtained and compared using the Chi-square test (Sigma 
Stat) (all measurements are relative to whole dendrite VP-eGFP intensity).   
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The % displacement from midpoint was calculated for each lysosome 
measured.  Bins of 5% displacements were obtained to analyse where lysosomes 
were preferentially located throughout the width of dendrites. 
 
Results 
Correlation of lysosomal localisations with VP-eGFP intensity in 
magnocellular dendrites 
To compare whether lysosomal locations are preferentially situated where there is a 
high density of VP-containing vesicles, lysosomes were stained with the LAMP1 
antibody as described above.  LAMP1 is the lysosome associated membrane protein 
1 and a specific marker for lysosomes.  The signal intensity of eGFP endogenously 
tagged to VP was used as a measurement of VP vesicle density.  An area of 1 µm in 
diameter was drawn around each stained lysosomes.  Mean VP-eGFP intensity 
measurements (density/area) were calculated for each area (spot intensity).  Areas of 
interest were also made for whole dendrites and mean VP-eGFP intensity 
measurements recorded.  The difference between the mean spots VP-eGFP 
fluorescent intensity and the whole dendrite VP-eGFP fluorescent intensity was 
obtained and compared using the Chi-square test where positive intensity = location 
of lysosome correlated to high VP-eGFP density, zero = no difference and negative 
intensity = location of lysosome correlated to low VP-eGFP density (all 
measurements are relative to whole dendrite VP-eGFP intensity).  Figure 2 shows the 
Chi-square plot (mean spot intensity – mean whole dendrite intensity for each 
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dendrite measured).  Chi-square test showed that the spot intensities were 
significantly different from zero (p<0.001) suggesting a positive correlation of 
lysosome locations and areas with high VP vesicle density.  This indicates that 
lysosomes are either targeted to areas of high concentration of VP vesicles to be 
degraded.  Another possibility is that aged/spent vesicles aggregate preferentially 
around lysosomes.  However, this study cannot conclude which of these mechanisms 
was taking place. 
 
Localisation of lysosomes in magnocellular dendrites 
Staining of lysosomes showed that lysosomes are mostly localised in the centre of 
dendrites.  Figure 3 shows optical sections of representative lysosome staining in VP-
eGFP-expressing dendrites.  Figure 3A and B show that lysosomes are located in the 
centre of dendrites.  However, lysosomes are not exclusively localised in the centre, 
as depicted in Figure 3C.  % displacement from the midpoint of dendrites was 
calculated for each lysosome measured and these measurements were grouped into 
bins of 5% (Figure 3D).  The positive skewness of this graph represents that most 
lysosomes were located near the centre of dendrites.  Moreover, normality test 
showed that lysosomes were not normally distributed throughout the dendrite 
(p<0.001).  The preferential localisation of lysosomes in the centre of dendrites also 
agree with a previous study showing that aged, non-released dense core vesicles are 
preferentially located at the centre of the cell (17), indicating that degradation of 
spent vesicles occur in the centre of the dendrites.  Meanwhile, clustering of 
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lysosomes in one specific segment of the dendrite was not seen (Figure 3A-C), 
indicating that dendrites do not contain specialised compartments for degradation. 
 
Discussion 
The Herring bodies in magnocellular terminals are filled with lysosomes and 
are the final destination for aged vesicles (4) providing a local capacity for 
degradation where aged vesicles do not need to be transported back to the cell body.   
It was not known whether dendrites, like neuhypophyseal terminals contain 
specialised compartments for degradation.  Magnocellular dendrites have been 
shown to contain lysosomes (6), however, their functional significance in dendrites 
was not known.  In hippocampal neurones, lysosomes were found only in cell bodies 
and very proximal segments of dendrites, and endocytosed materials were found to 
be retrogradely transported to cell bodies, where lysosomes were found (11).  This 
study indicated that local degradation occurs in the dendritic compartment of 
magnocellular neurones.  Since magnocellular dendrites contain a large reserve of 
vesicles, it is possible that “centres” for degradation occur in the dendritic 
compartment.  In the present study, it was found that instead of clustering of 
lysosomes found in one special part of the dendrite, lysosomes were found to be 
located at areas where there was high density of vasopressin vesicles.  These hot 
spots for degradation were found throughout the dendrites.  Since magnocellular 
dendrites were not found to contain accumulations of lysosome clusters, it is unlikely 
that dendrites are the destination of all aged and non-released vesicles.  However, 
lysosomes were found where vasopressin-eGFP vesicles cluster suggesting that non-
  Appendix II – Hot spots for degradation in dendrites of magnocellular neurones 
xxiii 
released vesicles gather as a pool around these lysosomes or lysosomes were 
preferentially transported to these non-released pools of vesicles.  Dendritic 
lysosomal content is known to be variable where the number of lysosomes increases 
during high cellular activity, e.g. dehydration, and decreases during low activity, e.g. 
rehydration  (6).  Similarly, in axon terminals, lysosomes-containing Herring bodies 
were found to be abolished during rehydration (4) suggesting that Herring bodies are 
plastic structures that disappeared when old vesicles were spent and newly 
synthesised vesicles do not enter the lysosomal pathway.  Hence, it is likely that 
lysosomes are targeted to loci where there is a high demand for degradation; i.e. 
where pools of non-released secretory vesicles reside.  In the magnocellular neuronal 
terminal, the smooth endoplasmic reticulum (SER) was found to contribute to the 
formation of lysosomes (18).  Elements of the rough endoplasmic reticulum (RER) 
had been shown in magnocellular dendrites (19), however, elements of the SER had 
not been studied.  Hence, there could be two ways in which lysosomes are targeted to 
dendrites: 1) translocation from the soma to sites of aged, non-released vesicle pools 
in dendrites; and/or 2) local synthesis of lysosomes in dendrites.  However, the 
capability of dendrites to synthesise lysosomes require further studies.  Nevertheless, 
there is evidence of transport of lysosomes between the soma and dendrites of 
magnocellular neurones (20,21). 
 In many different cell types, lysosomal degradation is a plastic process which 
increases in activity according to the demand of the cell.  Early studies in rat anterior 
pituitary cells showed that lysosomes have important functions in the regulation of 
prolactin secretion (22).  When suckling pups were separated from lactating mothers, 
production of prolactin continued until there was an increase in the number of 
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lysosomes and lysosomal enzyme activity.  In secretion deficient β-pancreatic islet 
cells, increased autophagic activity was shown to control hormone content in the 
cells under stimulation for insulin production (23).  Crinophagy and autophagy both 
occur in this cell type.  Crinophagy is the process where β-granules fuse with a pre-
existing lysosome-related body, and autophagy is where β-granules form 
autophagosomes, a pre-lysosomal body, which subsequently forms the lysosome 
either through maturation and acquisition of lysosomal proteins or by fusion to pre-
existing mature lysosomes (24).  There is no evidence of crinophagy in 
magnocellular neurones.  Intracellular degradation is believed to be via autophagy 
and aged/spent organelles, including unreleased peptides, form autophagosomes 
before being degraded by mature lysosomes (13). Previous studies where truncated 
VP peptides were expressed showed an increase in the number of lysosomes in 
magnocellular neurones (13) and this increase in lysosomal activity was found to be 
important in the survival of these neurones (25), indicating that autophagy has a role 
in regulating the content of peptides in magnocellular neurones as well as having 
pro-survival effects. The results from the present study suggest that autophagy is an 
important mechanism for regulation of intracellular peptide content in magnocellular 
dendrites where evidence of lysosomes were found to be preferentially situated at 
areas of high VP-vesicle density.  It should be noted that not every lysosome stained 
was correlated to high VP-eGFP density.  The magnocellular VP neurone produces 
and releases other neuroactive substances in addition to VP (26-29).  Hence, 
lysosomes can also be situated where there is a segregation of other neuropeptides 
than VP in the dendrite. 
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In the present study, it was also found that lysosomes are located in the centre 
of dendrites (Figure 3).  In bovine adrenal chromaffin cells (17,30) and PC12 (31) 
cells newly synthesised vesicles are preferentially targeted to the cell membrane and 
aged vesicles reside in the centre of the cell.  Since aged vesicles were shown to be 
associated with lysosomal degradation (4), this suggests that aged, non-released 
vesicles reside in the centre of dendrites allowing newly synthesised vesicles to be 
primed close to the plasma membrane in accordance with the findings in bovine 
adrenal chromaffin cells.  However, as discussed so far, whether aged, non-released 
vesicles actively aggregate to lysosomal localisations, or whether lysosomes are 
targeted to areas of high density of aged organelles is unknown.  Figure 3C and D 
shows that lysosomes are not exclusively located at the centre of the dendrite, 
indicating lysosomes have other roles in addition to degradation of aged, unreleased 
peptide vesicles.  A dehydration protocol, using different time periods of 
dehydration, can be employed to increase exocytosis and hence, membrane retrieval 
from endocytosis.  Labelling endocytosed membranes or membrane cargoes with 
extracellular markers will enable localisation of endocytosed materials.  Hence, it 
will be possible to identify whether more lysosomes and endosomes were targeted to 
dendrites after prolonged dehydration and whether these lysosomes are colocalised 
with endocytosed markers, indicating that lysosomes may be targeted to areas of high 
density of organelles to be degraded or recycled. 
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Figure 1. Measurement of VP-eGFP intensity relative to locations of LAMP1 
immunofluorescence. (A) Schematic diagram of VP-eGFP intensity measurement. 
Red circles in the top panel = LAMP1 labelling of lysosomes; green circles in bottom 
panel = VP-eGFP. Masks of 1 µm diameter (bold circles) were drawn on images with 
the green VP-eGFP channel switched off to identify locations of LAMP1 labelling. 
These masks were then imported onto the green channel of the same image and the 
intensity of VP-eGFP at these locations was measured as spots (mean intensity/area). 
The whole dendrite in 3-dimension was taken into account by taking a sum of the 
image stack. The intensity of the whole dendrite was then measured for comparison 
(B) Determination of areas of interest as discussed above; one optical section is 
shown. (C) 3-D image stack converted to 2-D by the sum slices function in ImageJ 
where the sum of the pixels from the stack of images were displayed from 32-bit 
optical slices. Areas of interest described in (A) were then imported onto this image 
to measure VP-eGFP intensiy. (D) VP-eGFP intensity of the whole dendrite was then 
obtained by measuring sum slices image of the whole dendrite. Scale bar = 3 µm. 
 
Figure 2.  Correlation of LAMP1 labelling with VP-eGFP intensity in the dendrite.  
Full circles represent mean spot intensity – mean dendrite intensity for dendrites 
measured.  Filled box represent the mean of all the data points (error bar = ±SEM).  
Chi-squared test showed that there is a significant difference between the mean 
intensity of spots and the mean intensity of whole dendrites (p<0.001; n = 26).  This 
suggests that lysosomes were predominantly located in areas with high density of 
vasopressin vesicles.  
 
Figure 3.  A-C) LAMP1 immunofluorescence labelling (red) in VP-eGFP dendrite.  
Scale bar = 5 µm.  D) Localisations of lysosomes in dendrites measured as % 
displacement.  391 lysosomes were measured in 18 dendrites.  A and B) 
Representative images of lysosome localisation in the centre of dendrites (arrows).  
C) Lysosomes are not exclusively located in the centre of dendrites.  D) % 
displacement of lysosome localisations from the midpoint of dendrites grouped in 
5% bins.  Normality test showed that lysosomes are not normally distributed 
throughout the width of dendrites (p<0.001).  The positive skew indicates that 
lysosomes are preferentially located near the midpoint of dendrites.   








  Appendix II – Hot spots for degradation in dendrites of magnocellular neurones 
xxxii 
 
Figure 3 
 
 
